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ABSTRACT
The pu lm ona ry  d y n a m ic s ,  p h a r m a c o k i n e t i c s  and r e c e p t o r  b i n d i n g  o f  
3 -m e thy l  i n d o l e  (3MI) we re  d e t e r m in e d  in  E q u id ae .
Changes i n  pu lm onary  dynamics  f o r  t h e  10 and 20 mg/kg body w e ig h t  
d o s a g e s  o f  3MI f rom 0 t o  48 h o u r s  a f t e r  d o s i n g  were d e t e r m in e d  by 
whole  body p l e t h y s m o g r a p h y .  P a r a m e t e r s  f o r  r e s p i r a t o r y  r a t e ,  m i n u te  
vo lume,  t h o r a c i c  gas  vo lume,  e x p i r a t o r y / i n s p i r a t o r y  t i m e  r a t i o ,  
t h o r a c i c  gas  vo lume,  i n s p i r a t o r y  and e x p i r a t o r y  f l o w ,  and e x p i r a t o r y  
a i r w a y  r e s i s t a n c e  were n o t  s i g n i f i c a n t l y  d i f f e r e n t  from t h e  t i m e  0 
c o n t r o l  r e a d i n g .  Poo led means o f  t i d a l  volume i n c r e a s e d  s i g n i f i c a n t l y  
(PC0.05)  a t  6 , 8 and 10 h o u r s  a f t e r  d o s i n g .  S i g n i f i c a n t  i n c r e a s e s  
(P < 0 .0 5 )  i n  i n s p i r a t o r y  a i r w a y  r e s i s t a n c e  were o b s e r v e d  a t  t h e  6 , 10,  
24 and 48 ho u r  r e a d i n g s .  These  changes  were b e g i n n i n g  t o  r e v e r s e  
w i t h i n  48 h o u r s  a f t e r  d o s i n g .
The p h a r m a c o k i n e t i c s  p l a s m a - c o n c e n t r a t i o n  p r o f i l e s  f o r  3MI (10 
and 20  mg/kg) i n  h o r s e s  were  b e s t  r e p r e s e n t e d  by a tw o-c ompar t m en t  
open model w i th  f i r s t  o r d e r  a b s o r p t i o n  as d e t e r m in e d  by n o n - l i n e a r  
l e a s t  s q u a r e s  r e g r e s s i o n  a n a l y s i s .  A b s o r p t i o n  o f  3MI a t  bo th  d o s a g e s  
was r a p i d .  D e t e r m i n a t i o n s  o f  t h e  p o s t - d i s t r i b u t i o n  h a l f  l i f e ,  t o t a l  
c l e a r a n c e ,  and a r e a - u n d e r - c u r v e  o f  t h e  p l a s m a - c o n c e n t r a t i o n  p r o f i l e  
s u g g e s t e d  t h e  p r e s e n c e  o f  n o n - l i n e a r  o r  d o s e - d e p e n d e n t  k i n e t i c s  f o r  
3MI in  h o r s e s .
A n a l y s i s  o f  t h e  s t r u c t u r e  a c t i v i t y  r e l a t i o n s h i p s  o f  3MI and some 
o f  i t s  known m e t a b o l i t e s  s u g g e s t  t h a t  t h e s e  compounds may b ind  
m u s c a r i n i c  r e c e p t o r s  in  t h e  l u n g .
• xv
[ 3 h]-QNB ( q u i n u d i d i n y l  benzyl  a t e )  b i n d s  t o  membranes o f  r a t  
l u n g ,  pony lu ng  and r a t  b r a i n  i n  a manner  i n d i c a t i n g  s e l e c t i v e  
i n t e r a c t i o n  w i th  a m u s c a r i n i c  r e c e p t o r .  P h a r m a c o l o g ic a l  p o t e n c i e s  o f  
v a r i o u s  m u s c a r i n i c  a n t a g o n i s t s  and a g o n i s t s  as  d e t e r m in e d  by d ru g 
i n h i b i t i o n  c u r v e s  in  t h e  p r e s e n c e  o f  lOOuM [ ^H]-QNB re s em b le d  t h o s e  
o b s e r v e d  f o r  o t h e r  t i s s u e s .  3MI and i t s  m e t a b o l i t e  o r t h o - a m i n o -  
a c e t o p h e n o n e  (OAAP) were  o b s e r v e d  t o  have low p o t e n c y  f o r  b i n d i n g  t o  
m u s c a r i n i c  r e c e p t o r s .  From t h e s e  d a t a ,  i t  a p p e a r s  t h a t  3MI and OAAP 
may i n t e r a c t  a t  e i t h e r  a p e r i p h e r a l  s i t e  on t h e  r e c e p t o r  m acrom ole cu le  
o r  a f f e c t  membrane a s s o c i a t e d  components  o f  t h e  r e c e p t o r  s i t e .  These 
i n t e r a c t i o n s  may be t h e  c a u s e  o f  t h e  i n c r e a s e d  l e v e l  o f  b ronchomoto r  
t o n e  and r e s u l t i n g  i n c r e a s e d  a i r w a y  r e s i s t a n c e  o b s e r v e d  in  h o r s e s  
a f t e r  a d m i n i s t r a t i o n  o f  3MI.
Chapter I
INTRODUCTION TO CHRONIC OBSTRUCTIVE 
PULMONARY DISEASE OR HEAVES IN HORSES
INTRODUCTION
D e f i n i t i o n
The t e r m s  he aves  and broken wind a r e  l a y  t e rm s  which d e s c r i b e  a 
complex s e r i e s  o f  c l i n i c a l  s i g n s  a s s o c i a t e d  w i th  c h r o n i c  pulmonary  
d i s e a s e  in  h o r s e s .  Heaves  i s  a c t u a l l y  a d e s c r i p t i v e  t e rm  f o r  t h e  doub le  
e x p i r a t o r y  e f f o r t  s ee n  in  t h e s e  h o r s e s .  Horses  w i th  he aves  a r e  commonly 
p r e s e n t e d  w i th  c h r o n i c  co u g h ,  d y s p n e a ,  a d o u b le  e x p i r a t o r y  e f f o r t ,  
wh eez ing  and c r e p i t a n t  r e s p i r a t o r y  s o u n d s .  Horse s  5 y e a r s  and o l d e r  
have  a h i g h e r  i n c i d e n c e  o f  r e s p i r a t o r y  p ro blem s  o f  t h i s  d e s c r i p t i o n ;  
how e ver ,  t h e  c l i n i c a l  s i g n s  o f  h ea v es  have been see n in  6 month o ld  
f o a l s . 1 * 2 ,3  No p r e f e r e n c e  f o r  deve lo pm en t  o f  he aves  i s  c o n s i s t e n t l y  
o b s e r v e d  as  t o  g e o g r a p h i c a l  d i s t r i b u t i o n ,  s e x ,  b r e e d  and t h e  
s e a s o n . ^>3 However,  summer p a s t u r e  a s s o c i a t e d  c h r o n i c  o b s t r u c t i v e  
pulmona ry  d i s e a s e  i s  l i m i t e d  t o  t h e  S o u t h e a s t e r n  Un i ted  S t a t e s  in  t h e  
summer m on ths .
The c l i n i c a l  s i g n s  o f  heaves  a r e  b e t t e r  d e s c r i b e d  as a c h r o n i c  
o b s t r u c t i v e  pu lmonary  d i s e a s e  o r  COPD. In h o r s e s ,  t h e  t e rm  COPD r e f e r s  
t o  a g ro up  o f  c o n d i t i o n s  which a r e  p o t e n t i a l l y  c a p a b l e  o f  d i s r u p t i n g  
normal  gas  exc h an g e  in  t h e  l u n g .  These c o n d i t i o n s  i n c l u d e  as thm a ,  
b r o n c h i t i s ,  b r o n c h i o l i t i s  and emphysema.2*3 By c o r r e c t  d e f i n i t i o n ,
COPD r e f e r s  t o  c o n d i t i o n s  c h a r a c t e r i z e d  by i n c r e a s e d  r e s i s t a n c e  t o  
a i r f l o w  due t o  o b s t r u c t i o n  o f  t h e  a i r w a y s .  C l a s s i c a l l y ,  COPD in  t h e
2
human l i t e r a t u r e  i s  d e f i n e d  by f o u r  c o n d i t i o n s ,  t h e y  a r e  ( 1 ) a s th m a ,  ( 2 ) 
c h r o n i c  b r o n c h i t i s ,  (3)  b r o n c h i o l i t i s  and (4) emphysema.5 . 6  
T h e r e f o r e ,  t h e  c o n t e n t s  o f  t h i s  i n t r o d u c t i o n  w i l l  r e f e r  t o  COPD w i t h  
r e s p e c t  t o  t h e  f o u r  c o n d i t i o n s  d e s c r i b e d  f o r  humans as t h e y  a r e  i n v o l v e d  
i n  p r o d u c t i o n  o f  e q u i n e  COPD.
H i s t o r y
The e q u i n e  COPD complex has  long been r e c o g n i z e d .  The c l i n i c a l  
s i g n s  o f  h ea v e s  were o b s e r v e d  by A r i s t o t l e  i n  33 BC who d e s c r i b e d  t h e  
d o u b l e  e x p i r a t o r y  e f f o r t  as  a d ra wing o f  t h e  f l a n k . 7 , 8 , 9
FI o y e r ' s  T r e a t i s e  on Asthma (1698) d e s c r i b e d  t h e  emphysematous 
l u n g s  o f  a h o r s e  as  r u p t u r e d  and d i l a t e d  " f l a t u l e n t  tumors"  o f  t h e  a i r  
b l a d d e r . 10 Thi s  f i n d i n g  r e p r e s e n t e d  t h e  v iew t h a t  heaves  was 
p r o b a b l y  t h e  r e s u l t  o f  a pu lm on ary  emphysema, c h a r a c t e r i z e d  by s e v e r e  
s t r u c t u r a l  damage t o  t h e  l u n g .  The h y p o t h e s i s  t h a t  heaves  was s o l e l y  
t h e  r e s u l t  o f  a s t r u c t u r a l  emphysema p r e v a i l e d  f o r  150 p l u s  y e a r s  u n t i l  
D e la fo nd  (1853)  c o n c lu d e d  t h a t  some c a s e s  o f  h eav es  were no t  
c h a r a c t e r i z e d  by l e s i o n s  c o n s i s t e n t  w i th  pu lmonary  emphysema.H 
T h u r lb e c k  in  1964 s t a t e d  t h a t  " w id e s p r e a d  d e s t r u c t i v e  emphysema was n o t  
a f e a t u r e  o f  h o r s e s  w i th  h e a v e s " ,  b u t  t h a t  t h e  m a jo r  l e s i o n  o f  t h i s  
c o n d i t i o n  was b r o n c h i o l i t i s . ^  i t  i s  a p p a r e n t  from t h e s e  r e p o r t s  
t h a t  CORD in  h o r s e s  may be b e t t e r  d e s c r i b e d  as a f u n c t i o n a l  change in  
t h e  lung  i n i t i a l l y  p r e s e n t  as a b r o n c h i o l i t i s  which may e v e n t u a l l y  
p ro d u c e  s t r u c t u r a l  damage t o  t h e  l u n g .
Today,  t h e  e t i o l o g y  o f  COPD i s  h y p o t h e s i z e d  t o  be t h e  r e s u l t  of  
i n h a l a t i o n  o f  a i r b o r n e  p a r t i c u l a t e s  from hay o r  f e e d .  The o r i g i n s  o f  
t h i s  t h e o r y  began around  t h e  m id d le  o f  t h e  n i n e t e e n t h  c e n t u r y  and g a in ed
3
s u p p o r t  in  t h e  l a t e  n i n e t e e n t h  c e n t u r y  and e a r l y  t w e n t i e t h  c e n t u r y  when 
s e v e r a l  i n v e s t i g a t o r s  l i k e  P e r c i v a l ,  Law, B ak e r ,  Axe and Fi tzwygram 
p ro p o se d  t h a t  d i e t  was a s s o c i a t e d  w i th  p r o d u c t i o n  o f  e q u i n e  h e a v e s . 2 
The i m p l i c a t i o n  o f  d i e t  i n  p r o d u c t i o n  o f  h e a v e s  e v e n t u a l l y  l e d  t o  t h e  
works  o f  Cook (1963) and R o s s d a l e ,  and T h u r l b e c k  (1964)  which s u g g e s t e d  
t h a t  h e a v e s  was a f u n c t i o n a l  emphysematous  d i s e a s e  o f  a l l e r g i c  
o r g i n . 1 2 , 1 3  A f u n c t i o n a l  emphysema i s  d e f i n e d  as a p o t e n t i a l l y  
r e v e r s i b l e  d i s e a s e  r e s u l t i n g  f rom c o n s t r i c t i o n  o f  t h e  smooth m uscl e  o f  
t h e  b r o n c h i o l e s  and lun g paren chym a.  In s u p p o r t  o f  t h e  a l l e r g y  
mechanism,  G erb er  in  1973 fo und  t h a t  a t  l e a s t  25% o f  t h e  c a s e s  o f  h eav es  
were a s s o c i a t e d  w i th  a c u t e  i n f l a m m a t o r y  cha ng es  o f  a l l e r g i c  n a t u r e  in 
t h e  b r o n c h i o l e s  o f  a f f e c t e d  a n i m a l s . 14 Thi s  b r o n c h i o l i t i s  was 
p o s t u l a t e d  t o  p r o g r e s s  t o  an emphysema a f t e r  many y e a r s  o f  c h r o n i c  
i n f l a m m a t i o n .  The s o u r c e  o f  t h e  a l l e r g i c  r e s p o n s e  was in  some c a s e s  t h e  
r e s u l t  o f  i n h a l a t i o n  o f  f u n g a l  a n t i g e n s  found  in  moldy hay o r  f e e d  as 
r e p o r t e d  by Erye  in 1972 and McPherson in  1 9 7 9 . 1 5 ,1 6  At p r e s e n t ,  
e n v i r o n m e n t a l  d u s t  and f u n g a l  c o n t a m i n a n t s  i n  bed d in g  and hay a r e  
c o n s i d e r e d  t o  be two o f  many a l l e r g i c  f a c t o r s  r e s p o n s i b l e  f o r  p r o d u c t i o n  
o f  COPD i n  h o r s e s .
ETIOLOGIES FOR PRODUCTION OF COPD IN HORSES 
The e t i o l o g i e s  o f  h e a v e s  i n  h o r s e s  a r e  t h o u g h t  t o  be o f  f i v e  
d i f f e r e n t  c a t e g o r i e s .  They a r e  (1) i n f e c t i o u s ,  (2)  a l l e r g i c ,  (3)  
n o n - i n f e c t i o u s  -  i r r i t a n t ,  (4)  g e n e t i c  and (5)  d i e t a r y  
r e l a t e d . 1 . 2 , 3
4
I n f e c t i o n
R e c u r r e n t  b a c t e r i a l  and v i r a l  i n f e c t i o n s  in  c o n j u n c t i o n  wi th  
a l t e r a t i o n s  in  normal  l ung  d e f e n s e  mechanisms from p r e v i o u s  lung damage 
a r e  s u s p e c t e d  t o  c a u s e  a c u t e  and c h r o n i c  cha nges  in  t h e  s t r u c t u r e  o f  t h e  
r e s p i r a t o r y  and t e r m i n a l  b r o n c h i o l e s . 1 7 ,1 8  These s t r u c t u r a l  
a b n o r m a l i t i e s  may l e a d  t o  de ve lo pm en t  o f  COPD in  h o r s e s .  Development  of  
COPD may be l i n k e d  t o  i n f e c t i o n s  from e q u i n e  i n f l u e n z a  v i r u s  and 
S t r e p t o c o c c u s  z o o e p i d e m i c u s . 4 , 1 8  However,  t h e  e x a c t  r o l e  of  
i n f e c t i o u s  a g e n t s  in  p r o d u c t i o n  o f  e q u i n e  h ea ves  r e m a in s  an a r e a  o f  h ig h  
i n t e r e s t .  N e v e r t h e l e s s ,  i f  e q u i n e  lung  r e s p o n d s  t o  i n f e c t i o u s  i n s u l t s  in 
a manner s i m i l a r  t o  human l u n g ,  i n f e c t i o n  i s  a major  c o n t r i b u t o r  t o  t h e  
p a t h o g e n e s i s  o f  h e a v e s .
A1 l e r g y
C o n s t r i c t i o n  o f  a i r w a y  smooth m usc le  wi th  o b s t r u c t i o n  o f  t h e  
a i r w a y s  o f t e n  o c c u r s  in  r e s p o n s e  t o  i n h a l a t i o n  o r  b lood  b o rn e  e x p o s u r e  
t o  f o r e i g n  m a t e r i a l s .  The r e s u l t i n g  c o n s t r i c t i o n  i s  t h e  r e s u l t  o f  an 
a l l e r g i c  a n t i g e n - a n t i  body m e d i a t e d  r e a c t i o n .  This  t y p e  o f  C O P D  i s  b e s t  
r e f e r e d  t o  as an e x t r i n s i c  a s th m a .  E x t r i n s i c  as thma i s  d i v i d e d  i n t o  (1) 
Type I ,  im med ia te  and d e l a y e d  ( IgE )  and (2)  Type I I I  -  A r t hus  o r  l a t e  
( immune-complex)  c a t e g o r i e s .  The s i g n i f i c a n c e  o f  t h e s e  mechanisms w i l l  
be r e v ie w ed  u nder  t h e  d i s c u s s i o n  o f  p a t h o g e n e s i s .  E v idenc e  f o r  a l l e r g i c  
r e s p o n s e s  o f  t h e  lung  from i n h a l a t i o n  o f  f u n g i  from t h e  g e n e ra  
M i c r o p o l y s p o r a  and A s p e r g i 11 us has  been p r e s e n t e d  t o  make t h e s e  a g e n t s  
p o s s i b l e  e t i o l o g i c a l  f a c t o r s  in p r o d u c t i o n  o f  h y p e r s e n s i t i v i t y  r e a c t i o n s  
i n  t h e  lu n g s  o f  h o r s e s  a f f e c t e d  by C O P D . 18
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A tm ospher i c  P o l l u t i o n  and N o n - I n f e c t i o u s  I r r i t a t i o n
A i r b o r n e  p a r t i c u l a t e s  and g a s e o u s  i r r i t a n t s  a r e  c o n s t i t u e n t s  o f  
i n d u s t r i a l  and a u t o m o t iv e  e f f l u e n t s  which can be t r a p p e d  in  t h e  lung 
upon i n h a l a t i o n .  The r e g i o n  o f  d e p o s i t i o n  in  t h e  lung  i s  a f u n c t i o n  of  
s i z e  o f  t h e  p a r t i c l e  o r  g a s e o u s  a e r o s o l  ( v a p o r )  and t h e  a n a to m ic a l  
a r r a n g e m e n t  o f  t h e  a i r w a y s . 5 , 6 , 1 9 , 2 0  The s i m i l a r i t y  in t h e  
a n a to m i c a l  a r r a n g e m e n t  o f  a i r w a y s  between h o r s e s  and humans sh o u ld  a l l o w  
c o m p a r i so n s  between s p e c i e s  as t o  t h e  r o l e  o f  . d e p o s i t i o n  o f  a t m o s p h e r i c  
p o l l u t a n t s  in  t h e  dev e lo p m en t  o f  COPD.21
For many y e a r s ,  t h e  m a jo r  c o n t r i b u t o r  t o  t h e  de ve lo pm en t  o f  
p o l l u t i o n  i n duced  COPD was f e l t  t o  be i r r i t a t i o n  o f  t h e  a i r w a y  e p i t h e l i a  
and lung  parenchyma by i n h a l a t i o n  o f  p a r t i c u l a t e  m a t e r i a l .  Dusts and 
ammonia v a p o r s  f rom p o o r l y  v e n t i l a t e d  s t a b l e s  and bed d in g  m a t e r i a l s  may 
p o s s i b l y  be one s o u r c e  o f  n o n - i n f e c t i o u s  n o n - a l l e r g i c  i r r i t a n t s  o f  t h e  
r e s p i r a t o r y  t r a c t .
In r e c e n t  y e a r s ,  i t  has  become i n c r e a s i n g l y  o b v io u s  t h a t  e x c e s s i v e  
a t m o s p h e r i c  l e v e l s  o f  s u l f u r  d i o x i d e  l e a d  t o  t h e  de ve lo pm en t  o f  a i r b o r n e  
a c i d i c  a e r o s o l s  which u l t i m a t e l y  become " a c i d  r a i n " .  In t u r n  when a c id  
a e r o s o l s  a r e  i n h a l e d ,  s e v e r e  i r r i t a t i o n  o f  t h e  lung o c c u r s  which may 
l e a d  t o  d ev e lo pm en t  o f  COPD a f t e r  y e a r s  o f  c h r o n i c  e x p o s u r e .
While  t h e  s i g n i f i c a n c e  o f  e n v i r o n m e n ta l  a t m o s p h e r i c  p o l l u t i o n  in  
p r o d u c t i o n  o f  h eav es  in  h o r s e s  has  n o t  been d e t e r m i n e d ,  t h e  s i m i l a r i t y  
i n  s t r u c t u r e  and f u n c t i o n  between t h e  human and e q u i n e  r e s p i r a t o r y  
sy s t em s  s h o u l d  p r e d i s p o s e  h o r s e s  t o  t h e  de ve lo pm en t  o f  COPD from 
e x p o s u r e  t o  a t m o s p h e r i c  p o l l u t a n t s  j u s t  as i s  s u g g e s t e d  t o  o c c u r  in  t h e  
human p o p u l u s .
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G e n e t i c  F a c t o r s
Human COPD i s  c o n s i d e r e d  t o  be t h e  r e s u l t  o f  a b a s i c  t i s s u e  d e f e c t  
i n  t h e  lu n g  which in  c o m b i n a t i o n  w i th  some e x t e r n a l  p r e c i p i t a t i n g  f a c t o r  
p r e d i s p o s e s  t h e  i n d i v i d u a l  t o  deve lopm ent  o f  COPD.20 In man, a 
sm a l l  p e r c e n t a g e  o f  emyphysema c a s e s  a r e  a s s o c i a t e d  w i th  a d e f i c i e n c y  in  
serum a l p h a - l - a n t i t r y p s i n . 2 2  No e v i d e n c e  e x i s t s  f o r  e i t h e r  
a l p h a - 1 - a n t i t r y p s i n  d e f i c i e n c y  o r  a h e r e d i t a r y  p r e d i s p o s i t i o n  f o r  COPD 
in  h o r s e s . 18 ,23  However,  i t  has  been s u g g e s t e d  t h a t  a h i g h e r  
i n c i d e n c e  o f  COPD i s  o b s e r v e d  in  h o r s e s  w i th  g e n o t y p e s  p ro d u c in g  
c h e s t n u t  c o l o r a t i o n . 2 
D i e t a r y ,  Drug o r  Toxin  Induc ed  COPD
The number o f  r e p o r t s  i d e n t i f y i n g  s p e c i f i c  t o x i n - i n d u c e d  COPD in  
h o r s e s  and humans i s  low.  Most a d v e r s e  r e s p o n s e s  which c a u s e  n a r r o w in g  
o f  t h e  a i r w a y s  have been a s s o c i a t e d  w i th  a l l e r g i c  r e a c t i o n s  from 
a d m i n i s t r a t i o n  o f  f o o d s t u f f s ,  d ru g s  o r  s u p p o s e d l y  i n e r t  m a t e r i a l s  
a s s o c i a t e d  w i th  drug d o s a g e  f o r m s .  However,  in some c a s e s  c h e m i c a l s  
which s t i m u l a t e  t h e  m u s c a r i n i c  r e c e p t o r s  o f  t h e  c h o l i n e r g i c  n e r v o u s  
sys tem  o r  a l p h a  r e c e p t o r s  o f  t h e  a d r e n e r g i c  sys tem  can e l i c i t  
b r o n c h o c o n s t r i c t i o n .  B e t a - tw o  a d r e n e r g i c  b l o c k e r s  a l s o  a l t e r  normal  
aut on om ic  b a l a n c e  in  t h e  a i r w a y s  by b l o c k i n g  t h e  a d r e n e r g i c  
b r o n c h o d i l a t o r  r e s p o n s e ,  which in  t u r n  a l l o w s  e x c e s s i v e  b ro nc homoto r
t o n e  t o  p r e d o m i n a t e . 24,25
C y t o t o x i c  damage t o  t h e  e p i t h e l i a  o f  a i r w a y s  o c c u r s  when some 
mammals a r e  expose d  t o  t h e  h e r b i c i d e  p a r a q u a t  o r  t o  t h e  t o x i n s  formed in  
moldy sweet  p o t a t o e s  and by t h e  p e r i  11 a p l a n t  known as 4 - ipom eano l  or
3 - s u b s t i t u t e d  f u r a n s . 2 6 ,2 7  r e s u l t i n g  d e s t r u c t i o n  o f  t y p e  I I
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pneumocytes  by t h e s e  t o x i n s  e v e n t u a l l y  p r o d u c e s  a pu lmonary  f i b r o s i s .  
However,  t h e s e  t o x i n s  have  n o t  been i d e n t i f i e d  as  a g e n t s  r e s p o n s i b l e  f o r  
p r o d u c t i o n  o f  a c u t e  o r  c h r o n i c  pulmonary d i s e a s e  in  h o r s e s .
PATHOGENESIS OF COPD IN HORSES
Asthma
Asthma in  h o r s e s  has  n o t  been wel l  c h a r a c t e r i z e d  but  i s  s u g g e s t e d  
t o  be one o f  t h e  c o n d i t i o n s  a s s o c i a t e d  w i th  t h e  COPD c o m p l e s . 2 , 4 , 1 8  
Asthma in  man i s  s e p a r a b l e  i n t o  e x t r i n s i c  and i n t r i n s i c  fo rms  based  upon 
t h e i r  r e s p e c t i v e  mechanisms f o r  p r o d u c in g  spasm of  a i rw ay  smooth m u s c l e .  
S i m i l a r  mechanisms may a p p l y  t o  h o r s e s .
Type I e x t r i n s i c  a s th m a .  E x t r i n s i c  as thma i s  t h e  r e s u l t  o f  an a l l e r g i c  
r e a c t i o n  i n v o l v i n g  Type I and Type I I I  immunological  
r e a c t i o n s . 6 , 1 8 , 2 8  j y p e i ( a t o p i c )  may be e i t h e r  immedia te  or 
d e l a y e d  h y p e r s e n s i t i v i t y  r e a c t i o n s  which a r e  m e d i a t e d  by a n t i b o d i e s  o f  
t h e  IgE v a r i e t y .  When a n t i g e n s  i n t e r a c t  w i th  IgE a n t i b o d i e s  bound t o  
t h e  c e l l  membranes o f  m as t  c e l l s  and b a s o p h i l s ,  t h e i r  membranes become 
u n s t a b l e  and in  t u r n  r e l e a s e  b r o n c h o a c t i v e  m e d i a t o r s  l i k e  h i s t a m i n e ,  
s e r o t o n i n  and S R S - A . 2 9  These  m e d i a t o r s  e l i c i t  c o n t r a c t i o n s  in 
a i r w a y  smooth m u s c l e .  The o n s e t  o f  b r o n c h i a l  h y p e r r e a c t i v i t y  i n  T y p e- I  
im media te  r e a c t i o n s  i s  w i t h i n  m i n u te s  and t h e  d u r a t i o n  o f  r e s p o n s e  i s  
a p p r o x i m a t e l y  two h o u r s  f rom t i m e  o f  ex p o s u r e  t o  t h e  a n t i g e n . 28 
Type I d e l a y e d  h y p e r s e n s i t i v i t y  r e a c t i o n s  peak f rom 6 t o  12 h o u r s  a f t e r  
c h a l l e n g e  and r e s o l v e  by 24 h o u r s . 31*32 j h i s  r e v e r s i b i l i t y  o f  
a i r w a y  c o n t r a c t i o n  and t h e  f a c t  t h a t  no s e r i o u s  i n f l a m m a t i o n  o c c u r s  in
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t h e  a i r w a y s  r e s u l t  in a n o t i c e a b l e  l a c k  o f  a c u t e  damage t o  t i s s u e s  of  
t h e  l u n g .  T h e r e f o r e ,  i t  i s  u n d e r s t a n d a b l e  why a n t i i n f l a m m a t o r y  
c o r t i c o s t e r o i d  t h e r a p y  i s  i n e f f e c t i v e  and s i m p le  b r o n c h o d i l a t o r  
t r e a t m e n t s  a r e  c o m p l e t e l y  e f f e c t i v e  a t  r e v e r s i n g  t h i s  
b r o n c h o c o n s t r i c t i o n  r e a c t i o n .
Type I I I  e x t r i n s i c  a s t h m a . E x t r i n s i c  as thma can a l s o  be t h e  r e s u l t  of  a 
n o n - a t o p i c  o r  Type I I I  -  A r th u s  r e a c t i o n s .  In Type I I I  r e a c t i o n s ,  
immune-complexes a r e  formed in  t h e  lung as a r e s p o n s e  t o  ex p o s u r e  
t o  some form o f  a n t i g e n i c  m a t e r i a l . 28 T h i s  immune-complex f i x e s  and 
a c t i v a t e s  t h e  complement sys tem  which in  t u r n  i n d u c e s  damage t o  t h e  
a i r w a y  e p i t h e l i a l  c e l l  membranes .  The o n s e t  o f  a Type I I I  r e a c t i o n  i s  
w i t h i n  3 t o  4 h o u r s  and may l a s t  up t o  48 h o u r s  a f t e r  e x p o s u r e  t o  t h e  
t r i g g e r i n g  a n t i g e n .  A Type I I I  r e a c t i o n  i s  se ldom e l i c i t e d  w i t h o u t  a 
p r e v i o u s  s e n s i t i z i n g  Type I r e a c t i o n  which r e s o l v e d  b e f o r e  t h e  Type I I I  
r e a c t i o n  a p p e a r e d .  Type I I I  r e a c t i o n s  c a u s e  p o o r l y  r e v e r s i b l e  or  
i r r e v e r s i b l e  o b s t r u c t i o n  o f  t h e  a i rw a y s  and in  r e s u l t  t h e s e  a i rw a y s  
r e s p o n d  i n c o n s i s t e n t l y  and o n l y  m a r g i n a l l y  t o  b r o n c h o d i l a t o r  t h e r a p y .
I n t r i n s i c  Asthma
,I n t r i n s i c  as thma i s  c h a r a c t e r i z e d  by a r e v e r s i b l e  o b s t r u c t i o n  of  
t h e  a i rw a y s  which i s  e l i c i t e d  by n o n - a l l e r g i c  s t i m u l i . 6 The l e s i o n s  
a s s o c i a t e d  w i t h  i n t r i n s i c  as thma in  humans and o t h e r  mammals a r e  
i d e n t i c a l  t o  t h o s e  found in e x t r i n s i c  a s th m a ,  b u t  have n o t  been 
i d e n t i f i e d  in  h o r s e s .
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The r e a c t i v i t y  o f  t h e  a i r w a y s  in  i n t r i n s i c  as thma i s  t h o u g h t  t o  be 
t h e  r e s u l t  o f  a n o n s p e c i f i c  i r r i t a n t  c a u s i n g  r e l e a s e  o f  (1) m e d i a t o r s  
f rom mas t  c e l l s  l i k e  t h a t  o b s e r v e d  in  e x t r i n s i c  as thm a or (2) f rom 
abnormal  s t i m u l a t i o n  o f  n e u r o g e n i c  r e f l e x e s .  F i g u r e  1 d e p i c t s  t h e  
r e l a t i o n s h i p  between t h e  mechanisms f o r  p r o d u c t i o n  o f  e x t r i n s i c  and 
i n t r i n s i c  a s t h m a . 6
N o n s p e c i f i c  s t i m u l a n t s  o f  i n t r i n s i c  as thma in  humans a r e  (1)  
i n f e c t i o u s ,  (2)  a t m o s p h e r i c  p o l l u t a n t s  (3) c o l d - a i r  and (4) 
p s y c h o g e n i c . 5 . 6  The i m p o r t a n c e  o f  i n f e c t i o n  and p o l l u t i o n  from 
s t a b l e  d u s t  in  t h e  e t i o l o g y  o f  e q u i n e  COPD in  h o r s e s  was p r e v i o u s l y  
d i s c u s s e d .  However,  t h e  s i g n i f i c a n c e  o f  c o l d - a i r  and p s y c h o g e n ic  or  
s t r e s s - r e l a t e d  i n d u c t i o n  o f  bronc hospasm has  n o t  been i n v e s t i g a t e d  in  
h o r s e s .
N e u ro g en ic  i n d u c t i o n  o f  as thma i s  a mechanism which s u g g e s t s  t h e  
p r e s e n c e  o f  an im b a la n c e  i n  t h e  au tono mic  c o n t r o l  o f  a i rw ay  t o n e  and 
mucus s e c r e t i o n  i n t o  t h e  a i r w a y s .  The i d ea  t h a t  as thma i s  t h e  r e s u l t  of 
an i m b a l a n c e  in  t o n e  t o  t h e  p a r a s y m p a t h e t i c  n e r v o u s  sys tem  o r i g i n a t e d  
o v e r  s i x t y  y e a r s  ago.  A ccord ing  t o  t h i s  mechanism,  b r o n c h o c o n s t r i c t i o n  
i s  p rovok ed by n o n - s p e c i f i c  s t i m u l a t i o n  o f  i r r i t a n t  r e c e p t o r s  foun d in  
t h e  a i r w a y  s u b e p i t h e l i a l  and e p i t h e l i a l  l i n i n g .  Im pu lses  g e n e r a t e d  by 
t h e s e  r e c e p t o r s  a r e  c a r r i e d  by v ag a l  f i b e r s  t o  t h e  b r a i n .  The r e f l e x  
pa thway  i s  c o m p le t ed  by e f f e r e n t  vaga l  f i b e r s  which t e r m i n a t e  on 
b r o n c h i a l  smooth m u s c l e .  S t i m u l a t i o n  o f  t h e s e  i r r i t a n t  r e c e p t o r s  can be 
b o th  m e c h a n i c a l  and ch em ic a l  in  o r i g i n .  F i g u r e  2 d e p i c t s  t h e  mechanism 
f o r  n e u r o g e n i c  i n d u ced  i n t r i n s i c  a s t h m a . 6 , 3 3 , 3 4
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EXTRINSIC 
• a l l e r g i c  
Dust  
P o l l e n  
Animal Dander
INTRINSIC 
n o n - a l l e r g i c  
I n f e c t i o n  
A i r  P o l l u t i o n  
E x e r c i s e  
Cold
P s y ch o g en ic




R e l e a s e  f rom  Mast C e l l s  <— 
h i s t a m i n e  
s e r o t o n i n
SRS-A ( l e u k o t r i e n e s  ) 
PgE
-N euro gen ic  R e f l e x  
vaga l
F i g u r e  1 -  Mechanism i n  t h e  p a t h o g e n e s i s  o f  b r o n c h i a l  c o n t r a c t i o n .
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F i g u r e  2 -  Mechanism f o r  p r o d u c t i o n  o f  n e u r o g e n i c  a s th m a .
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While d i r e c t  e v i d e n c e  f o r  an i n t r i n s i c  n e u r o g e n i c  mechanism has  not  
been i d e n t i f i e d ,  t h e  e f f e c t i v e n e s s  o f  t h e  p a r a s y m p a t h o l y t i c  drug 
a t r o p i n e  in  t h e  t r e a t m e n t  o f  COPD i n  some h o r s e s  i s  wel l  
d o c u m e n t e d . 3 5 ,36  T h i s  o b s e r v a t i o n  s u g g e s t s  t h a t  e x c e s s i v e  
p a r a s y m p a t h e t i c  o u t p u t  i s  p o s s i b l y  r e s p o n s i b l e  f o r  p r o d u c t i o n  o f  some o f  
t h e  c l i n i c a l  s i g n s  o f  h e a v e s .
B r o n c h i o l i t i s
B r o c h i o l i t i s  i s  an i n f l a m m a t i o n  o f  t h e  sm al l  a i r w a y s  p r o b a b l y  most 
commonly ca u s ed  in  mammals by i n f e c t i o n  o r  e x p o s u r e  t o  n o x io u s  
c h e m i c a l s .  T h i s  c o n d i t i o n  may be a c u t e  o r  c h r o n i c .  However,  a c u t e  
b r o n c h i o l i t i s  i s  more common. When a c u t e  b r o n c h i o l i t i s  i s  c h a r a c t e r i z e d  
by i r r e v e r s i b l e  o c c l u s i o n  o f  t h e  a i r w a y s ,  i t  i s  c a l l e d  b r o n c h i o l i t i s  
o b i i t e r a n s . 5 » 6  j h e  l e s i o n s  o f  b r o n c h i o l i t i s  in  h o r s e s  a r e  
c h a r a c t e r i z e d  by e p i t h e l i a l  h y p e r p l a s i a  and m e t a p l a s i a ,  p e r i b r o n c h i o l a r  
f i b r o s i s ,  m on o n u c lea r  c e l l  i n f i l t r a t i o n  and a c i n a r  o v e r i n f l a t i o n J 2
Mechan ica l  o b s t r u c t i o n  o f  t h e  a i r w a y s  in  b r o n c h i o l i t i s  o c c u r s  from 
s e c r e t i o n  in  t h e  lumen,  edematous  s w e l l i n g  o f  t h e  a i rw a y  w a l l ,  and 
e x t r u s i o n  o f  i n f l a m m a t o r y  c e l l s  and t h e i r  e x u d a t e s  i n t o  t h e  lumen.
Airway o b s t r u c t i o n  a l s o  o c c u r s  when i n f l a m m a t i o n  o f  t h e  a i r w a y s  c a u s e s  
i r r i t a n t  r e c e p t o r  r e f l e x  c o n s t r i c t i o n  o f  p e r i p h e r a l  a i r w a y s  as 
p r e v i o u s l y  d i s c u s s e d  f o r  i n t r i n s i c  n e u r o g e n i c  a s th m a .
R e c u r r e n t  i n f e c t i o n s  and i n f l a m m a t i o n  a s s o c i a t e d  w i t h  b r o n c h i o l i t i s  
o f t e n  c a u s e  changes  in  pu lm onary  f u n c t i o n  which rema in  u n d e t e c t a b l e  
u n t i l  t h e  undamaged a l v e o l a r  parenchyma o r  a i r w a y s  a r e  i n a d e q u a t e  in
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t h e i r  f u n c t i o n  t o  p r e v e n t  deve lopment  o f  s i g n s  o f  COPD. The 
m o r p h o l o g i c a l  s i m i l a r i t i e s  o f  human and e q u i n e  b r o n c h i o l i t i s  has  l e d  
many r e s e a r c h e r s  t o  c o n c l u d e  t h a t  j u s t  as in  humans,  a g e n t s  c a u s i n g  
i n f e c t i o n ,  i r r i t a t i o n  and a l l e r g y  were p r o b a b l y  r e s p o n s i b l e  f o r  t h e  
p r o d u c t i o n  o f  b r o n c h i o l i t i s  in  h o r s e s . 2 , 1 8  i n t u r n ,  b r o n c h i o l i t i s  
i s  c o n s i d e r e d  t o  be d i r e c t l y  r e s p o n s i b l e  f o r  t h e  p r o d u c t i o n  o f  emphysema 
in  h o r s e s  as p r e v i o u s l y  d i s c u s s e d .
Emphysema
Emphysema i s  a c o n d i t i o n  o f  t h e  lung  c h a r a c t e r i z e d  by an abnormal  
i n c r e a s e  i n  t h e  s i z e  o f  a i r s p a c e s  d i s t a l  t o  t h e  t e r m i n a l  b r o n c h i o l e s  
w i th  d e s t r u c t i o n  o f  t h e  a l v e o l a r  w a l l s . 6 L e s i o n s  o f  t h i s  d e s c r i p t i o n  
o n l y  o c c u r  in  f o c a l  a r e a s  in  h o r s e s . 89 P re s u m ab ly ,  emphysema a r i s e s
when i n h a l e d  i r r i t a n t s  o r  i n f e c t i o n s  c a u s e  r e l e a s e  o f  l e u k o c y t i c*
r e l e a s e  o f  l e u k o c y t i c  p r o t e a s e s  w i t h i n  t h e  lung which a r e  n o t  
c o u n t e r a c t e d  by normal  p r o t e a s e  i n a c t i v a t i n g  m e c h a n i s m s . 37
The p a t h o g e n e s i s  o f  emphysema a p p a r e n t l y  a r i s e s  f rom one o f  t h e s e  
f o u r  mechanisms (1) h y p o p l a s i a ,  (2)  a t r o p h y ,  (3)  o v e r i n f l a t i o n  and (4) 
d e s t r u c t i o n  o f  t h e  a l v e o l a r  p a r e n c h y m a . 8 Equine  emphysema p r o b a b l y  
r e s u l t s  f rom o v e r i n f l a t i o n  and d e s t r u c t i o n  o f  t h e  a l v e o l i .  O v e r i n f l a t i o n  
o c c u r s  when s e v e r e  a i r w a y  o b s t r u c t i o n  p r e v e n t s  normal em ptying o f  
t e r m i n a l  lu ng  u n i t s  upon e x h a l a t i o n ,  w h i l e  d e s t r u c t i o n  o f  t h e  t e r m i n a l  
a i r s p a c e s  i s  p ro du ced  by i n f l a m m a t i o n  and n e c r o s i s  o f  t h e  a l v e o l i .
C hro n ic  B r o n c h i t i s
C hro n ic  b r o n c h i t i s  i n  humans i s  d e f i n e d  as a c h r o n i c  i n f l a m m a t o r y  
c o n d i t i o n  o f  t h e  a i r w a y s  which c a u s e s  a h y p e r s e c r e t i o n  o f
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m u c u s . H y p e r s e c r e t i o n  o f  mucus r e s u l t s  in  cough and 
e x p e c t o r a t i o n  f o r  p r o l o n g e d  p e r i o d s  o f  t i m e .  The e x c e s s i v e  s e c r e t i o n  o f  
mucus i n t o  t h e  s m a l l e r  b r o n c h i o l e s  can c a u s e  t h e s e  a i r w a y s  t o  become 
o b s t r u c t e d  which in  t u r n  a l t e r s  normal  gas  ex change  in  t h e  
l u n g . 5 » & * 3 7
In h o r s e s ,  c h r o n i c  b r o n c h i t i s  p r o d u c e s  a v a r i a b l e  n a s a l  d i s c h a r g e  
which may be  s e r o u s ,  mucoid o r  m u c o p u r u l e n t .  Cough, dyspn ea  and poor 
e x e r c i s e  t o l e r a n c e  a r e  a l s o  p r e s e n t .  In a d d i t i o n  t o  t h e  abnormal  
s e c r e t i o n  o f  mucus,  h o r s e s  w i th  c h r o n i c  b r o n c h i t i s  p r o b a b l y  have 
im p a i r e d  c i l i a r y  f u n c t i o n  and a r e d u c t i o n  o f  o t h e r  lung d e f e n s e  
mechanisms which l e a v e s  them s u s c e p t i b l e  t o  r e c u r r i n g  i n f e c t i o n s .  Some 
a u t h o r s  s u g g e s t  t h a t  c h r o n i c  b r o n c h i t i s  in  h o r s e s  e v e n t u a l l y  p r o g r e s s e s  
i n  t i m e  t o  an e m p h y s e m a . 4 J 2 
Summary
The p a t h o g e n e s i s  o f  e q u i n e  COPD i s  t h e  r e s u l t  o f  a t  l e a s t  f o u r  
d i s t i n c t  d i s e a s e s  which r e l a t e  t o  (1) t h e  i n h a l a t i o n  o f  n o n - s p e c i f i c  
i r r i t a n t s ,  (2) r e s p i r a t o r y  i n f e c t i o n s ,  a n d / o r  (3) e x p o s u r e  t o  an 
a l l e r g e n .  P a t h o l o g i c a l l y ,  t h e s e  f o u r  d i s e a s e  s t a t e s  a l t e r  r e s p i r a t o r y  
p h y s i o l o g y  by two b a s i c  mechanisms which u l t i m a t e l y  a f f e c t  normal 
p u lm on ary  m e c h a n i c s .  These  mechanisms a r e  (1)  a d e c r e a s e  in  e l a s t i c  
r e c o i l  o f  t h e  lung and (2)  o b s t r u c t i o n  o f  t h e  a i r w a y s ,  e s p e c i a l l y  t h o s e  
a i r w a y s  l e s s  t h a n  2 mm in  d i a m e t e r .  Even though  t h e s e  b a s i c  mechanisms 
a r e  d i s t i n c t l y  d i f f e r e n t ,  t h e i r  e f f e c t s  on chang es  in  t h e  pu lmonary  
dynamic p a r a m e t e r s  o f  f l o w  and r e s i s t a n c e  a r e  s i m i l a r .  T h e r e f o r e ,  t h e  
n e x t  s e c t i o n  w i l l  d e s c r i b e  t h e  p a t h o p h y s i o l o g y  o f  a i rw a y  o b s t r u c t i o n  and
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a l v e o l a r  h y p o v e n t i l a t i o n  as  r e p r e s e n t a t i v e  o f  t h e  chang es  o c c u r i n g  in 
h o r s e s  w i t h  COPD complex.
PATHOPHYSIOLOGY AND PULMONARY DYNAMICS OF COPD IN HORSES3 8 *3 9 . 4 0 . 41
R e s p i r a t o r y  r a t e ,  t i d a l  volume and m in u te  v e n t i l a t i o n
Horses  w i th  COPD complex have  s l i g h t l y  i n c r e a s e d  r e s p i r a t o r y  r a t e s  
( r r )  and s m a l l e r  t i d a l  volumes (V ^ ) .  In r e s u l t ,  m i n u te  v e n t i l a t i o n ,  
t h e  p r o d u c t  o f  r r  and V- ,̂ i s  e i t h e r  unchanged or  i n c r e a s e d  o n l y  
s l i g h t l y  when compared t o  normal  h o r s e s .  The i n c r e a s e  in  m in u te  
v e n t i l a t i o n  would depend t o  a g r e a t  e x t e n t  on r e s p i r a t o r y  r a t e  which in 
t u r n  r e s p o n d s  t o  t h e  p a r t i a l  p r e s s u r e  o f  oxygen and ca rb o n  d i o x i d e  in  
t h e  s y s t e m i c  c i r c u l a t i o n .
Ai r  Flows in  Horses  w i th  COPD
Average or  peak i n s p i r a t o r y  f low  i n c r e a s e  and in  t u r n  i n s p i r a t o r y  
t i m e  i s  d e c r e a s e d  in  h o r s e s  w i t h  COPD. Mean e x p i r a t o r y  f low  and 
e x p i r a t o r y  t i m e  in  t h e s e  h o r s e s  i s  unchanged .  However,  when e x p i r a t o r y  
f l o w  i s  d e t e r m i n e d  a t  h ig h  v e r s u s  low lung vo lumes ,  f l o w  i s  i n c r e a s e d  a t  
h i g h e r  and d e c r e a s e d  a t  lower  lung  volumes.  The d e c r e a s e  in  e x p i r a t o r y  
f l o w  a t  lower  lung volumes i s  t h e  r e s u l t  o f  e i t h e r  o b s t r u c t i o n  o f  t h e  
a i r w a y s  o r  l o s s  o f  lung r e c o i l .  Loss in lung r e c o i l  c a u s e s  a i r w a y s  t o  
p r e m a t u r e l y  c o l l a p s e  a t  lower  volumes p r o d u c in g  an o b s t r u c t i o n  o f  t h e  
a i r w a y .
T o ta l  Pulmonary and Airway R e s i s t a n c e
T o t a l  pulmona ry  r e s i s t a n c e  i s  t h e  sum o f  both  e l a s t i c  r e s i s t a n c e  
and n o n - e l a s t i c  o r  a i rw ay  r e s i s t a n c e  which i s  g e n e r a t e d  by t h e
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m ech a n ica l  movements o f  t h e  lung which move a i r  i n t o  and o u t  o f  t h e  
a l v e o l i .  Both t o t a l  pu lm ona ry  r e s i s t a n c e  and a i r w a y  r e s i s t a n c e  a r e  
d e t e r m i n e d  a t  s p e c i f i c  lu n g  volumes d u r i n g  t h e  i n s p i r a t o r y  and 
e x p i r a t o r y  componen ts  o f  t h e  r e s p i r a t o r y  c y c l e .
O b s t r u c t i o n  o f  t h e  a i r w a y s  in  COPD h o r s e s  c a u s e s  i n c r e a s e d  t o t a l  
pulmona ry  r e s i s t a n c e  and e s p e c i a l l y  t h e  a i rw ay  component  o f  t h i s  
p a r a m e t e r .  The g r e a t e s t  i n c r e a s e  in t o t a l  pulmona ry  r e s i s t a n c e  i s  
o b s e r v e d  a t  e n d - e x p i r a t i o n  where  lung  volume i s  low.  I n c r e a s e s  in  
e n d - e x p i r a t o r y  r e s i s t a n c e  a r e  c h a r a c t e r i s t i c  o f  e i t h e r  n a r r o w in g  o f  t h e  
l a r g e r  a i r w a y s  o r  e x t e n s i v e  o b s t r u c t i o n  o f  t h e  s m a l l e r  p e r i p h e r a l  
a i r w a y s .
Volume o f  t r a p p e d  gas
Abnormal d e c r e a s e s  in  f low  and i n c r e a s e s  in a i rw a y  r e s i s t a n c e  from 
o b s t r u c t i o n  o f  t h e  a i rw a y s  as  o b s e r v e d  in  COPD h o r s e s  c a u s e  p r e m a t u r e  
co m p r e s s io n  or  c l o s u r e  o f  t h e  a i r w a y s .  P re m a tu re  c l o s u r e  o f  t h e s e  
o b s t r u c t e d  a i rw a y s  o f  COPD h o r s e s  t r a p s  l a r g e r  volumes o f  a i r  in  d i s t a l  
lu n g  u n i t s  i n c r e a s i n g  volume o f  t r a p p e d  g a s ,  r e s i d u a l  volume and 
f u n c t i o n a l  r e s i d u a l  c a p a c i t y  (FRC) o f  t h e  l u n g .  The volume o f  t r a p p e d  
gas  and FRC i n c r e a s e  as  a i r w a y  o b s t r u c t i o n  i n c r e a s e s .
V e n t i l a t i o n - p e r f u s i o n  A b n o r m a l i t i e s
Matching  o f  v e n t i l a t i o n  and p e r f u s i o n  in  t h e  l un g i s  r e s p o n s i b l e  
f o r  m a i n t a i n i n g  normal  l e v e l s  o f  oxygen and ca rb o n  d i o x i d e  in  t h e  body.  
V e n t i l a t i o n - p e r f u s i o n  m i s m a tc h in g  in  COPD h o r s e s  can r e s u l t  from 
d e c r e a s e d  a l v e o l a r  v e n t i l a t i o n  due t o  e x t e n s i v e  o b s t r u c t i o n  o f  t h e
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a i r w a y s .  In h o r s e s ,  m i s m a tc h i n g  o f  v e n t i l a t i o n  and p e r f u s i o n  c a u s e s  a 
d e c r e a s e  i n  a r t e r i a l  oxygen ( P a 02) o r  hypoxemia and in  some c a s e s  an 
i n c r e a s e  in  b lo o d  l e v e l s  o f  c a rb o n  d i o x i d e  r e s u l t i n g  in  a h y p e r c a r b i a .  
The e x t e n t  o f  v e n t i l a t i o n  p e r f u s i o n  m ism a tc h in g  and s u b s e q u e n t  hypoxemia 
i s  a c c e n t u a t e d  d u r i n g  e x e r c i s e  in  t h e s e  h o r s e s .
CURRENT CONCEPTS OF 3-METHYLINDOLE INDUCED LUNG TOXICOSIS
H i s t o r y
In 1965,  l a r g e  o r a l  d o s e s  o f  t h e  i n d o l i c  amino a c i d  t r y p t o p h a n  were 
fo und  t o  i n d u c e  a lung d i s e a s e  in  c a t t l e  which r e s em b le d  t h e  n a t u r a l l y  
o c c u r i n g  r e s p i r a t o r y  d i s e a s e  o f  c a t t l e  fog  f e v e r  o r  a c u t e  bov ine  
pu lm on ary  emphysema.4 2 ,4 3  i n a d d i t i o n ,  a r e l a t e d  i n d o l e ,  
i n d o l e a c e t i c  a c i d  ( IAA) ,  was foun d t o  in d u ce  r e s p i r a t o r y  d i s t r e s s  in  
c a t t l e  and g o a t s  i d e n t i c a l  t o  t h a t  seen a f t e r  t r y p t o p h a n  
a d m i n i s t r a t i o n . 44 Sub seq u en t  in v i t r o  s t u d i e s  found t h a t  t r y p t o p h a n  
and IAA were  m e t a b o l i z e d  i n t r a r u m i n a l l y  t o  3 -m et hy l  i n d o l e  by members o f  
t h e  L a c t o b a c i 11 us s p e c i e s  o f  b a c t e r i a  i n d i c a t i n g  t h a t  3MI may be t h e  
o r i g i n a l  damaging p n e u m o t o x i c a n t . 4 5 , 4 6  F u r t h e r m o r e ,  i t  was o b s e r v e d  
t h a t  t h e  c o n v e r s i o n  of  i n d o l e  p r e c u r s o r s  t o  3MI in  t h e  rumen o f  c a t t l e  
can be p r e v e n t e d  by p r e t r e a t m e n t  w i th  t h e  L a c t o b a c i l l u s  k i l l i n g  
a n t i b i o t i c  m o n e n s i n .4 7 , 4 8
The r o l e  o f  3MI- ind uc ed  p n e u m o t o x i c o s i s  was advanced when i t  was 
fo und  t h a t  i n t r a r u m i n a l  and i n t r a v e n o u s  a d m i n i s t r a t i o n  o f  3MI t o  c a t t l e  
and g o a t s  c a u s e d  i n t e r s t i t i a l  emphysema and pu lmonary  e d e m a . 4 3 ,4 4  
In a d d i t i o n  a f t e r  i n t r a r u m i n a l  d o s i n g  w i t h  IAA, 3MI o r  t r y p t o p h a n  a t  
h ig h  l e v e l s ,  3MI co u ld  be d e t e c t e d  in ru m in a l  f l u i d  and p l a s m a . 54
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I t  was co n c lu d e d  t h a t  3MI was r e s p o n s i b l e  f o r  t h e  p n e u m o t o x i c i t y  in 
c a t t l e  r e s e m b l i n g  fo g  f e v e r .
Fog f e v e r  o r  a c u t e  b o v in e  pulmonary  emphysema (ABPE) o c c u r s  in  v iv o  
a f t e r  a change  f rom po o r  t o  l u s h  p a s t u r e s  u s u a l l y  in  t h e  e a r l y  f a l l .  I t  
i s  g e n e r a l l y  a c c e p t e d  t h a t  i n g e s t i o n  o f  f o r a g e  c o n t a i n i n g  h ig h  l e v e l s  of  
t r y p t o p h a n  o r  r e l a t e d  i n d o l e s ,  which in  t u r n  a r e  i n t r a r u m i n a l l y  
m e t a b o l i z e d  t o  3MI, i s  r e s p o n s i b l e  f o r  t h e  p r o d u c t i o n  o f  A B P E . 5 5
M etab o l i sm  o f  3MI f o r  Toxin  P r o d u c t i o n
C l i n i c a l  s i g n s  o f  r e s p i r a t o r y  d i s t r e s s  in c a t t l e ,  shee p and g o a t s  
a d m i n i s t e r e d  3MI (60 mg/kg t o  200 mg/kg body w e ig h t )  began a t  
a p p r o x i m a t e l y  2 h o u r s  a f t e r  d o s i n g  and r e g r e s s e d  between 48 and 72 h o u rs  
i n  s u r v i v i n g  a n i m a l s . 4 9 , 5 0 , 5 2 , 5 6  p r e t r e a t m e n t  o f  g o a t s  wi th  
p h e n o b a r b i t a l  (Pb) o r  p i p e r o n y l  b u t o x i d e  (BT) b e f o r e  d o s i n g  w i t h  3MI a t  
60 mg/kg i n f l u e n c e d  t h e  s e v e r i t y  o f  pulmonary  l e s i o n s . 55 pb 
i n c r e a s e d  t h e  s e v e r i t y  w h i l e  BT d e c r e a s e d  t h e  s e v e r i t y  o f  l e s i o n s .  In 
a d d i t i o n ,  p l as m a c o n c e n t r a t i o n  h a l f - l i f e  o f  3MI was s h o r t e r  a f t e r  Pb 
p r e t r e a t m e n t  and p r o l o n g e d  in  BT p r e t r e a t e d  g o a t s .  The i n c r e a s e  in 
l e s i o n  i n t e n s i t y  and d e c r e a s e d  h a l f  l i f e  i s  c o n s i d e r e d  t o  be t h e  r e s u l t  
o f  i n d u c t i o n  o f  mixed f u n c t i o n  o x i d a s e  (MF0) by p h e n o b a r b i t a l  and 
s u g g e s t s  t h a t  m e t a b o l i s m  i s  r e q u i r e d  f o r  f o r m a t i o n  o f  an a c t i v e  t o x i n  
f rom  3 M I . 56*57
E f f e c t  o f  3MI in  Horses
E x p e r im e n ta l  i n t r a v e n o u s  and o r a l  a d m i n i s t r a t i o n  o f  3MI t o  h o r s e s  
and p o n i e s  c a u s e s  a r e s p i r a t o r y  d i s e a s e  which r e s e m b l e s  n a t u r a l l y
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o c c u r r i n g  C O P D . 5 8 , 5 9 , 6 0  /\s r e p o r t e d  by B ree ze  e t  a l . ,  d o s a g e s  of  
300 mg/kg body w e ig h t  ( p . o . )  i n  h o r s e s  ca u s ed  t a c h y p n e a  and h y p e r p n ea  a t  
24 h o u r s ,  which re m a in ed  up t o  72 h o u r s  a f t e r  d o s i n g .  C l i n i c a l  s i g n s  of 
a d o u b l e  e x p i r a t o r y  e f f o r t  and dy sp n ea  were  a p p a r e n t  f o r  5 days  a f t e r  
d o s i n g .  A r t e r i a l  oxygen l e v e l s  f e l l  f rom 80 t o  90 mm Hg t o  l e v e l s  as 
low a s  20 mm Hg a t  7 d ays  p o s t  a d m i n i s t r a t i o n .  Necropsy o f  t h e s e  h o r s e s  
r e v e a l e d  an e x t e n s i v e  b r o n c h i o l a r  e p i t h e l i a l  n e c r o s i s  which f i r s t  
a p p e a r e d  a t  5 h o u r s  a f t e r  d o s i n g  w i t h  200 mg/kg 3MI. These l e s i o n s  were 
c h a r a c t e r i z e d  as a b r o n c h i o l i t i s .
When p o n i e s  were o r a l l y  a d m i n i s t e r e d  3MI a t  a dosag e o f  100 mg/kg 
body w e i g h t ,  s i g n i f i c a n t  c h a n g e s  were o b s e r v e d  in  t h e  pu lm on ary  dynamic 
p a r a m e t e r s  o f  r e s p i r a t o r y  r a t e ,  t i d a l  volume,  i n s p i r a t o r y  t i m e ,  
e x p i r a t o r y  t i m e ,  minimum and maximum i n t r a p l e u r a l  p r e s s u r e  and a r t e r i a l  
oxygen l e v e l s . 60 Measurement s  o f  i n s p i r a t o r y  and e x p i r a t o r y  f l o w ,  
m i n u te  vo lume,  b lood  pH and p lasma b i c a r b o n a t e  were n o t  s i g n i f i c a n t l y  
chang ed  a f t e r  a d m i n i s t r a t i o n  o f  t h e  100 mg/kg d o s a g e . 50
In a n o t h e r  s t u d y  on p o n i e s ,  Derksen e t  a l . , r e p o r t e d  an i n c r e a s e d  
r e s p i r a t o r y  r a t e  and m i n u te  v e n t i l a t i o n ,  w h i l e  dynamic co m p l i an ce  and 
s p e c i f i c  r e s p i r a t o r y  c o n d u c t a n c e  were d e c r e a s e d . 51 These  cha nges  
were r e v e r s e d  by vago tomy,  i n d i c a t i n g  t h a t  t h e  o b s e r v e d  ch an g es  in  
pu lm on ary  f u n c t i o n  in d u ced  by a d m i n i s t r a t i o n  o f  3MI were in p a r t  
m e d i a t e d  by t h e  v ag a l  n e u r a l  r e f l e x  pa thways  in  t h e  l u n g .  F u n c t i o n a l  
r e s i d u a l  c a p a c i t y  (FRC) was i n c r e a s e d  as w e l l ,  b u t  was u n a f f e c t e d  by 
vagotomy.
C o l l e c t i v e l y  t h e s e  s t u d i e s  s u g g e s t  t h a t  t h e  m a jo r  p a t h o l o g y  
r e s p o n s i b l e  f o r  t h e s e  p a t h o p h y s i o l o g i c a l  a b n o r m a l i t i e s  i n  h o r s e s  and
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p o n i e s  dosed  w i th  3MI i s  l a r g e  or  smal l  a i r w a y  o b s t r u c t i o n .  In 
a d d i t i o n ,  a t  l e a s t  p a r t  o f  t h e  o b s t r u c t i v e  p a t h o g e n e s i s  o f  3MI- induced 
pu lmonary  t o x i c o s i s  may be t h e  r e s u l t  o f  a c t i v a t i o n  o f  vaga l  r e f l e x e s  
s i m i l a r  t o  t h e  mechanism d e s c r i b e d  f o r  i n t r i n s i c  as thma o f  n e u r o g e n i c  
o r i g i n .  The o n l y  l i m i t a t i o n  t o  a c c e p t a n c e  o f  t h i s  mechanism i s  t h e  
s l o w l y  r e v e r s i b l e  n a t u r e  o f  t h e  pu lm ona ry  dynamic ch a n g es  d e s c r i b e d  in  
t h e s e  s t u d i e s .
I t  has  been r e p o r t e d  t h a t  t h e  ch anges  in  pu lm on ary f u n c t i o n  in 
h o r s e s  t r e a t e d  w i t h  h ig h  d o s e s  o f  3MI and f o r  h o r s e s  d i a g n o s e d  as  COPD 
a r e  s i m i l a r . 5 8 , 6 1  knowledge t h a t  t r e a t m e n t  o f  h o r s e s  wi th  3MI
p r o d u c e s  a l un g d i s e a s e  s i m i l a r  t o  e q u i n e  COPD, and t h a t  g r a s s e s  
commonly found in  p a s t u r e s  c o n t a i n  h ig h  l e v e l s  o f  i n d o l i c  compounds 
which a r e  c a p a b l e  o f  b e i n g  c o n v e r t e d  t o  3MI o r  p o s s i b l y  an i n d o l e  w i t h  
s i m i l a r  a c t i v i t y ,  s u g g e s t s  t h a t  3MI o r  a n o t h e r  i n d o l e  may be r e s p o n s i b l e  
f o r  t h e  p a t h o g e n e s i s  o f  n a t u r a l l y  o c c u r i n g  f o r a g e  r e l a t e d  COPD as  s ee n 
p r e d o m i n a n t l y  in  t h e  S o u t h e a s t e r n  U n i t e d  S t a t e s .
RECEPTOR PHARMACOLOGY AND 3MI -  INDUCED LUNG TOXICOSIS IN HORSES
The o b s e r v a t i o n  t h a t  t h e  p a r a s y m p a t h o l y t i c  drug a t r o p i n e  b l o c k s  
some o f  t h e  abnormal  ch a n g es  in  pu lm ona ry  f u n c t i o n  a s s o c i a t e d  w i th  
a i r w a y  smooth m usc le  t o n e  in  bo th  COPD h o r s e s  and 3MI t r e a t e d  h o r s e s  
s u g g e s t s  t h a t  a t  l e a s t  p a r t  o f  t h e  pneumotoxic  mechanism o f  3MI i n v o l v e s  
mechanisms s i m i l a r  t o  t h o s e  d e s c r i b e d  f o r  i n t r i n s i c  a s t h m a . 35,61
R e a c t i v i t y  o f  t h e  a i r w a y s  in  p a t i e n t s  w i t h  i n t r i n s i c  as thma i s  
c a u s e d  by n o n - s p e c i f i c  i r r i t a n t s  which i n t e r a c t  w i th  a i r w a y  smooth 
m uscl e  o r  c e l l u l a r  componen ts  o f  t h e  a i r w a y  e p i t h e l i a .  Drugs o r
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t o x i c a n t s  which a r e  r e s p o n s i b l e  f o r  changes  in a i r w a y  to n e  may c a u s e  
c o n t r a c t i o n  o r  r e l a x a t i o n  by (1)  i n t e r a c t i n g  w i t h  s p e c i f i c  p h a r m a c o lo g ic  
r e c e p t o r s  on t h e  membranes o f  smooth m us cl e  o r  s e n s i t i z e d  mast  c e l l s ,
(2)  d i r e c t  n o n - r e c e p t o r  a c t i o n  on t h e  membrane i t s e l f  o r  (3)  by 
a f f e c t i n g  t h e  b i o c h e m i c a l  m e s s e n g e r s  which communicate  t h e  b i n d i n g  o f  a 
r e c e p t o r  t o  t h e  r e s p o n d i n g  t a r g e t  t i s s u e .  In t h e  c a s e  f o r  3MI- induced 
p n e u m o t o x i c i t y ,  t h e  r e p o r t e d  e f f e c t i v e n e s s  o f  a t r o p i n e  in b l o c k i n g  
c h a n g es  i n  a i r w a y  r e s i s t a n c e  o r  c o n d u c ta n c e  seems t o  i n d i c a t e  t h a t  a 
p h a r m a c o l o g i c a l  r e c e p t o r  mechanism i s  in o p e r a t i o n .
R e c e p t o r  m e d i a t e d  b r o n c h o c o n s t r i c t i o n  t o  3MI may o c c u r  when (1)  
n e u r o g e n i c - i r r i t a n t  r e f l e x e s  a r e  p ro v o k e d ,  or  (2) mas t  c e l l s  r e l e a s e  
b r o n c h o a c t i v e  m e d i a t o r s  ( F i g u r e  3) o r  (3) 3MI i n t e r a c t s  d i r e c t l y  on 
r e c e p t o r s  on a i r w a y  smooth m usc le  membrane.  R e g a r d l e s s  o f  t h e  
mechani sm,  c o n t r a c t i o n  o f  a i r w a y  smooth m usc le  may r e s u l t  when e i t h e r  an 
endogenous  n e u r o t r a n s m i t t e r  or  an e x o g e n o u s ly  a d m i n i s t e r e d  compound wi th  
s i m i l a r  s t r u c t u r e - a c t i v i t y  r e l a t i o n s h i p s  b in d s  d i r e c t l y  t o  a r e c e p t o r  o r  
i n d i r e c t l y  a l t e r s  normal  a f f i n i t i e s  o f  r e c e p t o r s  f o r  a g o n i s t s  by 
b i n d i n g  p e r i p h e r a l  s i t e s  ( a l l o s t e r i c )  on t h e  r e c e p t o r  i t s e l f  o r  
a s s o c i a t e d  membrane.
Nervous  System R e g u l a t i o n  o f  Airway R e a c t i v i t y
Tone o f  a i r w a y  smooth m usc le  and s e c r e t i o n  by muco se ro us  g l a n d s  
l i n i n g  t h e  a i r w a y s  i s  assumed t o  be d e t e r m in e d  by a b a l a n c e  between t h e  
p a r a s y m p a t h e t i c  ( c h o l i n e r g i c ) ,  s y m p a t h e t i c  ( a d r e n e r g i c )  and p o s s i b l y  a 
n o n - a d r e n e r g i c  ( p u r i n e r g i c )  n e r v o u s  s y s t e m s . 3 4 , 6 2 , 6 3  
S t i m u l a t i o n  o f  t h e s e  s y s t em s  r e s u l t s  in  e i t h e r  (1)  a c o n t r a c t i o n  o r
Alpha A d r e n e r g i c  C h o l i n e r g i c
guany l  c y c l a s e  
cGMP
SRS-A ( l e u k o t r i e n e s )
H i s t a m i n e
o t h e r s
F i g u r e  3 -  Mechanism f o r  r e c e p t o r  m e d i a t e d  r e l e a s e  o f  
b r o n c h o a c t i v e  a g e n t s  which  may c a u s e  c o n t r a c t i o n  o f  a i r w a y  
smooth  m u s c l e .
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r e l a x a t i o n  o f  a i rw ay  smooth m usc le  and (2) s e c r e t i o n  or  i n h i b i t i o n  o f  
s e c r e t i o n  o f  mucoserous  g l a n d s  l i n i n g  t h e s e  a i r w a y s .
C h o l i n e r g i c  n e r v o u s  s y s t e m . E f f e r e n t  p a r a s y m p a t h e t i c  pathways  in 
mammals a r i s e  in  t h e  v a g a l  n u c l e i  o f  t h e  b r a i n  t o  e v e n t u a l l y  s y n a p se  on 
g a n g l i a  l o c a t e d  in  t h e  submucosal  and e x t r a c h o n d r a l  r e g i o n s  e x t e r n a l  t o  
a i r w a y  smooth m u s c l e .  P o s t g a n g l i o n i c  f i b e r s  e x t e n d  from t h e s e  g a n g l i a  
t o  n e a r b y  a i r w a y  smooth m usc le  and s e c r e t o r y  g l a n d s .  The p r i m a ry  
p o s t s y n a p t i c  r e c e p t o r s  a r e  n i c o t i n i c  f o r  t h e  p r e s y n a p t i c  e f f e r e n t  
p a th w ay ,  and m u s c a r i n i c  f o r  t h e  p o s t - s y n a p t i c  pa thway .  The major  
n e u r o t r a n s m i t t e r  i s  a c e t y l c h o l i n e .  S t i m u l a t i o n  o f  t h e s e  c h o l i n e r g i c  
r e c e p t o r s  by a c e t y l c h o l i n e ,  5 - h y d r o x y t r y p t a m i n e  and o t h e r  m u s c a r i n i c  or 
n i c o t i n i c  a g o n i s t s  c a u s e s  a i rw a y  smooth m uscl e  t o  c o n t r a c t .
In v i t r o , h o r s e  lung  parenchymal  s t r i p s  c o n t r a c t  when t r e a t e d  wi th  
m u s c a r i n i c  a g o n i s t s  l i k e  c a r b e c h o l .  Thi s  r e s p o n s e  can be b locked  by 
p r e t r e a t m e n t  w i th  t h e  a n t i c h o l i n e r g i c  drug a t r o p i n e .  These 
p h a r m a c o l o g i c a l  r e s p o n s e s  s u g g e s t  t h a t  t h e  c h o l i n e r g i c  i n n e r v a t i o n  o f  
e q u i n e  lung  i s  i d e n t i c a l  in  r e s p o n s e  t o  t h e  c h o l i n e r g i c  sys tem s  o f  o t h e r  
mammal s .
A d r e n e r g i c  n e r v o u s  s y s t e m . The b a l a n c i n g  s y m p a t h e t i c  p r e g a n g l i o n i c  
i n n e r v a t i o n  i s  t h o u g h t  t o  b e g in  w i th  p r e g a n g l i o n i c  c e l l  b o d i e s  in  t h e  
s p i n a l  c o r d .  P r e g a n g l i o n i c  a d r e n e r g i c  f i b e r s  s y n a p s e  on p a r a v e r t e b r a l  
( p r e v e r t e b r a l ) g a n g l i a  and p o s t g a n g l i o n i c  f i b e r s  e x i t  t h e  g a n g l i a  and 
i n n e r v a t e  a i r w a y  smooth m u s c l e ,  s e c r e t o r y  g l a n d s  and t h e  pulmona ry  
v a s c u l a t u r e .  The n e u r o t r a n s m i t t e r s  f o r  t h e  p r e g a n g l i o n i c  pathway i s  
a c e t y l c h o l i n e  and t h e  p o s t g a n g l i o n i c  i s  n o r e p i n e p h r i n e .  The
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p r e g a n g l i o n i c  p o s t s y n a p t i c  r e c e p t o r  i s  n i c o t i n i c ,  w h i l e  t h e  
p o s t g a n g l i o n i c  p o s t s y n a p t i c  r e c e p t o r  i s  e i t h e r  a l p h a  o r  b e t a  a d r e n e r g i c .  
S t i m u l a t i o n  o f  t h e  b e t a  r e c e p t o r  o f  t h e  s y m p a t h e t i c  n e r v o u s  sys tem 
r e s u l t s  i n  a r e l a x a t i o n  o f  a i r w a y  smooth m u s c l e .  Alpha r e c e p t o r  
s t i m u l a t i o n  e l i c i t s  a c o n t r a c t i o n  o f  a i rw ay  smooth m u s c l e .
In v i t r o ,  h o r s e  lung parenchymal  s t r i p s  c o n t r a c t  when t r e a t e d  w i t h  
t h e  a l p h a  r e c e p t o r  a g o n i s t s  e p i n e p h r i n e ,  n o r e p i n e p h r i n e  (NE) and 
p h e n y l e p h r i n e . 6 4  This  r e s p o n s e  i s  n o t  b lo ck ed  by t r e a t m e n t  wi th  
i s o p r o t e r e n o l  ( b e t a - 2  s t i m u l a t o r ) ,  an a n t i h i s t a m i n e ,  o r  a t r o p i n e ,  b u t  i s  
r e v e r s e d  by t h e  a l p h a  b l o c k e r ,  p h e n t o l a m i n e .  I s o p r o t e r e n o l  r e l a x e s  
t h e s e  parenchymal  s t r i p s  when g iv e n  a l o n e .  T h e r e f o r e ,  t h e s e  f i n d i n g s  
r e p r e s e n t  i n d i r e c t  e v i d e n c e  t h a t  t h e  s y m p a t h e t i c  n e r v o u s  sys tem of  
h o r s e s  i s  i d e n t i c a l  in  r e s p o n s e  and t h e r e f o r e  com p ar ab le  t o  sys tem s  in  
o t h e r  mammals.
N o n - a d r e n e r g i c  n e r v o u s  s y s t e m . In a d d i t i o n  t o  t h e  c h o l i n e r g i c  and 
a d r e n e r g i c  p a t h w a y s ,  a n o n - a d r e n e r g i c  o r  a p u r i n e r g i c  i n h i b i t o r y  pathway  
which r e l a x e s  a i rw a y  smooth m us cl e  has  been i d e n t i f i e d . 20 The 
s u s p e c t e d  i n h i b i t o r y  n e u r o t r a n s m i t t e r s  o f  t h e  p u r i n e r g i c  o r  
n o n - a d r e n e r g i c  sys tem s  a r e  e i t h e r  p u r i n e s  l i k e  ATP and a d e n o s i n e ,  or  
v a s o a c t i v e  i n t e s t i n a l  p o l y p e p t i d e  (V I P) ,  r e s p e c t i v e l y . 6 3 , 6 5 , 6 6  
R e c e p t o r s  (P^ and P2 ) f o r  t h e  n u c l e o s i d e  t r a n s m i t t e r s  have been 
i n d i r e c t l y  i d e n t i f i e d .  VIP i s  a p e p t i d e  n e u r o t r a n s m i t t e r  f i r s t  
i d e n t i f i e d  in  t h e  g a s t r o i n t e s t i n a l  t r a c t  which i s  s u s p e c t e d  t o  be 
c o - r e l e a s e d  w i t h  a c e t y l c h o l i n e  o r  n o r e p i n e p h r i n e  and i s  n o t  a component  
o f  t h e  p u r i n e r g i c  n e r v o u s  sy s t em .  N o n - a d r e n e r g i c  i n h i b i t o r y  r e s p o n s e s  
may be a r e s u l t  o f  p o s t - g a n g l i o n i c  f i b e r s  s y n a p s i n g  on e x c i t a t o r y
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p r e s y n a p t i c  f i b e r s ,  o r  a p r e g a n g l i o n i c  i n h i b i t i o n ,  and n o t  t h e  r e s u l t  of  
d i r e c t  r e c e p t o r  m e d i a t e d  i n h i b i t i o n  o f  a i r w a y  smooth m usc le  as  o b s e r v ed  
f o r  t h e  a d r e n e r g i c  p a t h w a y s .
H e t e r o g e n e i t y  o f  P h a r m a c o l o g i c a l  R espon ses  i n  t h e  Horse Lung.
The amount o f  r e l a x a t i o n  o r  c o n t r a c t i o n  in  h o r s e  lung parenchymal  
s t r i p s  as p r e v i o u s l y  d e s c r i b e d  can v a r y  q u a n t i t a t i v e l y  and 
q u a l i t a t i v e l y ,  and t h e  h e t e r o g e n e i t y  o f  t h e s e  p h a r m a c o l o g i c a l  r e s p o n s e s  
depends  upon t h e  a n a t o m i c a l  o r i g i n  o f  t h e  lu ng  s t r i p  and t h e  dose  o f  t h e  
d ru g  a g o n i s t .  As an ex a m p l e ,  h o r s e  lung parenchymal  s t r i p s  c o n t r a c t  
more t o  h i s t a m i n e  t h a n  t o  c a r b a c h o l . The o p p o s i t e  o c c u r s  in 
t r a c h e o b r o n c h i a l  smooth m u s c l e ,  where  c o n t r a c t i o n  t o  c a r b a c h o l  i s  
g r e a t e r  t h a n  t h a t  f o r  h i s t a m i n e .  However,  in c o n t r a s t  t o  o t h e r  mammals, 
5 - h y d r o x y h y p ta m in e  ( 5 - H t )  does  n o t  c o n t r a c t  in  v i t r o  h o r s e  lung 
parenchymal  s t r i p s . 64 T h i s  s u g g e s t s  t h a t  t h e  r e c e p t o r s  f o r  t h e s e  
compounds a r e  n o t  hom og eneous ly  d i s t r i b u t e d  t h r o u g h o u t  t h e  l u n g .
A l t e r a t i o n  o r  E x c e s s i v e  S t i m u l a t i o n  o f  P h a r m a c o l o g ic a l  R e c e p t o r s  in  3MI 
Induced COPD in  Horses
I t  i s  l i k e l y  t h a t  a l t e r a t i o n s  in  t h e  s e n s i t i v i t y  o f  p h a r m a c o l o g i c a l  
r e c e p t o r  i n  t h e  l ung  can p ro d u c e  ch a n g es  in  t h e  t o n e  o f  a i r w a y  smooth 
m u sc l e  which in  t u r n  c a u s e  c o n t r a c t i o n  and o b s t r u c t i o n  o f  t h e  a i r w a y s .  
Many t h e o r i e s  have been p r e s e n t e d  f o r  mechanisms which may c a u s e  ch a n g es  
i n  a i r w a y  t o n e .  I t  has  been h y p o t h e s i z e d  t h a t  in a s th m a ,  t h e  b e t a - t w o  
r e c e p t o r  sys tem  r e s p o n s i b l e  f o r  t h e  r e l a x a t i o n  component  o f  a i r w a y  t o n e  
h as  r e d u c e d  r e s p o n s i v e n e s s . 6 7  Some i n v e s t i g a t o r s  f e e l  t h a t  b e t a
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r e c e p t o r s  can be c o n v e r t e d  by t o x i c  i n s u l t  or  c o l d - a i r  t o  a lp h a  
r e c e p t o r s  which in  t u r n  p ro d u c e  b r o n c h o c o n s t r i c t i o n . 6 8  Another  
p ro p o s e d  mechanism f o r  a i r w a y  h y p e r r e a c t i v t y  i s  e x c e s s i v e  c h o l i n e r g i c  
r e c e p t o r  s t i m u l a t i o n . 69
COPD as  i t  o c c u r s  in  t h e  S o u t h e a s t e r n  U n i t ed  S t a t e s  may be 
a s s o c i a t e d  w i t h  i n g e s t i o n  o f  f o r a g e  m a t e r i a l s  c o n t a i n i n g  h ig h  l e v e l s  o f  
i n d o l i c  compounds.  These  i n d o l e s  may be in  t u r n  c o n v e r t e d  t o  
3 -m e thy l  i n d o l e  o r  an i n d o l i c  compound w i th  s i m i l a r  s t r u c t u r e  a c t i v i t y  
r e l a t i o n s h i p s .  T h e r e f o r e ,  i t  i s  a p p a r e n t  t h a t  t h e  chang es  in  pulmonary  
f u n c t i o n  in  h o r s e s  and t h e  mechanism f o r  p r o d u c t i o n  o f  3MI -  induced  
lung d i s e a s e  s h o u l d  be d e t e r m i n e d .
S in c e  t h e  c l i n i c a l  s i g n s  and chang es  in  pulmonary  f u n c t i o n  of  
3 MI- indu ced  lun g d i s e a s e  and COPD a r e  s i m i l a r ,  i t  i s  p o s s i b l e  t h a t  t h e  
mechanism o f  3M I- induc ed  t o x i c i t y  c o u ld  be t h e  r e s u l t  o f  a l t e r a t i o n s  in 
r e c e p t o r  f u n c t i o n s  in  t h e  lung by one o f  t h e  mechanisms p r e v i o u s l y  
d e s c r i b e d .  Because  changes  in  a i r w a y  r e s i s t a n c e  a f t e r  t r e a t m e n t  wi th  
3MI a r e  r e v e r s e d  t o  some d e g r e e  by t h e  c h o l i n e r g i c  r e c e p t o r  b l o c k e r  
a t r o p i n e ,  t h e  mechanism o f  t o x i c i t y  f o r  3MI c o u ld  be t h e  r e s u l t  o f  
d i r e c t  o r  i n d i r e c t  i n t e r a c t i o n  o f  3MI w i th  lung c h o l i n e r g i c  n e u r a l  
p a thways  or  r e c e p t o r s .  The p u r p o s e  o f  t h i s  d i s s e r t a t i o n  i s  t o  (1) 
e s t a b l i s h  t h a t  low d o s e s  o f  3MI p ro d u c e  a r e v e r s i b l e  a i r w a y  o s t r u c t i o n  
in  h o r s e s  which i s  s i m i l a r  t o  t h a t  o b s e r v e d  f o r  f o r a g e  r e l a t e d  COPD, (2) 
d e t e r m i n e  t h e  p h a r m a c o k i n e t i c s  o f  3MI and r e l a t e  i t s  b i o a v a i l a b i l i t y  and 
d i s p o s i t i o n  t o  o n s e t  and d u r a t i o n  f o r  r e s p o n s e s  o f  t h e  l u n g ,  and (3) t o  
i n v e s t i g a t e  t h e  p o s s i b i l i t y  t h a t  t h e  mechanism o f  3MI- induced t o x i c i t y
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and t h u s  f o r a g e  r e l a t e d  COPD i n v o l v e s  i n t e r a c t i o n  o f  3MI o r  i t s  
m e t a b o l i t e s  w i t h  m u s c a r i n i c - c h o l i n e r g i c  r e c e p t o r s  o f  e q u i n e  l u n g .
Chapter I I
PULMONARY DYNAMICS OF LOW DOSES OF 3-METHYLINDOLE IN HORSES
INTRODUCTION
Heaves o r  e q u i n e  COPD in  t h e  S o u t h e a s t e r n  Uni t ed  S t a t e s  i s  a s s o c i a t e d  
w i t h  g r a z i n g  on l u s h  p a s t u r e s .  T h i s  c o n d i t i o n  u s u a l l y  a r i s e s  in t h e  s p r i n g  
months  and p e r s i s t s  u n t i l  t h e  growing s ea s o n  i s  o v e r  in  t h e  e a r l y  f a l l .  The 
c l i n i c a l  s i g n s  o f  f o r a g e  r e l a t e d  he aves  o f t e n  s u b s i d e  when h o r s e s  a r e  
removed f rom t h e  p a s t u r e .
At p r e s e n t ,  t h e  c a u s e  f o r  f o r a g e  r e l a t e d  e q u i n e  COPD in  t h e  S o u th ­
e a s t e r n  U.S.  i s  unknown, b u t  h y p e r s e n s i t i v i t y  t o  m o ld s ,  i n f e c t i o n  and 
d i e t a r y  f a c t o r s  a r e  a l l  p o s s i b l e  e t i o l o g i e s .  R e c e n t l y ,  3-m ethyl  i n d o l e  (3MI) 
has  been s u g g e s t e d  as  a p o s s i b l e  a g e n t  r e s p o n s i b l e  f o r  p r o d u c t i o n  o f  COPD in 
h o r s e s . 18 ,58  Thi s  ch e m ic a l  has  been found t o  p rod uc e s e v e r e  lung 
d i s e a s e  in  c a t t l e ,  sh ee p  and g o a t s ,  when a d m i n i s t e r e d  o r a l l y  and 
i n t r a v e n o u s l y  and has  been o b s e r v e d  in  t h e  p lasma o f  c a t t l e  s u f f e r i n g  from 
t h e  n a t u r a l l y  o c c u r i n g  r e s p i r a t o r y  d i s e a s e , f o g  f e v e r . 4 3 , 4 9 - 5 5  i t  i s  
p o s s i b l e  t h a t  h o r s e s  g r a z i n g  on lu s h  f o r a g e  p a s t u r e s  a r e  consuming 
s u f f i c i e n t  q u a n t i t i e s  o f  i n d o l i c  compounds which a r e  m e t a b o l i z e d  t o  t h e  
p e r c u r s o r  p n eu m o to x in ,  3MI o r  some i n d o l e  w i th  s t r u c t u r e  a c t i v i t y  
r e l a t i o n s h i p  s i m i l a r  t o  3MI.
Oral  and i n t r a v e n o u s  a d m i n i s t r a t i o n  o f  3MI t o  h o r s e s  and p o n i e s  a t  
d o s a g e s  o f  100 mg/kg body w e ig h t  and g r e a t e r  p roduced  d y sp n ea  and t a c h y p n e a  
which was most  s e v e r e  f rom 24 t o  72 h o u r s  a f t e r  d o s i n g . 58,61 /\t 72
h o u r s  a f t e r  d o s i n g ,  r e s p i r a t o r y  em b a ra s s m e n t ,  hypoxemia and a p ro no un ced  
d o u b l e  e x p i r a t o r y  were o b s e r v e d . 58 These c l i n i c a l  s i g n s  c o n t i n u e d  t o  
i n c r e a s e  i n  i n t e n s i t y  f o r  up t o  7 day s  a f t e r  d o s i n g .  Oral  a d m i n i s t r a t i o n  o f
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3MI a t  100 mg/kg t o  p o n i e s  ca u s ed  s i g n i f i c a n t  i n c r e a s e s  in f u n c t i o n a l  
r e s i d u a l  c a p a c i t y  w i t h  d e c r e a s e d  s p e c i f i c  dynamic co m p l i a n c e  and s p e c i f i c  
r e s p i r a t o r y  c o n d u c ta n c e  a t  24 and 48 h o u r s  a f t e r  d o s i n g . 61 These 
ch a n g e s  were  s u g g e s t e d  t o  be c o n s i s t e n t  w i t h  a d i a g n o s i s  o f  e x t e n s i v e  
o b s t r u c t i o n  o f  t h e  smal l  a i r w a y s .
O b s t r u c t i o n  o f  t h e  s m a l l e r  a i r w a y s  was co n f i r m e d  by p o s t -m o r tem  
e x a m i n a t i o n  o f  t h e  lu n g s  o f  3MI t r e a t e d  h o r s e s  and p o n i e s . 58 ,59  i n b0th  
s p e c i e s ,  t h e  p r e d o m in a n t  l e s i o n  was a b r o n c h i o l a r  e p i t h e l i a l  n e c r o s i s  o r  
b r o n c h i o l i t i s .  B r o n c h i o l i t i s  u n d o u b t e d l y  was r e s p o n s i b l e  f o r  t h e  a p p a r e n t l y  
i r r e v e r s i b l e  o b s t r u c t i o n  o f  t h e  s m a l l e r  a i r w a y s  and t h e  changes  in  pulmonary  
f u n c t i o n  o b s e r v e d  a f t e r  a d m i n i s t r a t i o n  o f  3MI a t  t h e s e  h i g h e r  d o s e s .
The e x t e n s i v e  i r r e v e r s i b l e  s t r u c t u r a l  damage p roduc ed  by 3MI a t  
d o s a g e s  o f  100 mg/'kg o r  g r e a t e r  seems t o  p r e c l u d e  h i g h e r  do ses  o f  3MI as 
b e i n g  r e s p o n s i b l e  f o r  i n d u c t i o n  o f  r e v e r s i b l e  f o r a g e  r e l a t e d  COPD as  i t  
o c c u r s  in t h e  S o u t h e a s t e r n  U n i t ed  S t a t e s .  However,  t h e  d e t e r m i n a t i o n  o f  
t h e  ch a n g e s  in  pulmon ary f u n c t i o n  and p o t e n t i a l  r e v e r s i b i l i t y  o f  t h e s e  
ch a n g es  as a r e s u l t  o f  a d m i n i s t r a t i o n  o f  low d o s e s  o f  3MI in  h o r s e s  has not  
been  i n v e s t i g a t e d .  The a d m i n i s t r a t i o n  o f  3MI a t  low d o s e s  may p o s s i b l y  
p ro d u c e  r e v e r s i b l e  chang es  in  t h e  pulmonary  dynamic v a r i a b l e s  o f  r e s p i r a t o r y  
r a t e ,  t i d a l  volume,  t h o r a c i c  gas  volume,  f l o w  and a i r w a y  r e s i s t a n c e  s i m i l a r  
t o  t h o s e  o b s e r v e d  in  f o r a g e  r e l a t e d  COPD in  h o r s e s .  In t h i s  s t u d y ,  t h e  
ch a n g es  in  pu lmonary  dynamic v a r i a b l e s  a f t e r  a d m i n i s t r a t i o n  o f  low d o s e s  o f  
3MI were m easured  by whole  body p l e t h y s m o g ra p h y .
The a d v a n t a g e s  t o  t h e  u se  o f  whole body p l e t h y s m o g r a p h y  t o  measu re  
ch a n g es  in  r e s p i r a t o r y  r a t e ,  t i d a l  volume,  t h o r a c i c  gas  volume,  f lo w  and 
a i r w a y  r e s i s t a n c e  a r e  (1) t h e  n o n - i n v a s i v e n e s s  o f  t h e  t e c h n i q u e  (2) t h e
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a c c u r a t e - s e n s i t i v e  measurement  o f  a i rw ay  r e s i s t a n c e  and (3) t h e  r a p i d  n a t u r e  
by which d a t a  can be g a t h e r e d  and s t o r e d  on a s t r i p - c h a r t  p o l y g r a p h  f o r  
m a i n t a i n i n g  permanen t  r e c o r d s .
The p u r p o s e  o f  t h i s  e x p e r i m e n t  was t o  (1) d e t e r m i n e  t h e  a c u t e  e f f e c t s  
o f  low o r a l  d o s e s  o f  3MI on t h e  pu lmonary  dynamic f u n c t i o n  o f  h o r s e s  u s i n g  
whole  body p l e t h y s m o g r a p h y  and t o  (2)  compare t h e s e  chang es  t o  t h o s e  
o b s e r v e d  in  COPD h o r s e s .
MATERIALS AND METHODS
Animals
S ix  h o r s e s ,  4 m al es  and 2 f e m a l e s ,  be tween 2 and 11 y e a r s  o f  age w i th  
body w e i g h t s  r a n g i n g  f rom 238 t o  457 kg were used in  t h i s  s t u d y .  B efo r e  
each  e x p e r i m e n t ,  h o r s e s  were examined f o r  p r e - e x i s t i n g  r e s p i r a t o r y  d i s e a s e  
and found  t o  have c l i n i c a l l y  normal  r e s p i r a t o r y  f u n c t i o n .
Dose P r e p a r a t i o n  and Dosing
3-Methyl  i n d o l e 3 was d i s s o l v e d  in  cor n  o i l  t o  a f i n a l  c o n c e n t r a t i o n  o f  
27 mg/ml f o r  t h e  10 mg/kg d o sag e  and 62 mg/kg f o r  t h e  20 mg/kg d o s a g e .  Each
o f  t h e  s i x  h o r s e s  was dosed  w i th  t h e  3MI co r n  o i l  p r e p a r a t i o n  a t  bo th  10
mg/kg and 20 mg/kg body w e i g h t .  The minimum t i m e  i n t e r v a l  be tween a d m i n i ­
s t r a t i o n  o f  t h e  f i r s t  and second d o se  was a t  l e a s t  two weeks .  The 3MI was 
a d m i n i s t e r e d  a f t e r  an o v e r n i g h t  f a s t  u s i n g  a n a s o - g a s t r i c  t u b e  which was 
f l u s h e d  w i th  t h r e e  60 ml volumes o f  t a p  w a te r  t o  remove any r e m a i n in g  3MI.
Three  o f  t h e  h o r s e s  r e c e i v e d  t h e  low do sag e  f i r s t  and t h r e e  r e c e i v e d  t h e
h ig h  do sag e  f i r s t .
a -  Sigma Che m ica l ,  S t .  Loui s  Mo.
31
Pulmonary Dynamic Measurements
D e t e r m i n a t i o n  o f  t i m e  d e r i v a t i v e  v a r i a b l e s . Pulmonary dynamic v a r i ­
a b l e s  o f  r e s p i r a t o r y  r a t e ,  e x p i r a t o r y / i n s p i r a t o r y  t i m e  r a t i o ,  t i d a l  volume,  
m i n u te  volume,  f l o w  and a i r w a y  r e s i s t a n c e  were d e t e r m in e d  u s i n g  a whole body 
p l e th y s m o g ra p h  s p e c i a l l y  d e s i g n e d  f o r  h o r s e s . R e s p i r a t o r y  r a t e ,  t i d a l  
volume and f l o w  were m easur ed  d i r e c t l y  u s i n g  a pneum otachog raph^  d i f f e r ­
e n t i a l  p r e s s u r e  t r a n s d u c e r 0 s y s t e m  as i l l u s t r a t e d  in  F i g u r e  1. Mouth and 
box p r e s s u r e  were a l s o  m easu red  w i t h  d i f f e r e n t i a l  p r e s s u r e  
t r a n s d u c e r s 1̂ e f o r  use  in c a l c u l a t i n g  t h o r a c i c  gas  volume and a i rw ay  
r e s i s t a n c e .  Al l  d a t a  were  r e c o r d e d  on a p o l y g ra p h ^  u s i n g  h e a t  s e n s i t i v e  
p a p e r .
D e t e r m i n a t i o n  o f  T h o r a c i c  Gas Volume
T h o r a c i c  gas  volume was d e t e r m i n e d  by p l e t h y s m o g ra p h y  as d e s c r i b e d  by 
DuBois e t  a l . ^ l  Th i s  measuremen t  was d e t e r m in e d  by p l a c i n g  t h e  h o r s e  
i n t o  t h e  p l e t h y s m o g r a p h .  Whi le  s t a n d i n g  in  t h e  p l e t h y s m o g r a p h ,  t h e  h o r s e  
b r e a t h e d  i n t o  a f a c e  mask t o  which a t r a n s d u c e r ^  was c o n n e c t e d  f o r  
d e t e r m i n a t i o n  o f  mouth p r e s s u r e .  A s e p a r a t e  t r a n s d u c e r 6 was a l s o  
c o n n e c t e d  t o  t h e  p l e t h y s m o g ra p h  f o r  m e a s u r in g  box p r e s s u r e  which when 
c a l i b r a t e d  was r e l a t e d  t o  volume changes  in t h e  lung  d u r i n g  i n s p i r a t i o n  and
b -  F l e i s c h  #4 D y n a s c i e n c e s ,  Blue B e l l ,  Pa.
c -  S ta tham  PM-5E, Hato Rey,  P u e r t o  Rico
d -  S ta tham  PM 131TC, Hato Rey, P u e r t o  Rico
e -  S ta tham  PM 9 7 ,  Hato Rey, P u e r t o  Rico
f  -  VR-6 E l e c t r o n i c s  f o r  M ed ic i ne
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e x p i r a t i o n .  Between t h e  f a c e  mask and t h e  room, as shown in F ig u r e  1 ,  was 
i n t e r p e r s e d  a f o o t  s w i t c h  c o n t r o l l e d  s o l e n o i d  s h u t t e r .  At t h e  end o f  a 
normal  e x p i r a t i o n ,  as d e t e r m i n e d  by o b s e r v i n g  t h e  chang es  in  box p r e s s u r e ,  
t h e  s h u t t e r  was c l o s e d  and t h e  h o r s e  c o n t i n u e d  t o  a t t e m p t  t h e  i n s p i r a t o r y  
m aneuve r .  When t h e  h o r s e  a t t e m p t e d  t o  i n s p i r e  a g a i n s t  t h e  s h u t t e r ,  gas  in 
t h e  lu ng  o r  t h o r a x  was decompressed  and t h e  a s s o c i a t e d  p r e s s u r e  chang es  were 
used  t o  c a l c u l a t e  t h e  volume o f  decompressed  gas  in  t h e  l u n g .  Th i s  volume 
r e p r e s e n t e d  t h o r a c i c  gas  volume.
D e t e r m i n a t i o n  o f  Airway R e s i s t a n c e
Ai rway r e s i s t a n c e  was d e t e r m in e d  by p l e th y s m o g r a p h y  u s i n g  t h e  method of  
DuBois e t  a l .  as  m o d i f i e d  f o r  t i d a l  b r e a t h i n g  by Jonson and 
B o u h u y s . 7 2 , 7 3  j h e  v a l u e s  f o r  a i rw ay  r e s i s t a n c e  were c a l c u l a t e d  from t h e  
e q u a t i o n
P -  P
-ELLY !E_> where Pa i v e q u a l s  a l v e o l a r
p r e s s u r e ,  Pm e q u a l s  mouth p r e s s u r e  and V equa l  f l o w .  A l v e o l a r  p r e s s u r e  
( P a l v ) was d e t e r m in e d  u s i n g  t h e  method d e s c r i b e d  by Jonson and 
B o u h u y s .7 ^
Data  and S t a t i s t i c a l  A n a l y s i s
R e s p i r a t o r y  r a t e ,  t i d a l  volume,  m i n u te  volume,  and i n s p i r a t o r y  and 
e x p i r a t o r y  f l o w  and r e s i s t a n c e  a t  25 ,  50 ,  and 75% o f  t i d a l  volume were
F i g u r e  1 -  Design o f  t h e  whole  body p l e th y s m o g ra p h  f o r  h o r s e s .
Mouth P r e s s u r e
S o le n o i d
Flow
Box P r e s s u r e
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r e c o r d e d  or  c a l c u l a t e d  a t  0 , 2 , 4 , 6 , 1 0 , 2 4  and 48 h o u r s  a f t e r  a d m i n i s t r a t i o n  
o f  3MI f o r  each  h o r s e  a t  e ach  d o s a g e .  A c o n t r o l  v a l u e  o r  t i m e  0 r e a d i n g  was 
t a k e n  b e f o r e  d o s i n g  w i th  3MI.
The mean _+ S.D.  (n=6) f o r  each  d ose  l e v e l  was d e t e r m i n e d  f o r  r e s p i ­
r a t o r y  r a t e ,  t h e  e x p i r a t o r y / i n s p i r a t o r y  t im e  r a t i o ,  t i d a l  volume,  m in u te  
volume,  and f o r  i n s p i r a t o r y ,  and e x p i r a t o r y  f l o w s  and a i r w a y  r e s i s t a n c e  a t  
t h e  2 5 ,  50 and 75 p e r c e n t  o f  t i d a l  volume lung vo lum es .  The mean o f  each 
p a r a m e t e r  f o r  a s p e c i f i c  t i m e  and dos e  was compared t o  t h e  t im e  z e r o  or  
c o n t r o l  v a l u e  and t o  o t h e r  t i m e s  f rom 2 t o  48 h o u r s  a f t e r  d o s i n g .  S t a t i s ­
t i c a l  s i g n i f i c a n c e  was d e t e r m i n e d  by co m par i so n  o f  means u s i n g  a n a l y s i s  of  
v a r i a n c e  (ANOV) and l e a s t  s i g n i f i c a n t  d i f f e r e n c e  (LSD) a t  P < 0 . 0 5 .
RESULTS
V a r i a b l e s  Not S i g n i f i c a n t l y  Changed by 3MI A d m i n i s t r a t i o n
Means (n=6) f o r  r e s p i r a t o r y  r a t e ,  m i n u te  volume,  t h o r a c i c  gas  volume,  
t h e  e x p i r a t o r y / i n s p i r a t o r y  t i m e  r a t i o ,  t h e  i n s p i r a t o r y  and e x p i r a t o r y  f l ow s  
and e x p i r a t o r y  a i rw a y  r e s i s t a n c e  f o r  t h e  10 and 20 mg/kg d o sag e s  o f  3MI as 
d e t e r m i n e d  f o r  t h e  0 t o  48 ho u r  r e a d i n g s  a r e  shown in  T a b l e s  1-11 and 
F i g u r e s  2 - 8 .  Values  f o r  e ach  o f  t h e s e  p a r a m e t e r s  were n o t  s i g n i f i c a n t l y  
d i f f e r e n t  w i th  r e s p e c t  t o  t i m e  f rom t h e  t i m e  z e r o  c o n t r o l  l e v e l  t o  t h e  48 
hou r  r e a d i n g .
T id a l  Volume
Means (n=6) f o r  t i d a l  volume n o r m a l i z e d  as m i l l i l i t e r s  p e r  k i l o g r a m  of 
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Mean  C h a n g e  in R e sp i r a t o ry  Ra te  
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2 0 m g / K g  3MI 
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F ig u re  2 -  Represents  mean (n=6)  changes in r e s p i r a t o r y  r a t e  ( r r )  f o r
the  10 and 20 mg/kg dosages o f  3MI.
T ab le  1 -  Means +_ S.D.  o f  change (n=6) in  r e s p i r a t o r y  r a t e  f o r  t h e  0 
t o  48 hour  r e a d i n g s  f o r  t h e  10 and 20 mg/kg d o s ag e s  o f  3M1.
Changes in R e s p i r a t o r y  Rate  
( b r e a t h s / m i n u t e )
Time 10 mg/kg 20 mg/kg
0 h r 0 0
2 +1 .5 0 + 2.77 0 .8 0 3 + 2.01
4 +0 .867 + 1 .8 6 2.51 + 2 .8 4
6 +0.215 + 4 .8 9 6 .45 + 1 1 . 0 9
8 - 1 . 2 8 + 3 .2 6 4.51 + 7 .17
10 +0 .9 0 + 2 .2 4 3 .8 5 + 8 . 2 8
24 +0 .2 3 + 3 .9 2 1.24 + 7 . 72
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- •  1 0  m g / K g  3MI
2 0  m g / K g  3MI
Hh
0  2 4 6  8 1 0  2 4  4 8
Time a f t e r  do s in g  (hours)
F ig u r e  3 -  Represents  means (n=6)  o f  minute  volume (Vm-jn ) a f t e r
dosing w i t h  t h e  10 and 20 mg/kg dosages o f  3MI.
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T ab le  2 -  Means (n = 6) f o r  m i n u te  volume f o r  t h e  0 t h r o u g h  48 ho u r  r e a d i n g s  f o r  
t h e  10 and 20 mg/kg d o s a g e s  o f  3MI.
Minute  Volume 
(m l /k g  j m i n u te )
T ime 10 mg/kg 20 mg/kg
0 hr 1 12 .0 108.0
2 1 12.0 117.1
4 9 9 .6 121.9
6 1 09 .9 121.6
8 9 4 . 8 119.1
.10 1 2 8 .3 106 .3
24 111 .4 9 8 .0
48 106 .6 112 .9
THORACIC GAS VOLUME 
m l / K g  Body Weight
•  2 0 m g / K g  3MI 
10 m g / K gc> 1 2 0
r- 1 0 0
2 A 4B
Time a f t e r  d o s i n g  (hours)
Figure 4 -  Represents  means o f  th o r a c i c  gas volume (TGV) normalized
kilogram o f  body weight  (n=6) f o r  th e  10 and 20 mg/kg dosages o f  3MI
40
Tab le  3 -  Means _+ S.D.  (n=6)  o f  t h o r a c i c  gas volume f o r  the  10 and 20 mg/kg
dosages o f  3MI.
T h o r a c i c  Gas Volume 
(m l / k g  Body Weight)
Time
A f t e r
Dosing
10 mg/kg 20 mg/kg
0 hr 1 0 7 + 0 8 110  + 10
2 108 + 09 117 ±  10
4 102 + 07 112 + 10
6 115 ±  10 1 1 8 + 1 9
8 106 + 16 111 + 14
10 1 0 8 + 1 5 112 + 09
24 1 0 4 + 1 3 112 + 12
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2 4  46
Time  a f t e r  d o s i n g  (hours)
Figure 5 -  Represents  means +_ S.D.  o f  the e x p i r a t o r y / i n s p i r a t o r y  t ime  
r a t i o  f o r  the  10 and 20 mg/kg dosages o f  3M1.
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T ab le  4 -  Mean _+ S.D.  ( n = 6 ) o f  t h e  e x p i r a t o r y  t o  i n s p i r a t o r y  t i m e  r a t i o  f o r  
t h e  10 and 20 mg/Kg d o s a g e s  o f  3MI. The p o o led  means (n=12) f o r  bo th  doses  
a r e  g i v e n  in  column t h r e e .
E x p i r a t o r y / I n s p i r a t o r y  Time R a t i o
Time
(H ours ) 10 mg/Kg 20 mg/Kg Pooled X
0 1 .1 0 + 0 .2 7 1 .0 6 + 0 .1 7 1.08
2 1 .18+ 0 .21 1 .1 1 + 0 .1 9 1 .15
4 1 . 1 7 + 0 .1 7 1 . 0 8 + 0 .0 3 1 .1 3
6 1 .2 2 + 0 .1 7 1 .2 4 + 0 .3 7 1 .23
8 1 . 1 8 + 0 .2 0 1 .08 +0 .11 1 .13
10 1 .09+0 .2 1 1 . 22 +0 . 2 0 1.15
24 1 . 1 0 + 0 .2 3 1 .1 6 + 0 .1 6 1 .13















INSPIRATORY FLOW 10  m g / K g  3MI
a •  2 5 %  of  V,
e- — 5 0 %  of Vj
o-.  -o 75°o o f  Vj
5 .0
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•  25%  of  V t
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3 .0 2 4  4 0
Time  a f t e r  d o s i n g  (hours )
Figure 6 -  Represents  means (n=6) o f  i n s p ir a t o r y  f low  at 25 ,  50 and 75% 
o f  in s p ir e d  t i d a l  volume f o r  th e  10 and 20 mg/kg dosages o f  3MI.
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Tab le  5 -  Means +_ S.D.  (n= 6)  o f  i n s p i r a t o r y  f lo w  f o r  the  10 mg/kg dosage of
3 M I .
I n s p i r a t o r y  Flow ( L i t e r s / s e c o n d )  3MI 10 mg/kg
Time
A f t e r
Dosing
P e r c e n t o f  T i d a l  Volume
( Hours) 25% 50% 75%
0 4 . 9 5  + 1 .3 4 4 . 4 0  + 0.71 4 . 3 2  + 0.11
2 4 . 9 5  + 1 . 1 0 4 . 7 0  + 0 .5 9 4 . 3 3  + 0.11
4 4 . 1 7  + 1 .05 3 .9 8  + 0 . 7 0 3 .9 8  + 0 .8 9
6 4 . 8 8  + 1 .1 9 4 . 3 7  + 0 .7 8 3 .9 8  + 0 .7 4
8 4 . 6 7  + 1 .1 8 4 . 1 5  + 0 .8 5 3 .8 8  + 1 .27
10 5 . 2 3  + 0 .3 2 4 . 8 3  + 0 .5 3 5 .4 8  + 0 .11
24 4 . 7 8  + 0.61 4 . 6 8  + 0 .7 3 4 .4 5  + 0 .8 7
48 4 . 3 3  + 0 .5 9 4 . 2 7  + 0 . 6 0 4 . 3 0  + 0 .5 3
I
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Tab le  6 -  Means +_ S .D.  o f  i n s p i r a t o r y  f lo w  f o r  the  20 mg/kg dosage o f  3MI .
I n s p i r a t o r y  Flow ( L i t e r s / s e c o n d )  3MI 20 mg/kg
Time
A f t e r
Dosing
(Hours )
P e r c e n t o f  T i d a l  Volume
25% 50% 75%
0 4 . 2 5  + 0 .7 9 3 . 9 0  + 0 .4 9 3 . 7 0  + 0 .6 0
2 4 . 7 5  + 1 . 3 2  . 4 . 4 8  + 1 . 1 3 4 . 4 8  + 1 .2 5
4 5 . 1 0  + 0.41 4 . 7 0  + 0 .8 6 4 . 7 8  + 0 .9 0
6 5 .2 7  + 0 . 9 4 4 . 8 0  + 1 . 2 2 4 . 9 7  + 1 .2 3
8 4 . 9 7  + 0 .71 4 . 6 8  + 1 .3 9 4 . 7 8  + 1 .0 8
10 4 . 8 8  + 1 .2 0 4 . 7 8  + 1.31 4 .6 7  + 1 . 1 4
24 4 .7 7  + 1 .01 4 . 6 8  + 0 .9 5 4 . 2 3  + 0.91
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Figure 7 -  Represents  means (n=6) o f  e x p i r a t o r y  f low  at 25 ,  50 and 75% 
o f  exp ired  t i d a l  volumes fo r  the 10 and 20 mg/kg dosages o f  3MI.
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T ab le  7 -  Means _+ S.D.  o f  e x p i r a t o r y  f l ow f o r  t h e  10 mg/kg do sag e  of  3MI.
E x p i r a t o r y  Flow ( L i t e r s / s e c o n d )  3MI 10 mg/kg
Time
A f t e r
Dosing
P e r c e n t o f  T id a l  Volume
( Hours) 25% 50% 75%
0 4 . 0 6  + 1 .0 6 4 .2 0  + 1 .1 6 4 . 9 0  + 1 . 02
2 4 .7 5  + 1 .7 3 4 .2 2  + 1 .4 3 5 . 1 0  + 1 .1 4
4 4 . 1 8  + 1 .3 0 3 .6 3  + 0 .8 5 4 . 3 8  + 1 .0 8
6 4 . 2 0  + 1 .7 2 3 .9 2  + 1 .07 4 . 7 0  + 0 .8 6
8 4 . 7 8  + 2 . 17 3 .6 7  + 1 .87 4 . 8 7  + 0 .064
10 5 .4 2  + 1 .1 8 4 . 6 0  + 0 .7 0 4 . 8 2  + 1 .3 8
24 4 . 4 0  + 1 .5 4 3 .8 8  + 0 .9 7 4 . 5 2  + 0 .7 0
48 5 . 1 0  + 1 .3 3 3 .6 8  + 1 .2 0 4 .1 7  + 0 .8 8
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T a b le  8 -  Means _+ S.D.  o f  e x p i r a t o r y  f lo w  f o r  t h e  20 mg/kg do sag e  o f  3MI.
E x p i r a t o r y  Flow ( L i t e r s / s e c o n d )  3MI 20 mg/kg
Time
A f t e r
Dosing
P e r c e n t o f  T i d a l  Volume
( Hours) 25% 50% 75%
0 4 . 0 2  + 2 .01 4 . 0 0  + 0 . 8 6 5 . 0 0  + 1 .3 8
2 4 . 6 7  + 2 .1 6 4 . 2 0  + 1 .8 3 4 . 7 2  + 1 .0 8
4 5 .2 7  + 1 .9 4 4 . 5 3  + 1 .5 4 4 . 7 3  + 1 .06
6 5 .8 8  + 2.81 4 . 8 7  + 2 .2 2 4 . 1 2  + 0 .5 6
8 5 .8 5  + 2 .01 4 . 8 5  + 0 .91 5 . 2 0  + 1 .55
10 5 . 1 3  + 3 .07 3 .9 5  + 1 .4 3 3 .7 7  + 0 . 55
24 3 .9 8  + 1 .5 2 3 .8 8  + 0 .8 6 4 . 2 0  + 1 .3 0














Exp iratory Airway R e s i s t a n c e  (Raw ) 
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E x p i r a t o r y  Airway R e s i s t a n c e  
(Raw) 2 0 m g / K g  3MI
2 5% of V
1.50
50% of Vt 
o - . - o  75% of Vt
1 . 0 0 -
0.5-
2 4  4 8
Time af t er  dos ing  (hours)
F i g u r e  8  -  R e p r e s e n t s  means ( n = 6 ) o f  e x p i r a t o r y  a i r w a y  r e s i s t a n c e  
a t  2 5 ,  50  and 75% o f  e x p i r e d  volume f o r  t h e  10 and 20 mg/kg d o s a g e s  o f  
3MI.
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Tab le  9 -  Means +_ S .D .  o f  e x p i r a t o r y  a i rway  r e s i s t a n c e  f o r  the  10 mg/kg
dosage o f  3MI.
E x p i r a t o r y  Airway R e s i s t a n c e  3MI 10 mg/kg
________ (CM HOH/L SEC-1) ___________________________
Time
A f t e r
Dosing
P e r c e n t o f  T id a l  Volume
Hours 25% 50% 75%
0 0 . 1 4  + 0 .0 8 0 . 2 2  + 0 . 2 0 0 . 2 8  + 0 . 2 2
2 0 . 2 2  + 0 .2 9 0 . 1 5  + 0 .1 5 0 . 2 8  + 0 .3 4
4 0 . 1 4  + 0 .1 0 0 . 2 2  + 0 . 2 1 0 . 3 3  + 0 .3 4
6 0 . 2 0  + 0 .1 7 0 .3 1  + 0 .1 7 0 . 2 2  + 0 .2 8
8 0 . 1 8  + 0 . 1 8 0 .1 5  + 0 .0 7 0 . 3 2  + 0 .2 5
10 0 . 1 0  + 0 .0 8 0 . 1 2  + 0 .1 3 0 . 1 4  + 0 . 11
24 0 . 2 8  + 0 . 2 8 0 .3 2  + 0 . 2 0 0 .2 9  + 0 .2 5
48 0 . 1 0  + 0 .0 9 0 . 2 2  + 0 . 2 8 0 . 2 0  + 0 .1 4
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T ab le  10 -  Means _+ S.D.  o f  e x p i r a t o r y  a i r w a y  r e s i s t a n c e  f o r  the  20 mg/kg
dosage o f  3 M I .
E x p i r a t o r y  Airway R e s i s t a n c e  3MI 20 mg/kg
________ (CM HOH/L SEC-1)_____________________________
Time
A f t e r
Dosing
P e r c e n t o f  T id a l  Volume
Hours 25% 50% 75%
0 0 . 4 4  + 0 . 3 8 0 . 3 8  + 0 .3 0 0 .2 6  + 0 .2 3
2 0 . 2 1  + 0 .2 6 0 . 3 0  + 0 .3 9 0 .3 2  + 0 .1 4
4 0 . 2 7  + 0 .2 3 0 .3 7  + 0 .2 7 0 . 4 3  + 0 .5 6
6 0 . 3 3  + 0 . 3 3 0 . 4 1  + 0 . 4 3 0 . 8 2  + 1 .3 8
8 0 . 1 9  + 0 . 1 8 0 . 2 4  + 0 .3 4 0 . 5 3  + 0 .6 8
10 0 . 4 4  + 0 .3 9 0 .7 9  + 0 .8 8 1 .24  + 1 . 7 9
24 0 . 4 5  + 0 .4 3 0 . 5 8  + 0 .7 4 1 .2 5  + 1 .90
48 0 . 3 2  + 0 . 4 0 0 . 3 0  + 0 .2 1 0 . 3 8  + 0 .4 3
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T ab le  11 -  Poo led means o f  e x p i r a t o r y  a i rw ay  r e s i s t a n c e  f o r  t h e  10 and 20
mg/kg d o s ag e s  o f  3MI.
Poo led  Means o f  E x p i r a t o r y  Airway R e s i s t a n c e  
(CM HOH/L SEC’ 1 )
Time
A f t e r
Dosing
P e r c e n t o f  T i d a l  Volume
( Hours) 25% 50% 75%
0 0 .287 0 .298 0 .266
2 0 . 2 1 2 0 . 2 2 2 0 .3 0 0
4 0 . 2 0 0 0 .2 9 4 0 .464
6 0 .371 0 .3 7 3 0 .569
8 0 .1 8 4 0 .197 0 .425
10 0 .269 0 .4 5 4 0 .694
24 0 .3 6 2 0 .447 0 .858
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Figure 9 -  Represents  means _+ S.O. (n=6) o f  t i d a l  volume in m i l l i l i t e r s  
per ki logram body weight  fo r  the  10 and 20 mg/kg dosages o f  3MI.
T a b le  12 -  Means and p o o led  mean (n=12) f o r  t i d a l  volume (ml p e r  kg of 
body w e i g h t )  f o r  t h e  10 and 20 mg/kg dose  o f  3MI f o r  t h e  0 t h r o u g h  48 
hour
r e a d i n g s .
♦ S i g n i f i c a n t l y  d i f f e r e n t  (P < 0 . 0 5 ) .
T ime 10 mg/kg 20 mg/Kg Pooled  X
0 hr 0 . 0 2 3 3  + .0058 0 . 0 2 2 0  + .0025 0.02 25
2 0 . 0 2 1 0  + .0026 0 .0 2 1 5  + .0021 0 .0214
4 0 .0 2 0 7  + .0031 0 .0 2 0 5  + .0023 0 .0206
6 0 . 0 2 0 0  + .0027 0 .0 1 9 0  + .0035 0 .0193 *
8 0 .0 2 0 5  + .0035 0 . 0 1 9 0  + .0049 0 .019 8*
10 0 .0 2 0 2  + .0027 0 . 0 1 7 7  + .0043 0 . 0 2 0 2 *
24 0 .0 2 2 7  + .0025 0 . 0 2 0 3  + .0055 0.0215
48 0 .0 2 2 5  + .0037 0 . 0 2 0 3  + .0033 0 .0214
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o f  3MI a r e  shown in  F i g u r e  9 .  Norm al iz ed  t i d a l  volume f o r  t h e  10 mg/kg 
d o s a g e  d e c r e a s e d  a t  2 h o u r s  and c o n t i n u e d  t o  d e c r e a s e  t o  i t s  l o w e s t  l e v e l  a t  
8 h o u r s  a f t e r  d o s i n g .  V a lues  f o r  t i d a l  volume a t  10 ,  24 and 48 h o u r s  a f t e r
d o s i n g  were  a p p r o a c h i n g  c o n t r o l  l e v e l s .
Vtkg f o r  t h e  20 mg/Kg dos e  o f  3MI (n =6 ) d e c r e a s e d  a t  2 h o u r s  
r e a c h i n g  i t s  l o w e s t  l e v e l  a t  10 h o u r s  a f t e r  d o s i n g .  Read ings  r e t u r n e d  t o  
n e a r  c o n t r o l  a t  24 and 48 h o u r s  a f t e r  d o s i n g .  S in ce  no s i g n f i c a n t  
d i f f e r e n c e  was o b s e r v e d  between t h e  two d o s a g e s  o f  3MI, means f o r  each  
d o s ag e  were p o o l e d .  Pooled  means (n=12) o f  V-^kg f o r  t h e  two d o s e s  o f  
3MI were s i g n i f i c a n t l y  d e c r e a s e d  f rom t h e  c o n t r o l  m e a n . ( t i m e  0) a t  6 , 8 and 
10 h o u r s  a f t e r  d o s i n g  (T a b le  1 2 ) .
I n s p i r a t o r y  Airway R e s i s t a n c e
I n s p i r a t o r y  a i rw ay  r e s i s t a n c e s  f o r  t h e  10 and 20 mg/kg d o sag e s  a t  25 ,
50 and 75% o f  i n s p i r e d  t i d a l  volume a r e  shown in  F i g u r e s  10 and 11 and 
l i s t e d  in  T a b le s  13 and 14.  S in c e  no s i g n i f i c a n t  d i f f e r e n c e  was o b s e r v e d  
be tw een  t h e  two d o s a g e s  o f  3MI, means a t  a s p e c i f i c  t i m e  and dosag e l e v e l  
f o r  25 ,  5 0 ,  and 75% o f  i n s p i r e d  t i d a l  volume were p o o l e d .  The poo led  means 
o f  i n s p i r a t o r y  a i r w a y  r e s i s t a n c e  f o r  t h e  0 t o  48 hour  r e a d i n g s  as  l i s t e d  in  
T a b le  15 were compared w i t h i n  t h e  t h r e e  lung vo lumes.  At 25% o f  i n s p i r e d  
t i d a l  volume i n s p i r a t o r y  a i r w a y  r e s i s t a n c e  was s i g n i f i c a n t l y  i n c r e a s e d  above 
c o n t r o l  ( t i m e  0) a t  6 , 10 ,  24 and 48 h o u r s  a f t e r  d o s i n g .  For t h e  50% t i d a l  
volume l e v e l ,  i n s p i r a t o r y  r e s i s t a n c e  was s i g n i f i c a n t l y  i n c r e a s e d  above 
c o n t r o l  r e a d i n g s  a t  6 and 24 a f t e r  d o s i n g .  Values  f o r  r e s i s t a n c e  a t  75% o f  
t i d a l  volume were s i g n i f i c a n t l y  i n c r e a s e d  a t  24 and 48 h o u r s  a f t e r  d o s i n g .
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Insp iratory Airway R e s i s t a n c e  10  m g /K g
0 .4 25%  o t V
50%  Of V,









24  4 8
Time a f te r  d os ing  (hours)
F i g u r e  1 0 -  R e p r e s e n t s  means (n = 6 ) o f  i n s p i r a t o r y  a i r w a y  r e s i s t a n c e  
a t  2 5 ,  50  and 75% o f  i n s p i r e d  t i d a l  volume f o r  t h e  10 mg/kg d o s ag e  o f  
3MI.
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Tab le  13 -  Means +_ S.D.  o f  i n s p i r a t o r y  a i rw ay  r e s i s t a n c e  f o r  the  10 mg/kg
dosage o f  3MI.
Airway R e s i s t a n c e  I n s p i r a t o r y  3MI 10 mg/kg 
(CM HOH/L SEC” 1 )
Time
A f t e r
Dosing
P e r c e n t o f  T i d a l  Volume
( Hours) 25% 50% 75%
0 0 . 1 4  + 0 . 1 0 0 . 7 0  + 0 .1 2 0 . 3 4  + 0 . 21
2 0 . 0 6  + 0 .0 4 0 . 1 6  + 0 .0 8 0 . 1 7  + 0 .1 5
4 0 . 1 6  + 0 . 1 0 0 . 2 7  + 0 .1 5 0 . 2 7  + 0 .2 2
6 0 . 1 9  + 0 .1 4 0 . 3 0  + 0 .1 2 0 . 3 0  + 0 .1 5
8 0 . 1 0  + 0 . 0 8 0 . 1 2  + 0 .0 8 0 . 1 4  + 0 .1 4
10 0 . 1 3  + 0 . 1 0 0 .1 7  + 0 .0 9 0 . 1 9  + 0 .1 2
24 0 . 2 4  + 0 .1 3 0 . 2 9  + 0 .2 2 0 . 3 4  + 0 .17











o . r Inspi ra tory  Airway R e s i s t a n c e  
2 0 m g / K g  3MI 
»---- •  25%  of V,
50 %  of Vt 
o  75 % of Vt
ni-
0 2 4 6 8  10  2 4  4 8
Time a f t e r  d o s in g  (hours)
F i g u r e  11 -  R e p r e s e n t s  means (n = 6 ) o f  i n s p i r a t o r y  a i r w a y  r e s i s t a n c e  a t  
2 5 ,  50  and 75% o f  i n s p i r e d  t i d a l  volume f o r  t h e  20 mg/kg d o s a g e  o f  3MI.
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Tab le  14 -  Means _+ S.D.  o f  i n s p i r a t o r y  a i rw ay  r e s i s t a n c e  f o r  the  20 mg/kg
dosage o f  3MI.
Airway R e s i s t a n c e  I n s p i r a t o r y  3MI 20 mg/kg 
(CM HOH/L SEC"1 )
Time
A f t e r
Dosing
P e r c e n t o f  T id a l  Volume
(Hours ) 25% 50% 75%
0 0-11  + 0 . 1 1 0 . 1 3  + 0.11 0 . 1 8  + 0 .0 8
2 0 . 0 7  + 0 .0 9 0 . 1 0  + 0 . 11 0 . 2 2  + 0 .1 4
4 0 . 0 8  + 0 .0 6 0 . 1 3  + 0 .11 0 . 2 8  + 0.31
6 0-24  + 0 . 2 3 0 . 2 4  + 0 .2 9 0 . 2 8  + 0.31
8 0 . 1 6  + 0 .1 9 0 .2 1  + 0 .2 4 0 . 2 8  + 0 .2 8
10 0 . 1 8  + 0 .2 3 0 . 2 7  + 0 .2 8 0.31 + 0 .2 8
24 0 . 2 7  + 0 .2 7 0 . 3 5  + 0.31 0 . 4 0  + 0 .3 3
48 0 . 2 6  + 0 .1 9 0 . 2 8  + 0 .2 7 0 .3 5  + 0 .2 8
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T ab le  15 -  Pooled  means _+ S.D.  o f  i n s p i r a t o r y  a i rw ay  r e s i s t a n c e  f o r  t h e  10 
and 20 mg/kg d o sag e s  o f  3MI.
♦ S i g n i f i c a n t l y  d i f f e r e n t  (P < 0 . 0 5 ) .
P oo le d  Means o f  I n s p i r a t o r y  Airway R e s i s t a n c e  
(CM H0H/L SEC"1 )
Time
A f t e r
Dosing
P e r c e n t of  T i d a l  Volume
(H ou rs ) 25% 50% 75%
0 0 .1 2 3 0 .1 6 8 0 .2 5 8
2 0.061 0 .1 1 6 0 .1 9 2
4 0 .1 2 3 0 . 2 0 0 0 .2 4 4
6 0 .2 1 3 * 0 .2 72* 0 .2 9 2
8 0 .1 2 7 0 .1 6 6 0 .2 0 8
10 0 .1 52* 0 . 2 2 2 0 .2 4 9
24 0 .2 5 4 * 0 .3 2 1 * 0 .370*
48 0 .1 8 0 * 0 .227 0 .307*
DISCUSSION
3-Methyl  i n d o l e  i n d u ced  lu ng  t o x i c o s i s  has  been p r e s e n t e d  as a 
f u n c t i o n a l  model o f  c h r o n i c  o b s t r u c t i v e  pulmonary  d i s e a s e  (COPD) or heaves  
in  h o r s e s . 5 8 ,59  j ^ e pu lm onary  dynamics  o f  COPD in  h o r s e s  have 
been d e s c r i b e d  by Robinson and o t h e r s . 3 8 , 3 9 , 4 0 , 4 1
The r e s p i r a t o r y  r a t e  o f  h o r s e s  w i t h  COPD may be i n c r e a s e d  o r  
unchanged .  When r e s p i r a t o r y  r a t e  i s  i n c r e a s e d ,  i n s p i r a t i o n  t i m e  and 
t i d a l  volume a r e  u s u a l l y  d e c r e a s e d .  Minute  volume may be i n c r e a s e d  o r  
unchanged as w e l l .  The i n c r e a s e  in r e s p i r a t o r y  r a t e  and m i n u te  volume 
a lo n g  w i th  t h e  d e c r e a s e  i n  t i d a l  volume a r e  in  m o s t . c a s e s  t h e  r e s u l t  o f  
d e c r e a s e d  a l v e o l a r  v e n t i l a t i o n  due t o  o b s t r u c t i o n  o f  t h e  a i r w a y s .  Decreased  
a l v e o l a r  v e n t i l a t i o n  c a u s e s  h y p o x ia  and o f t e n  h y p e r c a p n e a .  T o g e t h e r  t h e  
d e c r e a s e  in  t h e  p a r t i a l  p r e s s u r e  o f  oxygen and i n c r e a s e  in  t h e  p a r t i a l  
p r e s s u r e  o f  ca rb o n  d i o x i d e  in  a r t e r i a l  b lood p r o b a b l y  c a u s e  s t i m u l a t i o n  
o f  r e c e p t o r s  r e s p o n s i b l e  f o r  i n c r e a s i n g  v e n t i l a t i o n .  The r e s u l t i n g  
i n c r e a s e s  in  r e s p i r a t o r y  r a t e  and m i n u te  volume a r e  d e s i g n e d  t o  i n c r e a s e  
a l v e o l a r  v e n t i l a t i o n  and t o  c o r r e c t  b lood O2 and CO2 a b n o r m a l i t i e s .  
R e s p i r a t o r y  r a t e  can a l s o  be i n c r e a s e d  by s t i m u l a t i o n  o f  c h e m i c a l - i r r i t a n t  
r e c e p t o r s  l o c a t e d  in  t h e  e p i t h e l i a l  l i n i n g  o f  p e r i p h e r a l  a i r w a y s .
As r e s p i r a t o r y  r a t e  i n c r e a s e s  in  r e s p o n s e  t o  d e c r e a s e d  a l v e o l a r  
v e n t i l a t i o n  and h y p o x i a ,  i n s p i r a t o r y  and e x p i r a t o r y  f l o w s  i n c r e a s e .  Th is  
i n c r e a s e  i n  f lo w  i s  most  n o t i c e a b l e  a t  h i g h e r  lung  v o lu m es .  Whi le  f l o w  a t  
25 and 50 p e r c e n t  o f  e x p i r e d  t i d a l  volume i n c r e a s e s  f o r  COPD h o r s e s ,  f lo w  at  
75% o f  e x p i r e d  t i d a l  volume d e c r e a s e s  i n  h o r s e s  w i t h  COPD. When e x p i r a t o r y  
f l o w  a t  75% o f  e x p i r e d  volume d e c r e a s e s ,  a i rw ay  r e s i s t a n c e  i s  i n c r e a s e d .
62
The d e c r e a s e  in  f l o w  and i n c r e a s e  in  a i r w a y  r e s i s t a n c e  a r e  t h e  r e s u l t  
o f  e i t h e r  ch a n g e s  i n  t h e  lumenal  d i a m e t e r  o f  t h e  a i r w a y s  o r  a l t e r a t i o n  o f  
t h e  dynamic p r o p e r t i e s  which h o ld  a i rw a y s  open d u r i n g  t h e  e x p i r a t o r y  
m an eu v e r .  These  dynamic p r o p e r t i e s  a r e  c o n t r o l l e d  by t h e  e l a s t i c  p r o p e r t i e s  
o f  t h e  l u n g .  R e g a r d l e s s  o f  t h e  c a u s e ,  t h e s e  a i rw a y s  t e n d  t o  c o l l a p s e  
p r e m a t u r e l y  and become o b s t r u c t e d  a t  lower  lung volumes f rom a p r o c e s s  
c a l l e d  dynamic c o m p r e s s i o n .  P rem a tu re  c l o s u r e  o f  t h e s e  a i r w a y s  in  t u r n  
t r a p s  a i r  in  d i s t a l  lung u n i t s ,  i n c r e a s i n g  t h e  volume o f  t r a p p e d  g a s ,  
f u n c t i o n a l  r e s i d u a l  c a p a c i t y  and t h o r a c i c  gas  volumes in t h e  lu n g s  o f  
a f f e c t e d  h o r s e s .
3-Methyl  i n d o l e - i n d u c e d  p n e u m o t o x i c o s i s  c a u s e s  some changes  in pulmonary  
f u n c t i o n  s i m i l a r  t o  t h o s e  o b s e r v e d  f o r  h o r s e s  w i th  COPD. Tab le  16 compares 
t h e  ch a n g es  in  pu lm on ary  dynamic  f u n c t i o n  f o r  COPD h o r s e s  t o  t h o s e  f o r  3MI. 
Changes  in  t i d a l  volume,  r e s p i r a t o r y  r a t e ,  m i n u te  volume,  i n s p i r a t o r y  f lo w  
and t h e  e x p i r a t o r y / i n s p i r a t o r y  t i m e  r a t i o  f o r  3MI t r e a t e d  h o r s e s  in t h i s  
s t u d y  a r e  c o n s i s t e n t  w i th  t h o s e  d e s c r i b e d  p r e v i o u s l y  f o r  COPD h o r s e s .
A s i g n i f i c a n t  d e c r e a s e  in  e x p i r a t o r y  f lo w  and a i r w a y  c o n d u c ta n c e  a t  
75% o f  e x p i r e d  t i d a l  volume as  o c c u r s  i n  h o r s e s  w i t h  COPD was n o t  o b s e r v e d  
in  3MI t r e a t e d  h o r s e s  f rom t h i s  s t u d y .  However,  F i g u r e s  7 and 8 , and T a b le s  
7 - 1 1 ,  p r e s e n t  d a t a  which show a d e c r e a s e  i n  e x p i r a t o r y  f l o w  and an i n c r e a s e  
in  e x p i r a t o r y  r e s i s t a n c e  a t  75% o f  e x p i r e d  t i d a l  volume s i m i l a r  t o  t h a t  
d e s c r i b e d  f o r  COPD h o r s e s .  The d e c r e a s e  i n  e x p i r a t o r y  f l o w  and i n c r e a s e  i n  
a i r w a y  r e s i s t a n c e  s u g g e s t  a sm al l  d e g r e e  o f  smal l  a i rw a y  o b s t r u c t i o n  may be 
p r e s e n t .
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T a b le  16 -  Compar isons  o f  t h e  chang es  in  pulmonary  f u n c t i o n  p a r a m e t e r s  
between COPD and 3MI t r e a t e d  h o r s e s ,  
t  i n c r e a s e d
T d e c r e a s e d
± i n c r e a s e  or  d e c r e a s e d  
-H- no chan ge  o r  s l i g h t  d e c r e a s e  a t  lower  lung volumes
-►t no change o r  s l i g h t  i n c r e a s e
-+ no change
COPD HORSES3 9 ’ 40 3MI T r e a t e d  Horses
(h eavey)  ( 1 0  and 20  mg/kg)
____________________________________________________   (n=6)__
T i d a l  Volume (V-t) i 4
R e s p i r a t o r y  r a t e  ( r r ) ■+f f
Minute  Volume (V min) -+■ ■+
I n s p i r a t o r y  f l o w  (Vj) t i
I n s p i r a t o r y  r e s i s t a n c e  (Ra wl) Unknown i
E x p i r a t o r y  f l o w  (Vf )* -»4
E x p i r a t o r y  r e s i s t a n c e  ( RawE) i f
I n s p i r a t o r y  t i m e  (T j ) 4 4
E x p i r a t o r y  t i m e i i
E x p / I n s p  t i m e  r a t i o  ( E / I ) i
* a t  lower  l un g volumes
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I n c r e a s i n g  o b s t r u c t i o n  o f  t h e  smal l  a i r w a y s  i s  o f t e n  i n s i d i o u s  and 
o f  a s i l e n t  n a t u r e  b e c a u s e  o f  t h e  e x t e n s i v e  c r o s s  s e c t i o n a l  a r e a  o f  a i rw ays  
in  p e r i p h e r a l  r e g i o n s  o f  t h e  l u n g .  T h e r e f o r e ,  e x t e n s i v e  o b s t r u c t i o n  i s  
r e q u i r e d  b e f o r e  c l i n i c a l  s i g n s  o f  d e c r e a s e d  e x p i r a t o r y  f l o w  and i n c r e a s e d  
a i r w a y  r e s i s t a n c e  a r e  p r e s e n t .  I t  i s  l i k e l y  t h a t  t h e  low d o s e s  o f  3MI used 
in  t h i s  s t u d y  were  n o t  s u f f i c i e n t  t o  c a u s e  s e v e r e  f u n c t i o n a l  o r  s t r u c t u r a l  
damage o f  t h e  s m a l l e r  a i r w a y s .  In r e s u l t ,  t h e  v a l u e s  f o r  e x p i r a t o r y  f l ow  
and r e s i s t a n c e  were  n o t  s i g n i f i c a n t l y  d i f f e r e n t  f rom c o n t r o l  v a l u e s  f o r  
h o r s e s  t r e a t e d  w i th  3MI a t  10 and 20 mg/kg d o s a g e s .
When h o r s e s  were g i v e n  l a r g e r  d o s e s  o f  3MI, t h e  r e s u l t  was e x t e n s i v e  
i r r e v e r s i b l e  damage o f  t h e  b r o n c h i o l a r  e p i t h e l i a  o f  t h e  s m a l l e r  p e r i p h e r a l  
a i r w a y s . 5 8 , 5 9  j h e  r e s p i r a t o r y  d i s t r e s s  in duced  by t h e s e  h i g h e r  dosages  
(100 mg/kg o r  g r e a t e r )  was s e v e r e  enough t o  c a u s e  d e a t h  i n  some o f  t h e  
t r e a t e d  h o r s e s .  All h o r s e s  used in  t h i s  s t u d y  s u r v i v e d ,  and t h o s e  h o r s e s  
which had c l i n i c a l  s i g n s  o f  t a c h y p n e a ,  l a b o r e d  b r e a t h i n g  and ch anges  in  
e x p i r a t o r y  f l o w  a f t e r  d o s i n g  w i th  3MI a t  10 and 20 mg/kg ap p ea red  c l i n i c a l l y  
r e c o v e r e d  by t h e  end o f  t h e  e x p e r i m e n t .  Thi s  s u g g e s t s  t h a t  (1) an i r r e v e r ­
s i b l e  s t r u c t u r a l  damage d i d  n o t  o c c u r  a t  lower  d o s e s  o f  3MI o r  t h a t  (2) 
damage t o  t h e  b r o n c h i o l a r  e p i t h e l i a  o r  a l v e o l i  was n o t  s e v e r e  enough t o  
e l i c i t  s i g n i f i c a n t  cha nges  in  e x p i r a t o r y  f l ow  and r e s i s t a n c e .
Changes in  i n s p i r a t o r y  f l o w  and r e s i s t a n c e  have n o t  been r e p o r t e d  f o r  
COPD h o r s e s .  Horses  t r e a t e d  w i th  3MI in  t h i s  s t u d y  were found t o  have 
s i g n i f i c a n t  i n c r e a s e s  in  i n s p i r a t o r y  r e s i s t a n c e  a t  6 ,  10,  24 ,  and 48 h o u r s  
a f t e r  d o s i n g .  T h i s  i n c r e a s e  in  i n s p i r a t o r y  a i rw ay  r e s i s t a n c e  may be 
a t t r i b u t e d  t o  e i t h e r  (1)  a d e c r e a s e  in  t h e  c a l i b e r  o f  c e n t r a l  o r  l a r g e
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a i r w a y s ,  (2) e x t e n s i v e  o b s t r u c t i o n  o f  s m a l l e r  a i r w a y s  or  (3) c o m b in a t io n  of  
l a r g e  and smal l  a i r w a y  o b s t r u c t i o n .
S in c e  t h e  m a jo r  s i t e  o f  damage t o  t h e  a i rw a y s  f o r  h ig h  d o s e s  o f  3MI 
was t h e  b r o n c h i o l a r  e p i t h e l i a ,  one would e x p e c t  t h e  i n c r e a s e d  r e s i s t a n c e  
t o  be c o n f i n e d  m o s t l y  d u r i n g  e x p i r a t i o n  a t  lower  lung volumes as 
p r e v i o u s l y  d e s c r i b e d .  The i n c r e a s e  i n  i n s p i r a t o r y  a i r w a y  r e s i s t a n c e  even a t  
h i g h e r  lung volumes w i t h o u t  a c o m p l im e n ta ry  i n c r e a s e  in  e x p i r a t o r y  a i rw ay  
r e s i s t a n c e  a t  lower  lung  volumes s u g g e s t s  t h a t  some o f  t h e  a i rw ay  
o b s t r u c t i o n  o c c u r r e d  in  t h e  l a r g e  c e n t r a l  a i r w a y s  as a r e s u l t  o f  a d e c r e a s e  
i n  d i a m e t e r  o f  t h e s e  a i r w a y s .
T ab le  17 compares  ch anges  in  pulmonary dynamic v a r i a b l e s  f o r  t h e  100 
mg/kg d o s a g e  o f  3MI60 t o  t h o s e  o b s e r v e d  f o r  t h e  d o s ag e s  o f  10 and 20 
mg/kg used in  t h i s  e x p e r i m e n t .  Changes in  pu lmon ary  f u n c t i o n  f o r  h ig h  and 
low do ses  o f  3MI were s i m i l a r  w i th  i n c r e a s e d  r e s p i r a t o r y  r a t e  and a i rw ay  or 
pulmonary  r e s i s t a n c e  and a d e c r e a s e  in  t i d a l  volume.
At t h e  100 mg/kg d o s ag e  o f  3MI, i n c r e a s e s  in t o t a l  pulmonary  r e s i s t a n c e  
and r e s p i r a t o r y  r a t e  were b lo c k ed  by v ago tom y .61 The d e c r e a s e  in 
r e s p i r a t o r y  r a t e  and t o t a l  pu lmon ary  r e s i s t a n c e  a f t e r  vagotomy s u g g e s t s  t h a t  
a t  l e a s t  p a r t  o f  t h e  i n c r e a s e  in  r e s i s t a n c e  was t h e  r e s u l t  o f  a d y s f u n c t i o n  
o f  normal  au tonomic  b a l a n c e  c o n t r o l  o f  bronchomoto r  t o n e .  As an example ,  
bronchospasm as i t  o c c u r s  in  some forms o f  i n t r i n s i c  as thma r e s u l t s  from 
i n i t i a t i o n  o f  n e u r o g e n i c  r e f l e x e s .  Thi s  o c c u r s  when i r r i t a n t  r e c e p t o r s  
l o c a t e d  in t h e  e p i t h e l i a l  r e g i o n  o f  t h e  t r a c h e o b r o n c h i a l  t r e e  or  p e r i p h e r a l  
a i r w a y s  a r e  s t i m u l a t e d .  Mec han ical  o r  ch e m ica l  s t i m u l a t i o n  c a u s e s  s e n s o r y  
i m p u ls e s  from i r r i t a n t  r e c e p t o r s  in t h e  a i rw ay  e p i t h e l i a l  l i n i n g  t o  be 
c a r r i e d  by a f f e r e n t  v ag a l  f i b e r s  t o  t h e  c e n t r a l  n e r v o u s  s y s t e m  where t h e
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T ab le  17 -  Comparison o f  t h e  changes  in  pulmonary f u n c t i o n  p a r a m e t e r s  
f o r  p o n i e s  t r e a t e d  w i th  3MI (100 m g / k g ) ^ ’£o h o r s e s  t r e a t e d  wi th  3MI 
p o o le d  f o r  t h e  10 and 20 mg/kg d o s a g e s  o f  3MI.
P o n ie s  Horses
100 mg/kg____________________________10 and 20 mq/kg
Vt 4 4
r r 4 4







E / I 4 -*-4
Cdyn 4 ND
^ t o t 4 ND
FRC(TGV) 4 - >
NO -  n o t  d e t e r m in e d
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r e f l e x  a r c  i s  c o m p le t ed  by e f f e r e n t  vaga l  f i b e r s  t o  t h e  b r o n c h i a l  smooth 
m u sc l e  and p o s s i b l y  m as t  c e l l s  l o c a t e d  i n  t h e  submucosal  l a y e r  o f  t h e  a i rw ay  
l i n i n g .
The mechanism f o r  ch em ica l  or  i r r i t a n t  r e c e p t o r  s t i m u l a t i o n  may be 
t h e  r e s u l t  o f  p e r t u r b a t i o n s  o f  t h e  membrane components  r e g u l a t i n g  ion 
c o n d u c ta n c e s  r e s p o n s i b l e  f o r  t h e  e l e c t r o g e n i c  p r o p e r t i e s  o f  t h e s e  s e n s o r y  
r e c e p t o r s .  In a d d i t i o n ,  d e p o l a r i z a t i o n  o f  smooth m usc le  membranes can be 
c a u s e d  by (1) d i r e c t  r e c e p t o r  s t i m u l a t i o n  or  (2) damage t o  t h e  b r o n c h i o l a r  
e p i t h e l i a .  B in d in g  o f  n e u r o t r a n s m i t t e r s  o r  compounds w i th  s i m i l a r  s t r u c t u r e  
a c t i v i t y  r e l a t i o n s h i p s  t o  a n e u r o t r a n s m i t t e r  t o  s p e c i f i c  r e c e p t o r s  can 
c hange  t h e  d e p o l a r i z a t i o n  p r o p e r t i e s  o f  lung c e l l  membranes and ca u s e  
r e l e a s e  o f  i n f l a m m a t o r y  and b r o n c h o a c t i v e  m e d i a t o r s  f rom mast  c e l l s .
B ind ing t o  r e c e p t o r s  i s  e s p e c i a l l y  i m p o r t a n t  f o r  t h o s e  c h o l i n e r g i c  
m u s c a r i n i c  r e c e p t o r s  o f  t h e  e f f e r e n t  vagal  pathways  a s s o c i a t e d  wi th  l o c a l  
c o n t r o l  mechanisms o f  b ro n ch o m o to r  t o n e .  S t i m u l a t i o n  o f  t h e s e  m u s c a r i n i c  
r e c e p t o r s  c a u s e s  b r o n c h o c o n s t r i c t i o n .
Normal au tonom ic  b a l a n c e  can a l s o  be a l t e r e d  by t h e  b i n d i n g  o f  a g o n i s t  
compounds t o  a l p h a  and m u s c a r i n i c  r e c e p t o r s  o f  mas t  c e l l s  w i t h i n  
t h e  l u n g .  S t i m u l a t i o n  o f  m u s c a r i n i c  r e c e p t o r s  on mast  c e l l s  i n c r e a s e  i n t r a ­
c e l l u l a r  l e v e l s  o f  cGMP which e n h a n ce s  r e l e a s e  o f  b r o n c h o a c t i v e  m e d i a t o r s  
l i k e  h i s t a m i n e  and SRS-A. T h i s  sys tem  o f  mast  c e l l s  and m e d i a t o r s  i s  
c o n s i d e r e d  t o  be a l o c a l  c o n t r o l  mechanism f o r  normal  b ronchomoto r  t o n e  and 
mucus s e c r e t i o n  in  t h e  a i r w a y s . 6 O v e r s t i m u l a t i o n  o f  t h i s  s y s t em  coul d  
r e s u l t  i n  an e x a g g e r a t e d  r e s p o n s e ,  e x c e s s i v e  b ro nc hom oto r  t o n e  and an 
i n c r e a s e  in  a i r w a y  r e s i s t a n c e .
Chem ica ls  w i th  s i m i l a r  s t r u c t u r e  a c t i v i t y  r e l a t i o n s h i p s  t o  a c e t y l ­
c h o l i n e  may p o s s i b l y  s t i m u l a t e  e f f e r e n t  vaga l  c h o l i n o r e c e p t o r s  o r  t h o s e  
c h o l i n e r g i c  r e c e p t o r s  on m as t  c e l l s .  I t  i s  p o s s i b l e  t h a t  3MI may i n t e r a c t  
d i r e c t l y  on m u s c a r i n i c  r e c e p t o r s ,  i n d i r e c t l y  by i n h i b i t i n g  m e t a b o l i s m  o f  
e n d o g e n o u s ly  r e l e a s e d  a c e t y l c h o l i n e  or  by a f f e c t i n g  membrane p r o p e r t i e s  
a s s o c i a t e d  w i t h  m u s c a r i n i c  r e c e p t o r - m e d i a t e d  s t i m u l a t i o n  o f  t h e  vaga l  r e f l e x  
pathways  r e s p o n s i b l e  f o r  c o n t r a c t i n g  a i rw ay  smooth m u s c l e .  In r e s u l t ,  t h e  
o b s e r v e d  v a g a l - l i k e  r e f l e x  r e s p o n s e s  t o  3MI which were r e v e r s e d  t o  some 
e x t e n t  by t h e  a d m i n i s t r a t i o n  o f  a t r o p i n e  as r e p o r t e d  by Derksen 
e t  a l . , 6 1  c o u ld  be e x p l a i n e d  on t h e  p re m is e  t h a t  t h e  t o x i c  mechanism was 
t h e  r e s u l t  o f  an o v e r s t i m u l a t i o n  o f  m u s c a r i n i c  r e c e p t o r  f u n c t i o n .
CONCLUSION
A d m i n i s t r a t i o n  o f  10 and 20 mg/kg d o s e s  o f  3MI ca u s e d  ch a n g e s  in  t i d a l  
vo lume,  r e s p i r a t o r y  r a t e  and i n s p i r a t o r y  a i rw a y  r e s i s t a n c e  which were 
b e g i n n i n g  t o  r e v e r s e  w i t h i n  48 h o u r s  a f t e r  d o s i n g .  The i n c r e a s e  in  
i n s p i r a t o r y  a i r w a y  r e s i s t a n c e  was s i m i l a r  t o  t h a t  e x p e c t e d  f o r  n e u r o g e n i c  
i n d u ce d  bronc hos pas m o r  n o n - a l l e r g i c  abnormal  m e d i a t o r  r e l e a s e  as  o c c u r s  in  
i n t r i n s i c  a s th m a .  The mechanism o f  t h i s  n e u r o g e n i c - i n d u c e d  bronchospasm may 
i n v o l v e  i n t e r a c t i o n  o f  3MI w i t h  components  o f  t h e  c h o l i n e r g i c  n e r v o u s  sys tem  
in  t h e  lung e s p e c i a l l y  t h o s e  a s s o c i a t e d  wi th  m u s c a r i n i c  r e c e p t o r  f u n c t i o n .
The f o l l o w i n g  c h a p t e r  i n v e s t i g a t e s  t h e  p h a r m a c o k i n e t i c s  o f  3MI in  
h o r s e s .  U n d e r s t a n d i n g  t h e  p h a r m a c o k i n e t i c s  o f  3MI i s  i m p o r t a n t  t o  
d e t e r m i n i n g  t h e  r e l a t i o n s h i p  between plasma c o n c e n t r a t i o n ,  d i s t r i b u t i o n  and 
t h e  o n s e t  and d u r a t i o n  o f  3MI- induced lung t o x i c i t y  and i t s  i n vo lvem en t  in 
p r o d u c t i o n  o f  n a t u r a l l y  o c c u r i n g  COPD in  h o r s e s .
C h ap te r  I I I
PHARMACOKINETICS OF LOW DOSES OF 3-METHYLINDOLE IN HORSES 
3-Methyl i n d o l e  (3MI) i s  a p o t e n t i a l  p n eu m o to x ican t  which i s  formed 
in  t h e  g a s t r o i n t e s t i n a l  t r a c t  o f  some mammals when t h e  b a c t e r i u m  
L a c t o b a c i l l u s  d e c a r b o x y l a t e s  i n d o l e a c e t i c  a c i d . 46 In a d d i t i o n ,  3MI 
i s  fo u n d  n o t  o n l y  i n  t h e  i n t e s t i n a l  t r a c t  and f e c a l  m a t e r i a l  o f  man, 
h o r s e s  and o t h e r  mammals,  i t  i s  a l s o  a major  c o n s t i t u e n t  o f  c i g a r e t t e  
s m o k e .5 3 , 7 4 , 7 5
N a t u r a l l y  o c c u r r i n g  a c u t e  b o v in e  pulmonary  emphysema ( A B P E )  or 
a t y p i c a l  i n t e r s t i t i a l  pneumonia  has  been a s s o c i a t e d  w i th  i n g e s t i o n  o f  
f o r a g e  c o n t a i n i n g  t r y p t o p h a n  and o t h e r  i n d o l i c  p r e c u r s o r s . 4 3 ,55  
Try p to p h a n  and t h e s e  i n d o l i c  p r e c u r s o r s  a r e  c o n v e r t e d  by i n t r a r u m i n a l  
m i c r o o r g a n i s m s  t o  3MI, which in  t u r n  i s  m e t a b o l i z e d  by t h e  pulmonary 
mixed f u n c t i o n  o x i d a s e  s y s t em  t o  p o t e n t i a l  pneumotoxic  
m e t a b o l i t e ( s ) . 5 5 , 5 6  o r a l  or  i n t r a v e n o u s  a d m i n i s t r a t i o n  o f  3MI t o  
c a t t l e ,  sh ee p  and g o a t s  r e s u l t s  in  an a c u t e  lung  d i s e a s e  c h a r a c t e r i z e d  
by pu lmon ary  edema s i m i l a r  t o  t h a t  s ee n in  A B P E . 5 0 , 5 1 , 5 2 , 5 8 , 6 1
I t  has  been s u g g e s t e d  t h a t  3MI i s  p o s s i b l y  t h e  a g e n t  r e s p o n s i b l e  
f o r  p r o d u c t i o n  o f  f o r a g e  r e l a t e d  h ea v es  o r  c h r o n i c  o b s t r u c t i v e  pu lmon ary  
d i s e a s e  i n  h o r s e s  o f  t h e  S o u t h e a s t e r n  Uni t ed  S t a t e s .  A d m i n i s t r a t i o n  o f  
3MI t o  h o r s e s  a t  d o s a g e s  o f  1 0 0  mg/kg o r  g r e a t e r  p rovokes  b r o n c h i o l a r  
n e c r o s i s  which c a u s e s  t a c h y p n e a ,  dyspnea  and gas  exchange  
a b n o r m a l i t i e s . 5 9 - 6 1  i n c o n t r a s t ,  mea su rem en ts  by whole body 
p l e t h y s m o g r a p h y  o f  t h e  c h a n g e s  in  a i r w a y  r e s i s t a n c e ,  e x p i r a t o r y  f l o w ,  
t i d a l  volume,  t h o r a c i c  gas  volume and r e s p i r a t o r y  r a t e  a f t e r  
a d m i n i s t r a t i o n  o f  3MI a t  10  and 2 0  mg/kg d o sag e s  a r e  c o n s i s t e n t  w i t h  a
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r e v e r s i b l e  o b s t r u c t i v e  pu lm on ary  d i s e a s e  76 .  These  pulmonary 
dynamic ch a n g e s  f i r s t  a p p e a r e d  a t  2 h o u r s  and peaked between 8 and 
10 h o u r s  p o s t - d r u g  a d m i n i s t r a t i o n .  Al l p a r a m e t e r s  were b e g i n n i n g  t o  
a p p r o ac h  c o n t r o l  l e v e l s  a t  48 h o u r s  a f t e r  d o s i n g .
The p u r p o s e  of  t h i s  s t u d y  was t o  d e t e r m i n e  t h e  o r a l  
p h a r m a c o k i n e t i c s  o f  low d o s e  3MI in  h o r s e s .  D e t e r m i n a t i o n  o f  t h e  
h a l f - l i f e ,  e l i m i n a t i o n  c o n s t a n t s  (Ke ] and g ) ,  t o t a l  p lasma 
c l e a r a n c e  ( C l t ) ,  peak p las m a c o n c e n t r a t i o n  (Cpmax) ,  t i m e  t o  
CPmax ( TPmax) and a r e a  und e r  t h e  c u r v e  (AUC) a t  d o sag e s  of
10 and 20 mg/kg 8 .W. may a l l o w  p r e d i c t i o n  o f  t o x i c  p lasma l e v e l s .  From 
t h e s e  p h a r m a c o k i n e t i c  p a r a m e t e r s ,  b i o a v a i l a b i l i t y  and d i s p o s i t i o n  o f  
o r a l l y  dosed  3MI may a l s o  be d e t e r m i n e d .  D e t e r m i n a t i o n  o f  t h e  
b i o a v a i l a b i l i t y  and t h e  p a r a m e t e r s  f o r  d i s p o s i t i o n  o f  3MI w i l l  a l l o w  
c o r r e l a t i o n s  o f  d o s e  and p las m a c o n c e n t r a t i o n  (Cp) w i th  o n s e t  and 
d u r a t i o n  o f  t o x i c  pu lm on ary dynamic c h a n g e s .
MATERIALS AND METHODS 
Anim als ,  Drug P r e p a r a t i o n ,  Dos ing ,  Sampl ing and Sample P r e p a r a t i o n
Six  normal  h e a l t h y  h o r s e s ,  4 m a les  and 2 f e m a l e s ,  be tween 2 and 14 
y e a r s  o f  age  were each dosed  w i th  3-m et hyl  i n d o l e 3 a t  10 and 20 mg/kg 
body w e i g h t .  A w i t h d r a w a l  p e r i o d  o f  two weeks was a l low ed  between 
d o s e s .  3MI was d i s s o l v e d  in co rn  o i l  in c o n c e n t r a t i o n s  o f  27 and 62 
mg/ml f o r  t h e  10 mg/kg and 20 mg/kg d o s e s ,  r e s p e c t i v e l y .  The 3MI-corn
011 p r e p a r a t i o n  was a d m i n i s t e r e d  t h r o u g h  a n a s o - g a s t r i c  t u b e  and 
f o l l o w e d  by t h r e e  60 ml w a t e r  f l u s h e s .  J u g u l a r  b lood  sam pl es  (10 ml)
a -  Sigma C hem ical ,  S t .  L o u i s ,  Mo.
72
were t a k e n  a t  0 , 5 , 1 0 , 1 5 , 2 0 , 2 5 , 3 0 , 3 5 , 4 0 , 5 0 , 6 0 , 7 0 , 8 0 , 9 0 , 1 0 0 , 1 1 0 , 1 2 0 , 2 4 0 , -  
3 6 0 , 4 8 0 , 6 0 0 , 1 4 0 0  and 2880 m i n u t e s  a f t e r  d o s i n g .  Each b lo o d  sample  was 
c e n t r i f u g e d  f o r  5 m i n u te s  a t  9800g and t h e  p lasma l a y e r  d e c a n t e d  i n t o  
c r y o t u b e s . b Al l p lasma sam ples  were f r o z e n  a t  - 2 0 ° C f o r  f u t u r e  
c h r o m a t o g r a p h i c  a n a l y s i s .
E x t e r n a l  S t a n d a r d s
A s e r i e s  o f  s t a n d a r d s  was p r e p a r e d  f r e s h  f o r  each  s e t  o f  p lasma 
sam p le s  f rom i n d i v i d u a l  h o r s e s  f o r  each d ose  l e v e l  o f  3MI. These 
s t a n d a r d s  were a n a ly z e d  a t  t h e  same t i m e  as t h e  p lasma s a m p l e s .  The 
s t a n d a r d  s e r i e s  c o n s i s t e d  o f  t e n  t u b e s  t o  which 0 . 5  ml p o o led  e q u i n e  
p l asm a and a known amount o f  aqueous  3MI were added.  A plasma b lank  
c o n t a i n i n g  no aqueous  3MI was a l s o  p r e p a r e d .  C o n c e n t r a t i o n s  o f  3MI in  
t h e  t u b e s  ra n g ed  f rom 10 ng/ml  t o  4 u g / m l . E x t r a c t i o n  and a n a l y s i s  o f  
t h e s e  s t a n d a r d s  was i d e n t i c a l  t o  t h a t  d e s c r i b e d  f o r  p lasma sam ples  f rom 
h o r s e s  dosed  w i th  3MI.
Sample E x t r a c t i o n
S a t u r a t e d  sodium b o r a t e  ( 0 . 5  ml) was added w i th  v o r t e x i n g  t o  sc rew 
t o p  g l a s s  c u l t u r e  t u b e s  c o n t a i n i n g  0 . 5  ml o f  p l a s m a .  O n e - h a l f  
m i l l i l i t e r  o f  benz ene  c o n t a i n i n g  2 ug/ml 1 , 2 - d i m e t h y l  i n d o l e  (DMI)C as  
an i n t e r n a l  s t a n d a r d  was added t o  each t u b e .  All t u b e s  were mixed on a 
r o t a t o r  f o r  30 m i n u t e s  and c e n t r i f u g e d  f o r  5 m i n u te s  a t  9800g.  A 5 ul 
a l i q u o t  was drawn w i t h  a 10  ul m i c r o l i t e r  s y r i n g e  f rom t h e  be nzene  l a y e r  
b -  Nunc I n t e r m e d ,  Denmark 
c -  A l d r i c h  C h em ica l ,  Milwaukee ,  Ws.
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and i n j e c t e d  i n t o  a gas  c h r o m a to g rap h  f o r  a n a l y s i s . 77 R ecove ry  o f  
3MI f rom  pl asm a  u s i n g  t h i s  method was 90% o r  g r e a t e r .  The r e t e n t i o n  
t i m e s  f o r  3MI and DMI were 5 . 3 0  m i n u t e s  and 5 . 9 0  m i n u t e s  r e s p e c t i v e l y .
C hro m a to g ra p h ic  A n a l y s i s
F iv e  m i c r o l i t e r s  o f  t h e  benzen e plasma e x t r a c t  f o r  samples  and 
s t a n d a r d s  were  a n a l y z e d  by gas  c h r o m a to g ra p h y  u s i n g  a s e l e c t i v e  n i t r o g e n  
phosp h o ro u s  d e t e c t o r d . 7 7  j\ g f o o t  x 1 / 4  inch  0D x 2 mm ID g l a s s  
column c o n t a i n i n g  3% 0V-17 on a 8 0 - 1 0 0  mesh s t a t i o n a r y  p h a s e e which 
had been p r e c o n d i t i o n e d  a t  2 5 0 ° C  f o r  16 h r s  was used f o r  t h e  a s s a y . ^
Oven t e m p e r a t u r e  was 145°C.  Flow r a t e s  f o r  h e l i u m ,  hydrogen  and a i r  
were 25 m l / m i n u t e ,  3 m l / m i n u t e  and 100 m l / m i n u t e  r e s p e c t i v e l y .
The r e s u l t s  o f  t h e  a n a l y s i s  o f  t h e  s e t  o f  s t a n d a r d  t u b e s  were used 
t o  e s t a b l i s h  a r e l a t i o n s h i p  between t h e  a r e a  under  t h e  3MI peak on t h e  
ch ro ma togram  and t h e  c o n c e n t r a t i o n  o f  3MI i n j e c t e d  i n t o  t h e  
c h r o m a t o g r a p h .  T h i s  r e l a t i o n s h i p  was d e t e r m in e d  u s i n g  l i n e a r  r e g r e s s i o n  
a n a l y s i s .  The c o r r e l a t i o n  c o e f f i c i e n t  ( r )  f o r  t h e  l i n e  o f  b e s t  f i t  was 
> 0 . 9 9 .  The c h r o m a t o g r a p h i c  d e t e c t i o n  l i m i t  f o r  3MI was 50 p i c o g r a m s .
The p a r a m e t e r s  f o r  t h i s  l i n e  and t h e  a r e a  und er  t h e  a p p r o p r i a t e  peak 
were t h e n  used t o  d e t e r m i n e  t h e  c o n c e n t r a t i o n  o f  3MI in  p lasma samples  
f rom t h e  e x p e r i m e n t a l  s u b j e c t s ,  
d -  H e w l e t t - P a c k a r d  5840A 
e -  S u p e l c o p o r t ,  S u p e l c o ,  B e l l e f o n t e ,  Pa.  
f  -  T e k l a b ,  Baton Rouge,  La.
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P h a r m a c o k i n e t i c  and S t a t i s t i c a l  A n a l y s i s
7 0
K i n e t i c  p a r a m e t e r s  f o r  3MI were d e t e r m i n e d  by Autoan I I ,  0  a 
co m p u te r  a s s i s t e d  n o n - l i n e a r  l e a s t  s q u a r e s  r e g r e s s i o n  r o u t i n e  and 
a s s o c i a t e d  p h a r m a c o k i n e t i c  a n a l y s i s .  The p h a r m a c o k i n e t i c  p a r a m e t e r s  o f  
k21» k 12> k a» a  » 6 » ke l » l a 9 t i m e  and c o were
d e t e r m i n e d  by t h i s  p ro g r am .  The e x p o n e n t s  f o r  t h e  e q u a t i o n  r e p r e s e n t i n g  
t h e  t i m e  c o u r s e  o f  p lasma c o n c e n t r a t i o n s  o f  3MI were d e t e r m in e d  by cr u v e  
s t r i p p i n g .  A d d i t i o n a l  p h a r m a c o k i n e t i c  p a r a m e t e r s  were c a l c u l a t e d  
m a n u a l l y ,  u s i n g  s t a n d a r d  p h a r m a c o k i n e t i c  e q u a t i o n s .  S t a t i s t i c a l  
c o m p ar i so n  were p e r fo rm ed  u s i n g  S t u d e n t ' s  t - t e s t  (P < 0 . 0 5 ) . 79
RESULTS
P h a r m a c o k i n e t i c  Model
Changes in  mean p lasma l e v e l s  o f  3MI wi th  t i m e  a t  10 and 20 mg/kg 
d o s a g e s  a r e  shown in  T a b le  1 and i l l u s t r a t e d  in  F i g u r e  1. Best  f i t  o f  
t h e  d a t a  p o i n t s  f o r  b o th  d o s a g e s  was o b t a i n e d  u s i n g  a two-compar tm en t  
model w i t h  f i r s t  o r d e r  a b s o r p t i o n  ( F i g u r e  1 ) .  Thi s  model i s  r e p r e s e n t e d  
by t h e  e q u a t i o n :
C p = A a - t  +  B” B t  "  C o " K a t  ( r  > ° - 9 0 ) 8 0
Plasma C o n c e n t r a t i o n  -  Time P r o f i l e  f o r  3MI Horses
The pl asm a c o n c e n t r a t i o n - t i m e  p r o f i l e  f o r  3MI a t  t h e  20 mg/kg 
d o s a g e  was d i f f e r e n t  f rom t h e  10 mg/kg d o s ag e  as shown in  F i g u r e  1. 
Fo l lo w in g  t h e  10 mg/kg d o s a g e ,  3MI r e a c h e d  a mean peak p lasma 
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Time a f t e r  Dosing (hours)
F i g u r e  1 -  Mean plasma l e v e l s  o f  3-m ethyl  i n d o l e  in  s i x  h o r s e s  f o l l o w i n g  




T ab le  1 -  Changes in  mean (n =6 ) p l as m a l e v e l s  _+ S.D.  o f  3MI wi th  t im e  
a f t e r  o r a l  d o s i n g  o f  3MI in  h o r s e s .  P lasma l e v e l s  a r e  e x p r e s s e d  as  ug/ml 
d o s a g e .
Time A f t e r  Dosing 10 mg/kg 20 mg/kg
( h o u r s )
0 0 .0 0 4 + 0 .0 0 9 0 . 0 0 0 + 0 . 0 0 0
0 .8 3 3 0 . 0 3 8 T 0 .092 0 .008 T 0 .014
0.1667 0 .0 8 6 T 0 .0 7 2 0 .054 T 0 .0 7 3
0 .2500 0 .1 6 9 T0 .104 0 .268 T0 .377
0 .3 3 3 3 0 .2 9 2 T0 . 2 1 1 0 .6 2 0 T0 .419
0 .4166 0 .6 2 9 T0.641 1.277 T0 .919
0 .5 0 0 0 0 .741 + 0 .711 1.499 T0 .947
0 .5 8 3 3 0 . 7 4 4 T0 .635 2.245 T1.714
0 .6667 0 .7 1 5 T 0 .509 2 .613 T1.941
0 .8 3 3 3 0 .7 1 2 T0 .364 2.837 T1.670
1 . 0 0 0 0 0 .5 2 2 T 0 .254 2.498 T 1.758
1.167 0 .4 9 1 T0 .206 2.333 T 1.582
1 .333 0 .3 7 7 T 0 .1 8 4 2 .976 T 1.237
1 .500 0 .2 5 8 T 0 .170 1 . 6 6 8 T1.287
1 .667 0 .237 T 0 .1 5 8 1.421 T 1.226
1 .833 0 .2 2 8 T 0 .148 1.098 T 0 .9 9 6
2 . 0 0 0 0 .2 0 5 T 0 .1 2 3 1.078 T 0 .939
4 .0 0 0 0 .0 8 9 T 0 .083 0 .667 T1.124
6 . 0 0 0 0.071 T0 .077 0 .175 T 0 .235
8 . 0 0 0 0 .0 5 6 T0 .084 0 .0 8 4 T0 .0 8 8
1 0 . 0 0 0 0 . 0 0 0 T 0 . 0 0 0 0 .033 T 0 .0 3 8
2 4 .000 0 . 0 2 0 T 0 .035 0 .013 T0 . 0 2 2
4 8 .0 0 0 0 .0 3 5 T 0 .086 0 .005 T 0 .008
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(35 m i n ) .  P lasma c o n c e n t r a t i o n  ap p ea red  t o  d ec ay  from Cpmax by a 
b i e x p o n e n t i a l  k i n e t i c  p r o c e s s .  Thi s  d ec ay  p a t t e r n  r e p r e s e n t e d  bot h  
d i s t r i b u t i o n  in  and e l i m i n a t i o n  o f  3MI f rom t h e  c e n t r a l  co m par tm en t .
T ra c e  l e v e l s  o f  3MI were o b s e r v e d  up t o  48 h o u r s  a f t e r  d o s i n g .
A f t e r  a d m i n i s t r a t i o n  o f  3MI a t  20 mg/kg ,  a mean Cpmax o f  
2 . 8 4  _+ 1 .6 7  ug/ml (n=6 ) was o b s e r v e d  a t  0 . 8 3 3  h r  (50 m i n ) .  The plasma 
d e c a y  p a t t e r n  was b i e x p o n e n t i a l  f o r  t h e  20 mg/kg do sag e  as w e l l .  A l ag  
t i m e  o f  0 . 2 2 8  h r  was o b s e r v e d  f o r  a p p e a ra n c e  o f  3MI in  p lasma a t  t h i s  
d o s a g e .  3MI was d e t e c t e d  in  p lasma up t o  48 h o u r s  a f t e r  t h e  i n i t i a l  
d o s e .
P h a r m a c o k i n e t i c  P a r a m e t e r s  f o r  B i o a v a i l a b i l i t y  and D i s p o s i t i o n  o f  3MI IN 
Horses
Rate  o f  B i o a v a i l a b i l i t y .  K i n e t i c  p a r a m e t e r s  f o r  3MI a t  10 and 20 mg/kg 
a r e  l i s t e d  in  T a b l e s  2 and 3 .  A b s o rp t i o n  o f  3MI was r a p i d  w i th  a Ka 
o f  2 . 0 5  h r " l  f o r  t h e  10 mg/kg do sage  and a Ka o f  2 . 6 4  h r -  ̂ a t  
20 mg/kg .  The a b s o r p t i o n  h a l f - l i v e s  were 0 . 3 4  h r  and 0 . 2 6  h r  f o r  t h e  10 
and 20 mg/kg d o s e s  r e s p e c t i v e l y .  The t i m e s  t o  r e a c h  maximum plasma 
c o n c e n t r a t i o n  Tpmax, were 0 .5 8 3  and 0 . 8 3 3  h r  f o r  t h e  10 and 20 
mg/kg d o s a g e s  r e s p e c t i v e l y .  A l a g  t i m e  o f  0 . 2 2 8  h o u rs  was o b s e r v e d  f o r  
t h e  20 mg/kg d o s a g e .  D i s t r i b u t i o n  o f  3MI i n t o  t h e  p e r i p h e r a l  
compar tment  was s i g n i f i c a n t l y  more r a p i d  a t  10 mg/Kg ( k i 2 = 0 . 8 9 3  
h r " l )  t h a n  a t  20 mg/kg (k i2= 0 .381  h r _l ) .  3MI had a
p o s t - d i s t r i b u t i o n  e l i m i n a t i o n  h a l f  l i f e  o f  4 . 2  h r  and 5 . 5 4  h r  f o r  t h e  10 
and 20  mg/kg d o s a g e s ,  r e s p e c t i v e l y .
T a b le  2 -  P h a r m a c o k i n e t i c  p a r a m e t e r s  d e t e r m in e d  by Autoan I I  f o r  o r a l  
3 -m e thy l  i n d o l e  in  h o r s e s  (n =6 ) .
P a r a m e t e r U n i t s
DOSAGE
10 mg/kg 20  mg/kg
6 ( h r ’ 1 ). 0 . 165 0 .125
t i / 2  e ( h r ) 4 . 2 0 5 .5 4a ( h r ' 1 ) 0.921 0 .898
t l / 2a ( h r ) 0 .752 0 .7 7 2
Kel ( h r " 1 ) 0 .1 2 6  + 0 .2 8 8 0 .4 1 2  + 0 .4 2 2
Ka ( h r - 1 ) 2 .0 5  + 3 .02 2 .6 4  + 1 .4 4
ly2a ( h r ) 0 . 3 4 0 .2 6
*12 ( h r " 1 ) 0 .8 9 3  + 1 .80 0 .381 + 0 . 4 9 0
( h r " 1 ) 0 .0 5 3 2  + 0 .0 8 0 .137  + 0 .2 3 8
Co ( u g / m l ) 1 .1 0  + 1 .30 4.01 + 1 .49
l a g  t i m e ( h o u r s ) 0 0 .2 2 8  + 0 .0 2 6
r 2 0 .7 4 0 .8 7
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T ab le  3 -  A d d i t i o n a l  p h a r m a c o k i n e t i c  p a r a m e t e r s  c a l c u l a t e d  f o r  3MI in  
h o r s e s  (n=6 ) .
DOSAGE
P a ra m e t e r  10 mg/kg 20 mg/kg
Weight  (Kg) 389 +_ 80 397 +_ 79
Do (g)  3 . 9  _+ 0 . 8  7 .9  _+ 1 .6
C ( u g / m l ) 0 . 7 4 4 + 0 . 6 3 5  2 . 8 4 + 1 . 6 7
p max 3 — —
t  ( h r )  0 .5 8 3  0 .833
p max '
AUC0 ' 48  ( u g - h r /m l  ) 6 . 7 1 + 0 . 2 3  2 9 . 5 + 0 . 1 8
AUC/Kg B.W. 0 .0 1 7 3  0 .07 43
FDo/Vd (ug /m l )  0 .111  3 .69
FDo/Vc (ug /m l )  1 .15 4 . 81
Cl t  ( m l / h r )  0 .581 0 .268
Clt  / k g  B.W. 1 .4 9  x 10" 3 0 .6 9 5  x 10"3
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E x t e n t  o f  B i o a v a i l a b i l i t y . A co m par i son  o f  Cpmax and AUC^- ^  
f o r  t h e  two d o s ag e  l e v e l s  shows more t h a n  a do se  p r o p o r t i o n a l  
r e l a t i o n s h i p ,  w i th  bo th  p a r a m e t e r s  i n c r e a s i n g  by more t h a n  a f a c t o r  of
2- CPmax i n c r e a s e d  by a f a c t o r  o f  3 . 9 ;  w h e r e a s ,  AUC0"48 
i n c r e a s e d  4 . 4  t i m e s .  When AUC0- 48 was n o r m a l i z e d  t o  mean body 
w e ig h t  f o r  t h e  6 h o r s e s ,  t h e  i n c r e a s e  between dosag e l e v e l s  was a 4 . 3  
f o l d  f a c t o r .
FDo/V(j, a c o n c e n t r a t i o n  t e r m  which r e p r e s e n t s  a r a t e  i n d e p e n d e n t  
m easu re  o f  a d ru g ' ; s a v a i l a b i l i t y  t o  t h e  s y s t e m i c  c i r c u l a t i o n ,  v a r i e d  
w i th  d o s e .  At 20 mg/kg ,  t h e  p lasma F'Do/Vcj c o n c e n t r a t i o n  f o r  
a v a i l a b i l i t y  o f  3MI was 33 t i m e s  t h a t  found in  p lasma f o r  t h e  10 mg/kg 
d o s a g e .
The d a t a  f rom t h i s  s t u d y  were d e s c r i b e d  by both  a f i r s t  o r d e r  log  -  
l i n e a r  r e l a t i o n s h i p .  A l o g - l i n e a r  tw o-c ompar t m en t  open model w i t h  f i r s t  
o r d e r  a b s o r p t i o n  p r o v i d e d  b e s t  f i t .
DISCUSSION
The p h a r m a c o k i n e t i c s  o f  3MI i s  i n f l u e n c e d  i n i t i a l l y  by i t s  
b i o a v a i l a b i l i t y .  B i o a v a i l a b i 1i t y  m e a s u r e s  t h e  r a t e  (RBA) and e x t e n t  
(EBA) o f  3MI a b s o r p t i o n  o r  t r a n s f e r  f rom i t s  s i t e  o f  a d m i n i s t r a t i o n  t o  
t h e  s y s t e m i c  c i r c u l a t i o n  o r  s i t e  o f  a c t i o n .  T h e r e f o r e ,  b i o a v a i l a b i l i t y  
depend s  upon (1)  t h e  p h y s i o c h e m i c a l  p r o p e r t i e s  o f  3MI which a l l o w  i t s  
d i s s o l u t i o n  o r  l i b e r a t i o n  in  t h e  g a s t r o i n t e s t i n a l  l i q u o r ,  and ( 2 ) t h e  
a b s o r p t i o n  o f  3MI a c r o s s  t h e  g a s t r o i n t e s t i n a l  membrane b a r r i e r s .  Any 
v a r i a t i o n s  i n  t h e  e x t e n t  and r a t e  o f  d rug  a b s o r p t i o n  were p r i m a r i l y  t h e  
r e s u l t  o f  f a c t o r s  which p h y s i o l o g i c a l l y  m o d i f i e d  o r  do sag e  form m o d i f i e d
t h e  b i o a v a l i b i 1 i t y  o f  3MI. U l t i m a t e l y  t h e s e  f a c t o r s  d e t e r m in e d  t h e
amount o f  3MI which e n t e r e d  t h e  body,  and t h e  b o d y ' s  r e s p o n s e  t o  3MI.
E v a l u a t i o n  and c h a r a c t t e r i z a t i o n  o f  t h e  e x t e n t  and r a t e  o f  
b i o a v a i l a b i l i t y  o f  3MI f o r  t h e  10 and 20 mg/kg d o s e s  can be a c co m p l i s h e d  
by e x a m i n i n g ,  a t  a minimum, t h e  p a r a m e t e r s  f o r  a r e a  un de r  t h e  cu r v e  
(AUC), peak h e i g h t  p la sm a  c o n c e n t r a t i o n  (Cpmax) and t h e  t i m e  t o  
r e a c h  Cpmax ( t p max) .  The EBA was e v a l u a t e d  by compar ing  
Cpmax an d AUCO-48 between d o s e s  o f  3MI, w h i l e  t h e  RBA was 
d e t e r m i n e d  by compar ing  t p max and t h e  r a t e  c o n s t a n t s  and
h a l f - l i v e s  f o r  a b s o r p t i o n  and e l i m i n a t i o n  o f  3MI.
I f  t h e  RBA o f  3MI f rom t h e  GI t r a c t  were d i f f e r e n t  between d o s e s ,  
a b s o r p t i o n  would be d e l a y e d .  A b s o r p t i o n  o f  3MI was r a p i d  and no 
s i g n i f i c a n t  d i f f e r e n c e  was o b s e r v e d  between t h e  r a t e  c o n s t a n t  Ka o r  
t p  max, f o r  t h e  10 and 20 mg/kg d o s a g e s  o f  3MI. In a d d i t i o n ,  
d e l a y e d  a b s o r p t i o n  co u l d  c a u s e  a s i g n i f i c a n t  d e c r e a s e  in ke i and 
B . The e l i m i n a t i o n  c o n s t a n t s  ke ] and B were n o t  s i g n i f i c a n t l y  
d i f f e r e n t  between t h e  two d o s e s  o f  3MI. T h e r e f o r e ,  i t  a p p e a r s  t h a t  t h e  
r a t e  component  o f  b i o a v i l a b i 1 i t y  was n o t  s i g n i f i c a n t l y  d i f f e r e n t  between 
d o s e s  o f  3MI. In a d d i t i o n ,  s i n c e  a b s o r p t i o n  was s u f f i c i e n t l y  more r a p i d  
t h a n  d i s t r i b u t i o n  o r  e l i m i n a t i o n  o f  3MI, (Ka > a  > 8 ) ,  i t  may be 
co n c lu d e d  t h a t  t h e  RBA was n o t  r e s p o n s i b l e  f o r  t h e  o b s e r v e d  d i f f e r e n c e s  
in  t h e  p h a r m a c o k i n e t i c  p a r a m e t e r s  between t h e  10 and 20  mg/kg d o s a g e s  o f  
3MI.
Comparison o f  t h e  EBA f o r  t h e  10 and 20 mg/kg d o s a g e s  o f  3MI shows 
a 4 f o l d  i n c r e a s e  in  AUC0"48 ancj Cpmax f o r  t h e  20 mg/kg 
l e v e l .  AUC0“ 48 i s a r a t e  o f  i n d e p e n d e n t  measu re  o f  q u a n t i t y  o f  drug
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a b s o r p e d  and i s  d i r e c t l y  p r o p o r t i o n a l  t o  t h e  dose  a d m i n i s t e r e d  and 
f r a c t i o n  o f  d o se  a b s o r b e d ,  w h i l e  b e i n g  i n v e r s e l y  r e l a t e d  t o  c l e a r a n c e .  
T h e r e f o r e ,  t h e  i n c r e a s e  i n  EBR a t  t h e  20 mg/kg d o se  was p r o b a b l y  t h e  
r e s u l t  o f  d e c r e a s e d  c l e a r a n c e  o f  3MI f rom t h e  p l a s m a ,  i f  t h e  f r a c t i o n  o f  
d o s e  ab s o r p e d  (F) i s  assumed t o  be u n i t y  or  i s  unchanged between doses  
o f  3MI.
When 3MI r e a c h e s  t h e  s y s t e m i c  c i r c u l a t i o n  or  p l a s m a ,  t h e  o n s e t  and 
d u r a t i o n  o f  p h a r m a c o l o g i c a l  r e s p o n s e s  t o  t h i s  ch emical  depend upon i t s  
t o t a l  c l e a r a n c e  from t h e  body.  In a f i r s t  o r d e r  two-compar tm ent  open 
m o d e l ,  t h e  t o t a l  c l e a r a n c e  ( C l t )  ° f  3MI would be d e t e r m in e d  by i t s  
m e t a b o l i s m  and e x c r e t i o n  f rom t h e  c e n t r a l  co m p ar tm en t .  For a f i r s t  
o r d e r  k i n e t i c  r e l a t i o n s h i p s ,  t h e  e q u a t i o n  f o r  c l e a r a n c e  i s  Clt=BV<j.
In a d d i t i o n ,  t h e  p o s t - d i s t r i b u t i o n  e l i m i n a t i o n  c o n s t a n t ,  b . and C l t  
a r e  n o t  d i f f e r e n t  f o r  t h e  same drug when a d m i n i s t e r d  a t  two o r  more 
d i f f e r e n t  dos e  l e v e l s .
T o t a l  c l e a r a n c e  o f  3MI as d e t e r m in e d  by t h e  e q u a t i o n  AUC/FDo, was 
t w i c e  as r a p i d  f o r  t h e  10  mg/kg d o s a g e ,  as i t  was f o r  t h e  20  mg/kg 
d o s ag e  (T a b le  3 ) .  The d e c r e a s e  in  c l e a r a n c e  o f  3MI f o r  t h e  20 mg/kg 
do sag e  co u ld  be a t t r i b u t e d  t o  ( 1 ) a d e c r e a s e  in  t h e  a b s o r p t i o n  f r a c t i o n  
( F ) ,  (2)  a d e c r e a s e  in  t h e  volume o f  d i s t r i b u t i o n  (Vd) o r  (3) s a t u r a t i o n  
o f  d i s t r i b u t i o n  o r  e l i m i n a t i o n  mechanisms r e s p o n s i b l e  f o r  removing  3MI 
f rom t h e  s y s t e m i c  c i r c u l a t i o n .
Drugs which e x h i b i t  ch a n g es  in c l e a r a n c e  as  a f u n c t i o n  o f  do se  
( a s sum ing  F=1 o r  i s  unchanged between d o s e s )  f o l l o w  M ic h a e l i s - M e n to n  
t y p e  s a t u r a t i o n  k i n e t i c s .  When s a t u r a t i o n  k i n e t i c s  a p p l y ,  c l e a r a n c e  
d e c r e a s e s  w i th  i n c r e a s i n g  d o s e ,  e x c e p t  when Cp « <  Km, where t h e
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c a p a c i t y  l i m i t e d  d i s t r i b u t i o n  o r  e l i m i n a t i o n  i s  n o t  s a t u r a t e d  and pseudo 
f i r s t  o r d e r  k i n e t i c s  a r e  in  o p e r a t i o n .  C l e a r a n c e  f o r  c h e m i c a l s  
e x h i b i t i n g  s a t u r a t i o n  o r  M i c h a e l i s - M e n t o n  k i n e t i c s  i s  d e s c r i b e d  by t h e  
e q u a t i o n :
VC l .  = max
+ C m p
where Vmax i s '  t h e  t h e o r e t i c a l  maximum r a t e  o f  t h e  p r o c e s s  and Km 
i s  t h e  M i c h a e l i s - M e n to n  c o n s t a n t .  T h e r e f o r e ,  i t  a p p e a r s  t h a t  t h e  
p h a r m a c o k i n e t i c s  o f  3MI may be t h e  r e s u l t  o f  n o n - l i n e a r  s a t u r a t i o n  
k i n e t i c s .
E l i m i n a t i o n  o f  a ch em ica l  by n o n - l i n e a r  p h a r m a c o k i n e t i c s  i s  in 
o p e r a t i o n  when: (1) t 1 / 2  i n c r e a s e s  w i th  i n c r e a s i n g  d o s e ,  (2)  AUC
i s  n o t  p r o p o r t i o n a l  be tween d o s e s ,  (3)  t h e  c o m p o s i t i o n  o f  e x c r e t o r y  or  
m e t a b o l i c  p r o d u c t s  may be changed bo th  q u a l i t a t i v e l y  and q u a n t i t a t i v e l y ,  
(4)  d e c l i n e  o f  p lasma l e v e l s  o f  a ch e m ic a l  i s  no t  e x p o n e n t i a l  o r  (5) 
d o s e - r e s p o n s e  c u r v e s  show d i s p r o p o r t i o n a t e  r e s p o n s e  wi th  i n c r e a s i n g
d o s e . 81
When t h e  3MI plasma c o n c e n t r a t i o n  -  t i m e  p r o f i l e s  were n o rm a l i z e d  
f o r  t h e  10 and 20  mg/kg d o s a g e s  and p l o t t e d  on semi log  p a p e r ,  
s u p e r i m p o s i t i o n  o f  t h e  c u r v e s  sh o u ld  have been p o s s i b l e  i f  t h e  AUC was 
p r o p o r t i o n a l  be tween d o s e s  and l o g - l i n e a r  f i r s t  o r d e r  k i n e t i c s  were in 
o p e r a t i o n  ( F i g u r e  2 ) . 8 2  Such was no t  t h e  c a s e .  T h i s  i n d i c a t e s  t h e  
p r e s e n c e  o f  n o n - l i n e a r  o r  s a t u r a t i o n  k i n e t i c s .  Double r e c i p r o c a l  or  
m o d i f i e d  L in e w e av e r -B u rk e  p l o t s  o f  p o s t - a b s o r b t i o n  3MI plasma 
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F i g u r e  2 -  C o n c e n t r a t i o n  o f  3MI e x p r e s s e d  as  nanogram e q u i v a l e n t s  p e r  
gram o f  p l a sm a  ( m i l l i l i t e r )  in  h o r s e s  f o l l o w i n g  s i n g l e  o r a l  d o s e s  o f  10 
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F i g u r e  3 -  Double r e c i p r o c a l  p l o t  o f  p lasma c o n c e n t r a t i o n  o f  3MI f o r  t h e  
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F i g u r e  4 -  Double r e c i p r o c a l  p l o t  o f  3MI p la sm a  c o n c e n t r a t i o n  f o r  t h e  20 
mg/kg d o s a g e .
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t h e  p r e s e n c e  o f  n o n - l i n e a r  k i n e t i c s . 83  The d a t a  p o i n t s  f o r  t h e  
d o u b l e  r e c i p r o c a l  p l o t  f o r  3MI plasma c o n c e n t r a t i o n  i s  c a l c u l a t e d  from 
t h e  e q u a t i o n :
i -  Km l 1  w  1l ~ j n  v r  ' v
AC/At V mm
At h i g h e r  p lasma
c o n c e n t r a t i o n s  o f  3MI a t  t h e  10 mg/kg d o s a g e ,  a l i n e a r i z a t i o n  of  t h e  
d o u b l e  r e c i p r o c a l  p l o t  was o b s e r v e d  ( r  = . 9 9 4 ) .  In t h i s  l i n e a r  p hase  
3MI d i s a p p e a r e d  f rom p las m a a t  a c o n s t a n t  r a t e  w i th  t i m e  and t h e  
e l i m i n a t i o n  p r o c e s s  was i n d e p e n d e n t  o f  p lasma c o n c e n t r a t i o n ,  which i s  
c h a r a c t e r i s t i c  o f  n o n - l i n e a r  z e r o - o r d e r  k i n e t i c s .  For lower  
c o n c e n t r a t i o n s  o f  3MI in  p lasma f o r  t h e  10 mg/kg d o s a g e ,  t h e  r a t e  o f  
d i s a p p e a r a n c e  was n o t  c o n s t a n t ,  which i s  c h a r a c t e r i s t i c  o f  c o n c e n t r a t i o n  
d e p e n d e n t  f i r s t  o r d e r  o r  l o g - l i n e a r  k i n e t i c s .  In c o n t r a s t ,  
d i s a p p e a r a n c e  o f  3MI f o r  t h e  20 mg/kg dosag e was l i n e a r  from 0 . 5  t o  2 
h o u r s  a f t e r  d o s i n g  as shown in  t h e  d o u b l e - r e c i p r o c a l  p l o t  o f  F ig u r e  4 
( r  = 0 . 9 9 7 ) .  Thi s  l i n e a r i t y  i n d i c a t e s  t h a t  n o n - l i n e a r  s a t u r a t i o n  
p h a r m a c o k i n e t i c s  were in  o p e r a t i o n  f o r  t h e  20 mg/kg d o s ag e  o f  3MI.
The p h a r m a c o k i n e t i c s  o f  3MI were d e s c r i b e d  by a s a t u r a t i o n  or
d o s e - d e p e n d e n t  p r o c e s s  as shown by t h e  n o n - s u p e r i m p o s i t i o n  o f  t h e  p l o t
i n  F i g u r e  2 and t h e  l i n e a r i t y  o f  t h e  d o u b l e - r e c i p r o c a l  p l o t s  d e p i c t e d  in
F i g u r e s  3 and 4 .  The f o l l o w i n g  e q u a t i o n  p r o b a b l y  b e t t e r  r e p r e s e n t s
/̂a* FD^ K.  r  V Cd c / d t  = o a C a -  m p
Vh K + Cnd m p
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t h i s  s a t u r a t i o n  p r o c e s s .  In t h i s  e q u a t i o n ,  d i s t r i b u t i o n  a n d / o r  
e l i m i n a t i o n  from t h e  c e n t r a l  compar tment  i s  d e p e n d e n t  upon c a p a c i t y  
l i m i t e d  o r  s a t u r a b l e  p r o c e s s e s .
M e tab o l i s m ,  a c t i v e  u p t a k e ,  a c t i v e  t u b u l a r  s e c r e t i o n ,  p l a s m a  p r o t e i n  
o r  t i s s u e  p r o t e i n  s e q u e s t r a t i o n  a r e  a l l  examples  o f  p o t e n t i a l  c a p a c i t y  
l i m i t e d  p r o c e s s e s  which may a l l o w  3MI t o  d i s p l a y  s a t u r a t i o n  k i n e t i c s .  
S i n c e ,  3MI and o t h e r  i n d o l e s  a r e  m e t a b o l i z e d  by mixed f u n c t i o n  o x i d a s e ,  
t h e  en z y m a t ic  t r a n s f o r m a t i o n  o f  t h e s e  i n d o l e s  by MFO i s  a s a t u r a b l e  
p r o c e s s  which i f  s a t u r a t e d  may be in  p a r t  r e s p o n s i b l e  f o r  t h e  o b s e r v e d  
s a t u r a t i o n  k i n e t i c s  o f  3MI.56 D i s t r i b u t i o n  o f  3MI f rom t h e  p lasma 
may o c c u r  by an a c t i v e  t r a n s p o r t  mechanism and c o u ld  a l s o  be r e s p o n s i b l e  
f o r  t h e  a p p a r e n t  d o s e - d e p e n d e n t  p h a r m a c o k i n e t i c s  o f  3MI. As an example ,  
a c t i v e  t r a n s p o r t  o r  u p t a k e  mechanisms have been i d e n t i f i e d  in  r a t  lung
f o r  p a r a q u a t  and 5 - h y d r o x y t r y p t a m i n e . 8 4 , 8 5  j n f a c t ,
r a d i o l a b e l e d  [1^C]-3MI has  been found t o  b ind  in  v i t r o  t o  bov ine  
lung  t i s s u e  and i t  i s  p o s s i b l e  t h a t  t h i s  b i n d i n g  may be t h e  r e s u l t  o f  an 
u p t a k e  m e c h a n i s m . 8 6 , 8 7  j n a d d i t i o n ,  b i n d i n g  o f  [ ^ C ] - 3 M I  o r  i t s  
r a d i o l a b e l e d  m e t a b o l i t e s  t o  p lasma o r  t i s s u e  p r o t e i n s  may a l s o  a c c o u n t  
f o r  t h e  o b s e r v e d  s a t u r a t i o n  k i n e t i c s .  5 - h y d r o x i n d o l e a c e t i c  a c i d  (5IAA),  
an i n d o l i c  m e t a b o l i t e  o f  5 - h y d r o x y t r y p t a m i n e ,  i s  a c t i v e l y  e l i m i n a t e d  by 
s e c r e t i o n  i n t o  t h e  k i d n e y  t u b u l e s  which i s  a l s o  a s a t u r a b l e  
p r o c e s s . 88  3MI, l i k e  5IAA, may be dep e n d en t  upon a c t i v e  s e c r e t i o n  
f o r  i t s  e x c r e t i o n .  T h e r e f o r e ,  i t  i s  p o s s i b l e  t h a t  3MI may compete  f o r  
t h e  b i n d i n g  s i t e s  on any o f  t h e  s a t u r a b l e  p r o c e s s  o f  m e t a b o l i s m ,  u p t a k e ,  
p r o t e i n  b i n d i n g  o r  a c t i v e  t u b u l a r  s e c r e t i o n  which in  t u r n  co u ld  ac co u n t  
f o r  t h e  o b s e r v e d  s a t u r a t i o n  k i n e t i c s  o f  3MI in  h o r s e s .
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I t  a p p e a r s  t h a t  when one o r  more o f  t h e  mechanisms f o r  m e t a b o l i s m ,  
u p t a k e ,  a c t i v e  s e c r e t i o n - e x c r e t i o n  and p r o t e i n - t i s s u e  b i n d i n g  o f  3MI 
were s a t u r a t e d ,  3MI a c c u m u la t e d  in t h e  p lasma o r  t h e  c e n t r a l  
co m p ar tm e n t .  Thi s  s a t u r a t i o n  sh o u ld  have cau sed  t h e  p o s t - a b s o r p t i o n  
d i s t r i b u t i o n  h a l f - l i f e  e l i m i n a t i o n  o f  3MI t o  be p r o l o n g e d .
The p o s t - d i s t r i b u t i o n  h a l f - l i f e  o f  3MI in  c a t t l e  g i v e n  IV i n f u s i o n s  
o f  3MI a t  8  mg/kg was 1 4 .4  +_ 2 . 5  m i n u t e s . 51 At d o s ag e s  o f  340 mg/kg 
in  g o a t s  . t h e  h a l f - l i f e  o f  3M1 was 1 .5  h o u r s . 55 U n p u b l i sh ed  d a t a  on 
t h e  p h a r m a c o k i n e t i c s  o f  [1^C]-3MI in  p o n i e s  f o r  i n t r a v e n o u s  do ses  
g r e a t e r  t h a n  o r  eq u a l  t o  100  mg/kg have i n d i r e c t l y  r e p o r t e d  h a l f - 1 i f e s  
r a n g i n g  f rom 8 t o  24 h o u r s . 89 The h a l f - l i f e  o f  3MI in  h o r s e s  from 
t h i s  s t u d y  i n c r e a s e d  f rom 4 . 2  t o  5 . 5 4  hou r s  f o r  t h e  10 and 20 mg/kg 
d o s e s .  Whi le i t  a p p e a r s  t h a t  t h e  h a l f - l i f e  o f  3MI i n c r e a s e s  w i th  d o s e ,  
t h e  co m par i son  o f  h a l f - l i v e s  between s p e c i e s  s h o u l d  be v iewed w i th  
c a u t i o n  b e c a u s e  ( 1 ) t h e s e  an i m a l s  may u t i l i z e  e n t i r e l y  d i f f e r e n t  
mechanisms o f  d i s p o s i t i o n  f o r  3MI and (2) more t h a n  two dose  l e v e l s  o f  
3MI sh o u ld  be used t o  f i r m l y  e s t a b l i s h  a d o s e - d e p e n d e n t  i n c r e a s e  in  h a l f  
l i f e .
I t  i s  known t h a t  p r e t r e a t m e n t  o f  g o a t s  and p o n i e s  w i th  t h e  mixed 
f u n c t i o n  o x i d a s e  (MF0) i n d u c e r ,  p h e n o b a r b i t a l , o r  t h e  MF0 i n h i b i t o r ,  
p i p e r o n y l  b u t o x i d e  i n c r e a s e s  and d e c r e a s e s  r e s p e c t i v e l y ,  t h e  i n t e n s i t y  
o f  l e s i o n s  in  l u n g . 55 Th us ,  t h e  m e t a b o l i t e s  o f  3MI a r e  c o n s i d e r e d  
t o  be t h e  a c t i v e  p r i n c i p a l  f o r  i n d u c i n g  lung  t o x i c o s i s .
I f  t h e  p r i m a r y  m e t a b o l i c  r o u t e  f o r  e l i m i n a t i o n  o f  3MI i s  s a t u r a t e d  
by t h e  a d m i n i s t r a t i o n  o f  h i g h e r  d o s e s  o f  3MI, a g r e a t e r  f r a c t i o n  o f  3MI 
may be m e t a b o l i z e d  by a MFO d ep e n d e n t  s e c o n d a r y  r o u t e  as diagrammed in
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F i g u r e  5 .  As t h e  dos e  o f  3MI i n c r e a s e s ,  and t h e  mechanism f o r  
m e t a b o l i s m  becomes i n c r e a s i n g l y  s a t u r a t e d ,  more o f  t h e  s e c o n d a r y  o r  an 
i n t e r m e d i a t e  m e t a b o l i t e  would be formed.  Recent  r e p o r t s  have  shown t h a t  
p r i o r  d e p l e t i o n  o f  body g l u t a t h i o n e  l e v e l s  w i th  d i e t h y l m a l o n a t e  caus ed  
an i n c r e a s e  in  t h e  s e v e r i t y  o f  3MI' s pneumotoxic  e f f e c t  in  s h e e p . 90 
Th i s  s u g g e s t s  t h a t  t h e  p r i m a r y  m e t a b o l i t e s  o f  3MI were d e t o x i f i e d  by 
micros omal  g l u t a t h i o n e - s - t r a n s f e r a s e s . I t  a p p e a r s  t h a t  p r e t r e a t m e n t  
w i t h  p h e n o b a r b i t a l  i n c r e a s e d  t h e  p n e u m o t o x i c i t y  o f  3MI by i n d u c i n g  
pu lmonary  mixed f u n c t i o n  o x i d a s e  a c t i v i t y  which in t u r n  i n c r e a s e d  
p r o d u c t i o n  o f  a s e c o n d a r y  t o x i c  m e t a b o l i t e ( s )  a f t e r  t h e  p r i m a ry  
n o n - t o x i c  m e t a b o l i c  pathway was s a t u r a t e d .
CONCLUSIONS
The r e s u l t s  o f  t h i s  s t u d y  and o t h e r s  s u g g e s t  t h a t  t h e  t o x i c i t y  o f  
3MI may c o r r e l a t e  w i th  i t s  s a t u r a b l e  do se  dep e n d en t  p h a r m a c o k i n e t i c s .
Such a c o r r e l a t i o n  would seem t o  p r e c l u d e  t h e  p o s s i b i l i t y  t h a t  3MI i s  
pneumotoxic  when e x p o s u r e  i s  a t  o r  below s a t u r a t i o n  l e v e l  d o s e .  I t  
a p p e a r s  t h a t  t o x i c i t y  o c c u r s  o n l y  when s a t u r a b l e  or  c a p a c i t y  l i m i t  
mechanisms f o r  m e t a b o l i s m  o f  3MI become o v e r l o a d e d .  T h e r e f o r e ,  
r e p e t i t i v e  e x p o s u r e s  o r  s low i n f u s i o n s  o f  3MI a t  low n o n - s a t u r a t i n g  
d o s e s  s h o u l d  n o t  p ro d u ce  a pneum otox ic  m e t a b o l i t e .  No t o x i c i t y  would 
p r o b a b l y  be o b s e r v e d  a t  d o s a g e s  below 10 mg/kg body w e ig h t  b ec au s e  Cp i s  
much l e s s  t h a n  Km and t h e  p h a r m a c o k i n e t i c s  o f  3MI were d e s c r i b e d  by a 
pseudo  f i r s t  o r d e r  tw o-c ompar t m en t  open model .  At t h i s  low d o s e ,  
c l e a r a n c e  o f  3MI would be d e p e n d e n t  upon t h e  p lasma c o n c e n t r a t i o n  o f
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INPUT
P r i m a r y  M e t a b o l i t e
P r im ary  M e t a b o l i c  Pathway 
i s  s a t u r a t e d
P r o d u c t i o n  o f  a S e co n d a ry  
T o x ic  M e t a b o l i t e
F i g u r e  5 -  D iag ram m at ic  r e p r e s e n t a t i o n  o f  3MI s a t u r a t i o n  k i n e t i c s .  
I n c r e a s i n g  t h e  d o s e  c a u s e s  t h e  p r i m a r y  n o n - t o x i c  pa thway  t o  s a t u r a t e  
w i t h  p r o d u c t i o n  o f  a s e c o n d a r y  t o x i c  m e t a b o l i t e .
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3MI. The c u r v i l i n e a r  p o r t i o n  o f  F ig u r e  3 d e p i c t s  t h i s  p s u e d o - f i r s t  
o r d e r  r e l a t i o n s h i p .
In c o n t r a s t ,  t h e  t o x i c i t y  o f  3MI p r o b a b l y  c o r r e l a t e s  w i th  
s a t u r a t i o n  o f  t h o s e  mechanisms r e s p o n s i b l e  f o r  i t s  n o n - t o x i c  m e ta b o l i s m  
as  diagrammed in  F i g u r e  5 .  The 20 mg/kg do sag e  o f  3MI p r o b a b l y  
r e p r e s e n t s  t h e  a p p r o x im a te  l e v e l  in  h o r s e s  where  t h e  dose  o f  3MI was 
s a t u r a t i n g .  At t h i s  d o s e ,  t h e  k i n e t i c s  o f  3MI in  h o r s e s  became pseudo 
z e r o - o r d e r  and c l e a r a n c e  became l e s s  d e p e n d e n t  o f  p lasma c o n c e n t r a t i o n .  
Because  r e l a t i v e l y  smal l  ch anges  in  t h e  dosage  o f  3MI from 10-20 mg/kg 
ca u s e d  l a r g e  ch a n g es  in  p l asm a c o n c e n t r a t i o n ,  t h e  p lasma c o n c e n t r a t i o n s  
o f  3MI c a n n o t  be used t o  e s t a b l i s h  a u n i f y i n g  t o x i c  l e v e l  o r  a 
d o s e - r e s p o n s e  r e l a t i o n s h i p  t o  p r e d i c t  t h e  o n s e t  and d u r a t i o n  o f  
pulmona ry  dynamic c h a n g e s .  The o n s e t  and d u r a t i o n  o f  changes  in 
pu lm on ary  dynamic p a r a m e t e r s  would most  p r o b a b l y  c o r r e l a t e  w i th  p lasma 
l e v e l s  o f  t o x i c  m e t a b o l i t e ( s )  which c a n n o t  be p r e d i c t e d  based upon 
pl as m a l e v e l s  o f  3MI. In f a c t ,  t h e  p lasma c o n c e n t r a t i o n  o f  t h e  t o x i c  
m e t a b o l i t e  i s  more a f u n c t i o n  o f  t h e  m e t a b o l i c  competency o f  each 
i n d i v i d u a l  h o r s e .  T h e r e f o r e ,  t h e  mere p r e s e n c e  o f  unchanged 3MI a t  what  
a p p e a r s  t o  be a t o x i c  l e v e l  may n o t  be d i a g n o s t i c  u n l e s s  c l i n i c a l  s i g n s  
o f  r e s p i r a t o r y  d i s t r e s s  a r e  p r e s e n t .
In c o n c l u s i o n ,  i f  pneum otox ic  3MI o r  some i n d o l i c  p r e c u r s o r  o f  3MI 
a r e  p r e s e n t  i n  g r a s s e s ,  h o r s e s  c o u l d  consume low l e v e l s  o f  3MI o r  i t s  
p r e c u r s o r s  o v e r  long p e r i o d s  o f  t i m e  w i t h o u t  any o b s e r v e d  lung  f u n c t i o n  
a b n o r m a l i t i e s  as long  as t h o s e  m e t a b o l i c  pathways  which do n o t  produ ce 
t o x i c  m e t a b l i t e s  a r e  n o t  s a t u r a t e d .  However,  i f  t h e s e  h o r s e s  i n g e s t
s l i g h t l y  l a r g e r  d o s e s  o f  3MI o r  i n d o l e  p r e c u r s o r s  from t h e  g r a s s e s  of  
r a p i d  growing  p a s t u r e s ,  a c u t e  t o x i c i t y  can r e s u l t  when t h e  n e a r l y  
s a t u r a t e d  mechanisms f o r  n o n - t o x i c  e l i m i n a t i o n  become s a t u r a t e d .
C h a p t e r  IV
ANALYSIS OF THE METABOLIC PATHWAYS AND STRUCTURE ACTIVITY RELATIONSHIPS 
OF SOME POTENTIAL PNEUMOTOXIC INDOLES: A PROBABLE
MECHANISM IN TOXICITY
INTRODUCTION
A d m i n i s t r a t i o n  o f  3-m ethy l  i n d o l e  (3-MI) t o  h o r s e s  r e s u l t s  in two
d i s t i n c t  and s e p a r a t e  r e s p i r a t o r y  syndromes a c c o r d i n g  t o  t h e  d o s e .
La rge  d o s e s  (lOOmg/kg) p ro d u c e  a lu ng  d i s e a s e  r e s e m b l i n g  COPD.^®*^
There  i s  n e c r o s i s  o f  t h e  C l a r a  c e l l s  in t h e  a i r w a y s  w i th  s u b s e q u e n t
s l o u g h i n g  and o b s t r u c t i v e  d i s e a s e . ^  V a r i a b l e  amounts o f  i n t e r s t i t i a l
f i b r o s i s  p r o v i d e  an i r r e v e r s i b l e  n a t u r e  t o  t h e  c o n d i t i o n .  I t  i s  t h o u g h t
t h a t  3-MI o r  a m e t a b o l i t e  i s  r e s p o n s i b l e  f o r  t h i s  c o n d i t i o n . 5 6 , 7 6 , 8 9 , 9 3
S m a l l e r  d o s e s  o f  3-MI (lOmg/kg t o  20mg/kg) p ro d u ce  a c o n d i t i o n  which
a l s o  r e s e m b le s  COPD, but  t h e  s i g n s  of  t h i s  c o n d i t i o n  a p p e a r  r e v e r s i b l e
1 f\
w i t h i n  48 h ours  a f t e r  d o s i n g .
At t h i s  t i m e ,  t h e  mechanisms f o r  t h e s e  syndromes a r e  unknown. I t  i s
a l s o  unknown i f  t h e  same mechanism p e r t a i n s  t o  bo th  synd romes .  Th ere
may be a c y t o t o x i c  r e a c t i o n  t o  3-MI a n d / o r  i t s  m e t a b o l i t e s  o r  t h e s e  
compounds may be a f f e c t i n g  s p e c i f i c  d ru g r e c e p t o r s  in t h e  l u n g  which in 
t u r n  ca u s e  b r o n c h o c o n s t r i c t i o n .  A n a l y s i s  o f  t h e  s t r u c t u r e - a c t i v i t y  
r e l a t i o n s h i p s  of  s u s p e c t e d  pneumotox ic  3-MI and i t s  m e t a b o l i t e s  may
p r o v i d e  some i n d i c a t i o n  as  t o  t h e  mechanism o f  t o x i c i t y .
A c y t o t o x i c  a t t a c k  on b r o n c h i o l a r  e p i t h e l i a  co u ld  r e s u l t  in l ung  
t i s s u e  damage and o b s t r u c t i v e  b r o n c h i o l i t i s  o r  i r r i t a n t  r e c e p t o r  r e f l e x  
b r o n c h o c o n s t r i c t i o n .  An a l t e r n a t e  h y p o t h e s i s  i s  t h a t  s t e r e o s p e c i f i c  
b i n d i n g  by 3-MI a n d / o r  i t s  m e t a b o l i t e s  t o  membrane r e c e p t o r s  of  mast 
c e l l s  o r  a i rw a y  smooth m u s c le s  may r e s u l t  in b r o n c h o c o n s t r i c t i o n .
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P a t h o p h y s i o l o g i c a l  changes  in a i rw ay  p a t e n c y  w i t h  an accompanying 
i n c r e a s e  in b r o n c h o c o n s t r i c t i o n  can r e s u l t  from c h o l i n e r g i c ,  
s e r o t o n e r g i c ,  a l p h a  a d r e n e r g i c  r e c e p t o r  s t i m u l a t i o n  and b e t a  a d r e n e r g i c
a l s o  r e l e a s e  b r o n c h o c o n s t r i c t i v e  a g e n t s  such as  h i s t a m i n e  and SRS- 
A> 2 4 , 2 9 , 3 3 , 3 4
The p u r p o s e  o f  t h i s  p ap e r  i s  t o  a n a l y z e :  (1)  t h e  c h e m i s t r y  and
p o s s i b l e ,  m e t a b o l i t e s  o f  3-MI,  (2)  t h e  s t r u c t u r e - a c t i v i t y  r e l a t i o n s h i p s  
o f  3-MI m e t a b o l i t e s  w i t h  r e g a r d  t o  s p e c i f i c  b r o n c h o c o n s t r i c t i v e  
r e c e p t o r s  in t h e  l u n g s ,  (3)  t h e  a n t i c h o l i n e s t e r a s e  a c t i v i t y  o f  3-MI and 
i t s  m e t a b o l i t e s  and (4) t h e  p o s s i b l e  c y t o t o x i c  mechanism o f  3-MI and i t s  
m e t a b o l i t e s .
CHEMISTRY AND METABOLISM OF 3-METHYLINDOLE AND INDOLE 
3-MI c o n t a i n s  an i n d o l e  n u c l e u s  w i t h  a p o s i t i o n  3 methyl 
s u b s t i t u t i o n .  The chemical  p r o p e r t i e s  o f  3-MI a r e  s i m i l a r  t o  t h o s e  o f  
i n d o l e  from which i t  i s  d e r i v e d .  The c h e m i s t r y  o f  i n d o l e  and 3-MI a r e  
d e s c r i b e d  in d ep th  in S u n d b e r g ' s  t e x t . ^
I n d o l e  ( F i g u r e  1) i s  a p l a n a r  h e t e r o a r o m a t i c  m o l e c u l e  w i th  a t en  
e l e c t r o n  pi (n )  c l o u d  s y s t e m .  Two e l e c t r o n s  a r e  from t h e  p y r r o l e  r i n g  
n i t r o g e n  and e i g h t  e l e c t r o n s  f rom a s s o c i a t e d  ca rbon a t om s .  P o s i t i o n s  3, 
2 ,  1 and 6 o f  i n d o l e  and 3-MI ( F i g u r e  1) have t h e  f o u r  h i g h e s t  e l e c t r o n
b l o c k a d e .  » L a s t l y ,  c h o l i n e r g i c  b i n d i n g  t o  mast  c e l l  membrane may
H
I n d o l e  3-MI
F i g u r e  1 -  S t r u c t u r a l  f o r m u l a s  f o r  I n d o l e  and 3-MI
d e n s i t i e s .  Resonance  i s  r e s p o n s i b l e  f o r  d e l o c a l i z a t i o n  of  e l e c t r o n s  
away f rom t h e  n i t r o g e n  tow ard  n e a r b y  c a r b o n s .  T h i s  i n c r e a s e s  e l e c t r o n  
d e n s i t y  between c a rb o n s  a t  p o s i t i o n s  2 and 3. The h e t e r o c y c l i c  n i t r o g e n  
atom o f  i n d o l e  i s  weak ly  b a s i c  ( p K a - 2 .5 )  and e x h i b i t s  c h a r g e  
d i s t r i b u t i o n s  as  in F i g u r e  2.  The pKa o f  3-m ethyl  i n d o l e  e q u a l s  - 4 . 5 5 .
F i g u r e  2 -  Charge  d i s t r i b u t i o n s  o f  i n d o l e  
The t h e o r e t i c a l  bond l e n g t h s  (A) f o r  3-MI and i n d o l e  a r e  found in 
F i g u r e  3. These  d i s t a n c e s  were d e t e r m i n e d  by X-ray d i f f r a c t i o n  of  
c r y s t a l l i n e  s t r u c t u r e s  f o r  3-MI as a t r i n i t r o b e n z e n e  complex and by 
s e l f - c o n s i s t e n t  f i e l d  m o l e c u l a r  o r b i t a l  c a l c u l a t i o n s  f o r  i n d o l e .  The 
d e t e r m i n a t i o n  o f  bond l e n g t h s  i s  i m p o r t a n t  f o r  v i s u a l i z i n g  t h e  
i n t r a m o l e c u l a r  d i s t a n c e  r e q u i r e d  f o r  b i n d i n g  t o  r e c e p t o r  models  as  w i l l  
be d i s c u s s e d  in t h i s  r e v ie w .
3 - m e t h y l i n d o l e  I n d o l e
F i g u r e  3 -  C a l c u l a t e d  bond l e n g t h s  f o r  3-MI and I n d o l e
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C h a r a c t e r i s t i c s  of  E l e c t r o p h i l i c  S u b s t i t u t i o n s  and R e a c t i v i t y  of  3-MI 
I n d o l e  and 3-MI a r e  n u c l e o p h i l e s  o r  Lewis b a s e s  ( e l e c t r o n  
d o n o r s ) .  Compounds d e f i c i e n t  in  e l e c t r o n s  a r e  e l e c t r o p h i l e s  o r  Lewis 
a c i d s  and a r e  e l e c t r o n  s e e k e r s .  E l e c t r o p h i l e s  r e a c t  w i t h  e l e c t r o n - r i c h  
d o n o r s  or  n u c l e o p h i l e s  by e l e c t r o p h i l i c  s u b s t i t u t i o n .  The i n d o l i c  
it e l e c t r o n  s y s t em  c o n f e r s  r e s o n a n c e  upon 3-MI which i n c r e a s e s  t h e  
a v a i l a b i l i t y  o f  e l e c t r o n s  and a l l o w s  e l e c t r o p h i 1 i c  a t t a c k ,  e s p e c i a l l y  a t  
p o s i t i o n  3.
M e t a b o l i c a l l y ,  3 - s u b s t i t u t e d  i n d o l e s  such as  3-MI s h o u l d  underyo  
e l e c t r o p h i l i c  s u b s t i t u t i o n  d i r e c t l y  a t  h i g h  e l e c t r o n  d e n s i t y  s i t e s  2,  3 
and 6 . P o s i t i o n  3 s u b s t i t u t i o n s  may u n d e r g o  i n t r a m o l e c u l a r  
r e a r r a n g e m e n t  t o  t h e  2 p o s i t i o n  as  shown in F i g u r e  4 .
F i g u r e  4 -  I n t r a m o l e c u l a r  r e a r r a n g e m e n t  o f  3 - s u b s t i t u t e d  i n d o l e s  
The p o s i t i o n  3 s u b s t i t u t e d  i n t e r m e d i a t e  in F i g u r e  4 i s  more s t a b l e  i f  
s t e r i c  r e p u l s i o n  between t h e  p o s i t i o n  3 methyl  group and E i s  
i n s i g n i f i c a n t .  T h i s  s t a b i l i t y  dep en d s  upon t h e  s i z e  of  t h e  p o s i t i o n  3 
m e thy l  group and E ( a t o m i c  v o lu m e ) .  The l a r g e r  t h e  a to m ic  vo lum e ,  t h e  
more s t e r i c  r e p u l s i o n  between R and E. The d e t e r m i n e d  e x p e r i m e n t a l  
v a l u e s  o f  p o s i t i o n a l  r e a c t i v i t i e s  f o r  e l e c t r o p h i l i c  s u b s t i t u t i o n  on 3- 
i n e t h y l i n d o l e  a r e  3>2>6>4>5>7.®^
M e t a b o l i t e s  o f  I n d o l e  in R a t s  and Humans
When i n d o l e  i s  ad ded  t o  r a t  l i v e r  mic rosome p r e p a r a t i o n s ,  two major
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m e t a b o l i c  pathways can be i d e n t i f i e d  as  shown in F ig u r e  5.^® I n d o l e  i s  
a e r o b i c a l l y  h y d r o x y l a t e d  a t  t h e  3 p o s i t i o n  t o  form 3 - h y d r o x y i n d o l e .
T h i s  r e a c t i o n  may i n v o l v e  t h e  microsomal  enzyme,  a r y l  h y d r o x y l a s e .  3- 
h y d r o x y i n d o l e  can th en  be c o n j u g a t e d  as a s u l f a t e  or  g l u c u r o n i d e  and 
e x c r e t e d .  The e l e c t r o n  r e l e a s i n g  p r o p e r t i e s  o f  t h e  OH group  a t  p o s i t i o n  
3 i n c r e a s e  t h e  e l e c t r o n  d e n s i t y  and ch em ica l  r e a c t i v i t y  a t  p o s i t i o n  2. 
T h i s  a l l o w s  h y d r o x y l a t i o n  a t  p o s i t i o n  2 ,  as  w e l l .  P o s i t i o n  2 
h y d r o x y l a t i o n  p r o b a b ly  i n v o l v e s  an arene.  o x i d e - e p o x i d e  h y d r a s e  
r e a c t i o n .  Red uct ion  o f  t h i s  a r e n e  ox id e  forms an i n d o l i c  d i h y d r o d i o l ,  
2 , 3 - d i h y ' d r o x y i n d o l e ,  which in t u r n  i s  o x i d i z e d  t o  i s a t i n ,  a 2 , 3 - q u i n o n e  
o f  i n d o l e .  Serum o r  t i s s u e  p y r r o l o x y g e n a s e  m e t a b o l i z e s  i s a t i n  t o  N- 
f o r m y l a n t h r a n i l i c  a c i d  which i s  m e t a b o l i z e d  in t u r n  by f o r a m id a s e  t o  
a n t h r a n i l i c  a c i d .
I n d o l e  can a l s o  be m e t a b o l i z e d  a n a e r o b i c a l l y  t o  form o x i n d o l e .  
Ox indo le  i s  h y d r o x y l a t e d  a t  p o s i t i o n  5 by a r y l  h y d r o x y l a s e  t o  form 5- 
h y d r o x y o x i n d o l e  which i s  then  c o n j u g a t e d  t o  a s u l f a t e  o r  g l u c u r o n i d e . ^ ®  
O x indo le  can a l s o  undergo  r i n g  o p en in g  by p y r r o l o x y g e n a s e  t o  form o-  
a m i n o p h e n y l a c e t i c  a c i d
M e t a b o l i t e s  of  3-MI in R a t s  and Humans
L i v e r  microsomal  m e ta b o l i s m  o f  3 - s u b s t i t u t e d  i n d o l e s  in humans and
r o d e n t s  t o  s u l f a t e  c o n j u g a t e d  h y d r o x y l a t e d  i n d o l e s ,  o x i n d o l e s  and 3-
Q7 Qfto x i n d o l e s  has  been r e p o r t e d .  ’ The m a jo r  m e t a b o l i t e s  o f  3-MI in r a t s  
and man a r e  5, 6 o r  7 - h y d r o x y - 3 - m e t h y l i n d o l e  and 3 -m e t h o x y o x i n d o l e  as 
i l l u s t r a t e d  in F i g u r e  6 . In r a t s  and humans,  6 - h y d r o x y - 3 - m e t h y l i n d o l e  
i s  found in h i g h e r  q u a n t i t i e s  t h an  5 or 7 s u b s t i t u t e d  i n d o l e s .  These  
h y d r o x y l a t e d  i n d o l e s  e v e n t u a l l y  become s u l f a t e  c o n j u g a t e s  in r a t s  and 
humans.  However,  c o n j u g a t e d  s u l f a t e s  of  h y d r o x y i n d o l e s  have n o t  been
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A naerob ic  Pathway a?
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N -fo n n y l a n t h r a n i l i c  a c i d
A n th ra n i l ic  a c id
F i g u r e  5 -  M e t a b o l i c  pa thways  o f  i n d o l e .
2-H ydroxy-3-m ethyl in d o le5 , 6 , o r 7 - H y d r o x y - 3-m ethyl In d o le
R.H
i h







O rtho-am inoacetophenone 
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F i g u r e  6  -  M e t a b o l i c  pa thways  f o r  3MI in  mammals. 
(R) R a t s  (H) Humans (G) Goa ts  (P)  P o n ie s
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a b s o l u t e l y  i d e n t i f i e d  as  m e t a b o l i t e s  in a n i m a l s  w i th  3-MI in duced  
p n e u m o t o x i c i t y .
M e t a b o l i t e s  of  3MI in Goats  and P o n ie s
At l e a s t  10 d i f f e r e n t  m e t a b o l i t e s  of  3-MI h a v e b e e n  i d e n t i f i e d  in 
goa t  u r i n e  by a n i o n i c  e l u t i o n  c h r o m a t o g r a p h y . ^ 7 The major  m e t a b o l i t e s  
in g o a t s  a r e  o f  t h e  o x i n d o l e  s e r i e s ,  where t h e  m a jo r  s i t e  of  m e tab o l i s m  
i s  t h e  3-methyl  group of  3-MI. In g o a t s  t h e  f i r s t  majo r  m e t a b o l i t e  i s
3 -m e th 'o xyox indo le .  3 -m e t h o x y o x i n d o l e  i s  t h o u g h t  t o  be m e t a b o l i z e d  t o  
o r t h o - a m i n o a c e t o p h e n o n e  (OAAP) and N-form ain idoacetophenone (FAP) in 
g o a t s  and p o n i e s  as  has been s u g g e s t e d  t o  o c c u r  in r a t s .  The above 
pathways  a r e  i l l u s t r a t e d  in F i g u r e  6 . Both OAAP and FAP have an 
a r o m a t i c  g ro u p ,  but  have n o t  r e t a i n e d  t h e i r  i n d o l e  n u c l e u s .  In g o a t s ,  
e i g h t  of  t h e  t en  m e t a b o l i t e s  have l o s t  t h e i r  i n d o l e  n u c l e u s .  T h i s
s u g g e s t s  t h a t  OAAP and FAP may be m e t a b o l i t e s  o f  3-MI in g o a t s .  In
92p o n i e s ,  e l even  e l u t i o n  peaks  from u r i n e  have been i d e n t i f i e d .  These
pea ks  a r e  s i m i l a r  in e l u t i o n  volume number t o  t h o s e  found in g o a t s ,  but
a r e  n o t  i d e n t i c a l  in q u a n t i t y .  T h e r e f o r e ,  i t  has been s u g g e s t e d  t h a t
many o f  t h e  m e t a b o l i t e s  o f  3-MI in p o n i e s  a r e  i d e n t i c a l  t o  t h o s e  found 
q?
in g o a t s .
T h e o r e t i c a l  Met ab o l i sm  o f  3-MI in Horses
The s i m i l a r i t y  in m e t a b o l i s m  o f  3-MI by t h e  o x i n d o l e  r o u t e  in r a t s ,
g o a t s  and p o s s i b l y  p o n i e s  may s u g g e s t  t h a t  h o r s e s  u t i l i z e  s i m i l a r  
pa thways  of m e ta b o l i s m .
In t h e o r y ,  t h e  m e t a b o l i s m  o f  3-MI s h o u l d  r e s e m b le  t h a t  of  i n d o l e  in 
o t h e r  a n i m a l s .  The e l e c t r o n  r e l e a s i n g  p r o p e r t i e s  o f  t h e  3 p o s i t i o n  
methyl group i n c r e a s e  t h e  e l e c t r o n  d e n s i t y  and r e a c t i v i t y  f o r
n u c l e o p h i l i c  s u b s t i t u t i o n  a t  p o s i t i o n s  2 and 3. A e ro b ic  h y d r o x y l a t i o n  
a t  p o s i t i o n s  2 and 3 by e p o x i d e  h y d r a s e  of  t h e  a r e n e  o x id e  i n t e r m e d i a t e  
s h o u l d  p ro duc e  3 - m e t h o x y o x i n d o l e .  Ring s c h i s m ,  between p o s i t i o n s  2 and 
3 .  by p y r r o l o x y g e n a s e  can th en  form N - f o rm am id o ace to p h en o n e .  The a c t i o n  
o f  serum fo rmamidase  on N -f o rm am idoace tophenone  y i e l d s  o r t h o -  
am in o a c e to p h e n o n e .  3-MI c o u l d  a l s o  be a e r o b i c a l l y  h y d r o x y l a t e d  a t  
p o s i t i o n  5 t o  form 5 - h y d r o x y - 3 - m e t h y l i n d o l e .  6 and 7 h y d r o x y - 3 -  
m e t h y l i n d o l e  would be formed by i n t r a m o l e c u l a r  h y d r o x i d e  s h i f t  or  
t h r o u g h  s e l e c t i v e  r e d u c t i o n  of  t h e  a r e n e  o x id e  i n t e r m e d i a t e .  Hy droxy-3-  
m e t h y l i n d o l e s  c o u l d  then  be c o n j u g a t e d  w i t h  s u l f a t e  o r  g l u c u r o n i d e .
Some o f  t h e s e  s u g g e s t e d  3-MI m e t a b o l i t e s  in h o r s e s  a r e  i l l u s t r a t e d  in 
F i g u r e  6 .
The che mic al  s i m i l a r i t y  o f  t h e s e  s u s p e c t e d  m e t a b o l i t e s  t o  a g e n t s  
which i n t e r a c t  w i th  c h o l i n e r g i c  and s e r o t o n e r g i c  r e c e p t o r s  w a r r a n t s  
compar i son  of  t h e i r  s t r u c t u r e  a c t i v i t y  r e l a t i o n s h i p s  (SAR) w i th  known 
a g o n i s t s  f o r  t h e s e  r e c e p t o r s .  The f o l l o w i n g  s e c t i o n s  a n a l y z e  t h e  SAR of  
some 3-MI m e t a b o l i t e s .
ANALYSIS OF POSSIBLE STRUCTURE-ACTIVITY RELATIONSHIPS OF 3-MI 
METABOLITES: 6 -HYDROXY-3-METHYLINDOLE, 3-METHOXYOXINDOLE, ORTHO
AMINOACETOPHENONE AND N-FORMAMIDOACETOPHENONE 
M u s c a r i n i c  R e c e p t o r  B in d in g  C h a r a c t e r i s t i c s
D i r e c t  s t i m u l a t i o n  o f  c h o l i n e r g i c  r e c e p t o r s  bo th  m u s c a r i n i c  and 
n i c o t i n i c ,  or  a c e t y l c h o l i n e s t e r a s e  (AChE) i n h i b i t i o n  can r e s u l t  in 
b r o n c h o c o n s t r i c t i o n .  S t r u c t u r a l l y ,  a c e t y l c h o l i n e  has  a c a t i o n i c  head 
c o n s i s t i n g  o f  a n i t r o g e n  atom w i th  t h r e e  a s s o c i a t e d  methyl  g r o u p s ,  
c o n n e c t e d  by a f u n c t i o n a l  e t h y l e n e  group t o  a p a r t i a l l y  n e g a t i v e l y  
c h a r g e d  e t h e r  oxygen as  shown in F i g u r e  7a.  M u s c a r i n i c  a c t i v i t y  i s
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g r e a t e s t  w i t h  a c e t y l c h o l i n e - l i k e  a g o n i s t s  in t h e  t r a n s  c o n f i g u r a t i o n  and
l e a s t  i f  t h e  d i s t a n c e  between t h e  c a t i o n i c  head n i t r o g e n  and n e g a t i v e l y
c h a r g e d  e t h e r  oxygen o f  t h e  a g o n i s t  i s  g r e a t e r  t h a n  6 c a r b o n s  in 
25 99l e n g t h .  » The t h e o r e t i c a l  c h a r g e  d i s t a n c e s  between a c t i v e  s i t e s  on
© T " J
f . l l j C  —  O C I I j C I I , —  x  —  C l  I,  
©  O CH,
7-a
F i g u r e s
5-7 A
7-b
7-b T h e o r e t i c a l  model f o r
t h e  m u s c a r i n i c  r e c e p t o r
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7-a  S t r u c t u r a l  fo rm ula  
f o r  a c e t y l c h o l i n e  
t h e  m u s c a r i n i c  r e c e p t o r  a r e  shown in F i g u r e  7 b . :
6 - H y d r o x y - 3 - m e t h y l i n d o l e  and m u s c a r i n i c  c h o l i n o r e c e p t o r  b i n d i n g .  
6 - H y d r o x y - 3 - m e t h y l i n d o l e  has  c h a r g e  d i s t r i b u t i o n s  as in F i g u r e  8 . The 
n e g a t i v e  c h a r g e  d i s t r i b u t i o n  a t  p o s i t i o n  3 r e s u l t s  from r e s o n a n c e  o f
-O 7 - jOqT1
H H
Charge d i s t r i b u t i o n s  o f  6 - h y d r o x y - 3 - m e t h y l i n d o l e
F i g u r e  8
t h e  a r o m a t i c  i n d o l e  n u c l e u s  and r e l e a s e  o f  e l e c t r o n s  by t h e  p o s i t i o n  3 
94methyl  g roup .  The c a l c u l a t e d  i n t r a m o l e c u l a r  d i s t a n c e  between t h e  
p o s i t i o n  1 p o s i t i v e  and p o s i t i o n  3 n e g a t i v e  c h a r g e  in 6 - h y d r o x y - 3 -  
m e t h y l i n d o l e  i s  2.748 which i s  l e s s  than b u t  c l o s e  t o  t h e  r e q u i r e d  
e t h y l e n e  s e p a r a t i o n  o f  3 .08 n e c e s s a r y  f o r  b i n d i n g  t o  t h e  m u s c a r i n i c  
r e c e p t o r .  The p o s i t i o n  6 h yd ro xy l  group i s  a n o t h e r  p o s s i b l e  s i t e  o f  
n e g a t i v e  c h a r g e  and c o u l d  b ind t o  s i t e  3 o f  t h e  m u s c a r i n i c  r e c e p t o r .
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T h i s  c h a r g e  i s  formed by t h e  w i th d r a w a l  o f  e l e c t r o n s  by t h e  a r o m a t i c  
i n d o l e  n u c l e u s  which  a l l o w s  hy drogen i o n s  t o  e s c a p e  f rom t h e  oxygen o f  
t h e  h ydro xy l  g r o u p .  The SAR r e q u i r e m e n t s  f o r  c h a r g e  and e t h y l e n e  group 
d i s t a n c e  a r e  t h u s  p r e s e n t  t o  a l l o w  b i n d i n g  t o  m u s c a r i n i c  r e c e p t o r s  f o r  
6 - h y d r o x y - 3 - m e t h y l i n d o l e .  However,  s u b s t i t u t i o n s  on t h e  a r o m a t i c  r i n g  
o f  6 - h y d r o x y - 3 - m e t h y l i n d o l e  a r e  p l a n a r .  T h i s  f i x e s  t h e  e n o l i c  an ion in 
s p a c e  and may h i n d e r  6 - h y d r o x y - 3 - m e t h y l i n d o l e ' s  a b i l i t y  t o  b i n d  
c h o l i n e r g i c  r e c e p t o r s .  In a d d i t i o n ,  t h e  d i s t a n c e  between t h e  p o s i t i o n  3 
n e g a t i v e  c h a r g e  and t h e  p o s i t i o n  6 n e g a t i v e  c h a r g e  i s  l e s s  t h a n  t h e  
r e q u i r e d  s e p a r a t i o n  t o  b in d  t o  t h e  m u s c a r i n i c  r e c e p t o r  a t  s i t e s  1 and 
3.  T h e r e f o r e ,  b i n d i n g  o f  6 - h y d r o x y - 3 - m e t h y l i n d o l e  t o  t h e  m u s c a r i n i c  
r e c e p t o r  i s  p o s s i b l e ,  b u t  e f f i c a c y  as  an a g o n i s t  o r  a n t a g o n i s t  i s  
q u e s t i o n a b l e .
M u s c a r i n i c  R e c e p t o r  B i n d in g  o f  3 - m e t h o x y o x i n d o l e , o r t h o -  
A m inoace tophenone  and N - f o r m a m i d o a c e t o p h e n o n e . The r e q u i r e m e n t s  f o r  
b i n d i n g  t o  s i t e s  1, 2 and 3 of  t h e  m u s c a r i n i c  r e c e p t o r  a r e  p r e s e n t  on 3- 
m e t h o x y o x i n d o l e ,  (3M0I) O -a m in o a ce to p h e n o n e  (OAAP) and N- 
f o r m a m i d o a c e t o p h e n o n e  (FAP) t h e  s t r u c t u r e s  o f  which a r e  shown in F i g u r e  
9.  The n e g a t i v e  c h a r g e  a t  p o s i t i o n  3 o f  3M0I, FAP, and OAAP
3 - m e t h o x y o x i n d o l e  o - a m i n o a c e t o p h e n o n e  N - f o rm am id o a ce to p h en o n e
F ig u re  9
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i s  p roduced  by t h e  e l e c t r o n e g a t i v e  oxygen and e l e c t r o n  r e l e a s i n g  methyl 
group  and i s  a v a i l a b l e  f o r  b i n d i n g  t o  s i t e  3 of  t h e  m u s c a r i n i c  
r e c e p t o r .  A c a t i o n i c  head n i t r o g e n  would p r o b a b l y  e x i s t  a t  
p h y s i o l o g i c a l  pH f o r  o - a m i n o a c e t o p h e n o n e  (OAAP) and N- 
fo rm a m id o a ce to p h en o n e  (FAP) and c o u ld  be bound t o  s i t e  1 o f  t h e  
r e c e p t o r .  The a r o m a t i c  r i n g  c o u l d  i n t e r a c t  a t  e l e c t r o n  d e f i c i e n t  s i t e  2 
on t h e  m u s c a r i n i c  r e c e p t o r .  A n a l y s i s  o f  t h e  SAR o f  3M0I, OAAP and FAP 
shows t h a t  t h e  r e q u i r e m e n t s  f o r  c h a r g e  a r e  p r e s e n t .  However,  t h e  
d i s t a n c e  r e q u i r e m e n t s  f o r  b i n d i n g  t o  t h e  m u s c a r i n i c  r e c e p t o r  a r e  
unknown.  T h e r e f o r e ,  b i n d i n g  of  3M0I, OAAP and FAP t o  t h e  m u s c a r i n i c  
r e c e p t o r  i s  p o s s i b l e  and i t  i s  l i k e l y  t h a t  OAAP and FAP c o u ld  b ind w i th  
a f f i n i t y  and e f f i c a c y  t o  t h i s  r e c e p t o r .  B ind in g  w i th  a f f i n i t y  and 
e f f i c a c y  would g i v e  OAAP and FAP m u s c a r i n i c  a g o n i s t - l i k e  p r o p e r t i e s .
P o t e n t i a l  A c e t y l c h o l i n e s t e r a s e  I n t e r a c t i o n  w i th  I n d o l e s
The a c e t y l c h o l i n e s t e r a s e  enzyme (AChE) c o n t a i n s  a c a t i o n i c -
QQe s t e r a t i c  and a n i o n i c  s i t e . * 33 Wi th in  t h e  c a t i o n i c - e s t e r a t i c  s i t e  
l i e s  a n e g a t i v e l y  and p o s i t i v e l y  c h a r g e d  s i t e  f o r  t h e  acyl  carbon and 
e t h e r  oxygen of  a c e t y l c h o l i n e  as  shown in F i g u r e  10.  The l i k e l i h o o d  o f  





F i g u r e  10 -  I n t e r a c t i o n  o f  a c e t y l c h o l i n e  w i t h  a c e t y l c h o l i n e s t e r a s e
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m e t a b o l i t e ' s  a b i l i t y  t o  b ind  c h o l i n e r g i c  r e c e p t o r s .  C e r t a i n  s t r u c t u r a l  
s i m i l a r i t i e s  e x i s t  be tween 3-MI,  i t s  m e t a b o l i t e s  and some AChE 
i n h i b i t o r s  as i l l u s t r a t e d  in F i g u r e  11.  In a d d i t i o n ,  t h e  i n d o l i c  
a n t h e l m i n t h i c  d r u g ,  l e v a m i s o l ,  i s  p o s s i b l y  an i n h i b i t o r  o f  AChE a t  h igh 
d o s e s  ( F i g u r e  1 1 ) .  At h ig h  enough d o s e s ,  3-MI may i n h i b i t  AChE in a 
manner s i m i l a r  t o  t h e s e  d r u g s .




i' /  7
CH-./ CH,> P h y s o s t i g m i n e
CH
, 0 — C —N
- q t  ,
N e o s t i  gmine
O r t h o - a m i n o a c e t o p h e n o n e  
-c h 3
ho- C X j
H
6 - h y d r o x y - 3 - m e t h y l i n d o l e
q " ' “ 3
-CH
H
N -fo rm am idoace tophen one
N ——
Levamisol
F i g u r e  11 -  Comparison of  t h e  s t r u c t u r a l  f o r m u l a s  f o r  s u s p e c t e d  
m e t a b o l i t e s  o f  3-MI and known a c e t y l c h o l i n e s t e r a s e  i n h i b i t o r s .
P o t e n t i a l  S e r o t o n e r g i c  R e c e p t o r  B in d in g  by 3MI and i t s  M e t a b o l i t e s
The s e r o t o n i n  (5 -H t )  r e c e p t o r  i s  d e p i c t e d  in F i g u r e  12 . 100  Bind ing
107
S i d e  C hai n S i d e  Chai n site site 2
( s i t e  1 )
 j V m u w i l d  I
( s i t e  2 )
F i g u r e  12a -  S e r o t o n i n  r e c e p t o r
model
12b -  P o s s i b l e  b i n d i n g  of
FAP t o  t h e  s e r o t o n i n
r e c e p t o r  model
a t  s i d e  c h a in  s i t e s  1 and 2 as  w e l l  as a t  s i t e s  IU,  U2 and l ^ - N  i s
w i t h o u t  a c t i v i t y  r e q u i r e s  b i n d i n g  a t  s i t e s  R1 and R2. The h y d r o p h o b i c  
i n d o l e  n u c l e u s  o f  5-Ht  b i n d s  a t  R p  R2 and R2 -N o f  t h e  r e c e p t o r  model .
A p o s i t i o n  3 s i d e  c h a in  n i t r o g e n  or an i s o s t e r i c  s u b s t i t u t e  i s  bound a t  
s i d e  c h a in  s i t e  2 o f  t h e  r e c e p t o r  f o r  a g o n i s t  a c t i v i t y .  The i n d o l e  
n u c l e u s  o f  e i t h e r  6 - h y d r o x y -3 -M I  or  3 - m e t h o x y o x i n d o l e  i s  c a p a b l e  o f  
b i n d i n g  a t  s i t e s  R l ,  R2 and R2 -N,  b u t  n o t  a t  s i d e  c h a in  s i t e s  1 and 2. 
B i n d in g  a t  R l ,  R2 and R2 -N would p o s s i b l y  g i v e  t h e s e  compounds 
a n t a g o n i s t - l i k e  p r o p e r t i e s .  T h i s  t y p e  o f  r e c e p t o r  b i n d i n g  has  h ig h  
a f f i n i t y  b u t  l i t t l e  or  no e f f i c a c y  or  r e s p o n s e .
O r t h o - a m i n o a c e t o p h e n o n e  and N - f o rm am id o ace to p h en o n e  may a l s o  b in d  
t o  h y d r o p h o b i c  s i t e s  Rl and R2 and R2 -N.  I l l u s t r a t i o n  o f  t h e  f u n c t i o n a l  
g ro u p s  o f  FAP a s  t h e y  r e l a t e  t o  t h e  b i n d i n g  s i t e s  o f  t h e  s e r o t o n i n  
r e c e p t o r  model a r e  shown in  F i g u r e  12b.  In a d d i t i o n ,  t h e  i s o s t e r i c  
s u b s t i t u t i o n  o f  CH3 i n  OAAP and FAP f o r  t h e  NH2 o f  5-Ht  would  
p o t e n t i a l l y  a l l o w  some a g o n i s t - l i k e  b i n d i n g  a t  s i d e  c h a i n  s i t e  2 .
r e q u i r e d  f o r  f u l l  5-Ht  a g o n i s t  a c t i v i t y . ^  5-Ht  r e c e p t o r  b i n d i n g
A g o n i s t  b i n d i n g  o f  OAAP and FAP w i t h  both  a f f i n i t y  and e f f i c a c y  coul d  
r e s u l t  in s t i m u l a t i o n  o f  s e r o t o n i n  r e c e p t o r s ,  w i t h  an i n c r e a s e  in 
v a g a l l y  m e d i a t e d  b r o n c h o c o n s t r i c t i o n .
P o t e n t i a l  A d r e n e r g i c  R e c e p t o r  B in d in g  by 3-MI o f  i t s  M e t a b o l i t e s
Optimum a d r e n e r g i c  a c t i v i t y  i s  seen w i t h  compounds w i th  a
p o s i t i v e l y  c h a rg e d  amine s e p a r a t e d  f rom an a r y l  group by 2 -  
?A QQc a r b o n s .  ’ T h i s  p h e n e th y l a m i n e  r e q u i r e m e n t  i s  n o t  p r e s e n t  in any 
known 3-MI m e t a b o l i t e .  The o x i d a t i o n  o f  6 -hydroxy-3 -M I between t h e  
phenyl  r i n g  and p y r r o l e  n i t r o g e n  c o u l d  p ro d u c e  a p h e n e t h y l a m i n e  as shown 
in F i g u r e  13.  However ,  t h i s  m e t a b o l i t e  has  n o t  been i d e n t i f i e d  and no 
o t h e r  m e t a b o l i t e s  have been r e p o r t e d  in any s p e c i e s  t h a t  would s u p p o r t  
a d r e n e r g i c  r e c e p t o r  b i n d i n g  a c t i v i t y .  T h e r e f o r e ,  i t  i s  u n l i k e l y  t h a t  3- 
MI and i t s  m e t a b o l i t e s  a r e  i n t e r a c t i n g  w i t h  a d r e n e r g i c  r e c e p t o r s .
F i g u r e  13 -  P o t e n t i a l  p h e n e t h y l a m i n e  f o r m a t i o n  f rom 6 - h y d r o x y - 3 -
m e t h y l i n d o l e
Some r e p o r t s  have s u g g e s t e d  a c y t o t o x i c  mechanism f o r  p r o d u c t i o n  of
3-methy l  i n d o l e  i n d u c ed  p n e u m o t o x i c o s i s .  The p r o d u c t i o n  of  lu n g  damage by 
c y t o t o x i c  mechanisms has  been d e s c r i b e d  f o r  t h e  h e r b i c i d e  p a r a q u a t  and a 
compound i s o l a t e d  from m old ly  swee t  p o t a t o e s  and p e r i l l a  min t  p l a n t
CH;
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known as 3 - s u b s t i t u t e d  f u r a n s >1 02 ,104 ,1 05  mechan isms  f o r  
p r o d u c t i o n  o f  t h e i r  t o x i c i t y  a r e  d i s c u s s e d  i n  t h e  f o l l o w i n g  s e c t i o n .
P a r a q u a t
The h e r b i c i d e  p a r a q u a t  d i c h l o r i d e  e x e r t s  i n d i r e c t  t o x i c i t y  on t h e  
l u n g  v ia  a redox  c o u p l i n g  r e a c t i o n  w i t h i n  cytochrome o x i d a s e  as shown in 
F i g u r e  1 4 . 2 4 ,1 0 1  The p e t  r e s u i t  j S an i n c r e a s e  in o x i d i z e d  NADP which 
a l t e r s  oxygen m e t a b o l i s m .  The p r o d u c t s  of  p a r a q u a t  m e tab o l i s m  a r e  
u l t i m a t e l y  o x i d i z e d  p a r a q u a t  and s u p e r o x i d e  r a d i c a l s  (0 2 _ ) .  S u p e ro x i d e  
r a d i c a l s  a l t e r  membrane p e r m e a b i l i t y  by l i p i d  p e r o x i d a t i o n .  P a r a q u a t  
a l s o  i s  r e p o r t e d  t o  i n c r e a s e  i n t r a c e l l u l a r  g u a n y l a t e  c y c l a s e  a c t i v i t y  
and in c o n j u n c t i o n ,  cGMP l e v e l s . * 04  The r e s u l t  of  i n c r e a s i n g  
i n t r a c e l l u l a r  cGMP i s  an a d v a n c i n g  h i s t o p a t h o l o g i c a l  change in l un g 
morphology known a s  pulmonary  f i b r o s i s .  C h ro n ic  e x p o s u r e  t o  c h e m i c a l s  
c a p a b l e  o f  i n c r e a s i n g  i n t r a c e l l u l a r  cGMP o r  t h e s e  which a l t e r  c e l l u l a r  
re dox  p o t e n t i a l s  may i n d u c e  pulmonary  f i b r o p r o l i t e r a t i v e  d i s e a s e .  At 
p r e s e n t ,  t h e  l i k e l i h o o d  t h a t  3-MI c o u l d  p ro d u c e  t y p i c a l  p e r o x i d a t i o n  by 
a mechanism s i m i l a r  t o  t h a t  o f  p a r a q u a t  r e q u i r e s  f u r t h e r  i n v e s t i g a t i o n .
4 - Ipo meano l
The f u r a n ,  4- ipom eano l  as  seen in F ig u re  15 i s  a h i g h l y  s e l e c t i v e
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pulmonary t o x i c a n t  found  in moldy sweet  p o t a t o e s .
F i g u r e  15 -  4 - ipo mea nol
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Paraquat d i c h l o r i d e
o x id iz e d  paraquat NADPH
reduced paraquat NADP
LIPIDS
o x i d iz e d  paraquat
Lipid  pe r o x id a t io n
Lipid Free r a d i c a l s
Membrane Free Radical Damage
Figure 14- Paraquat T o x i c i t y  Mechanism
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4-i p o in ean o l  i s  m e t a b o l i z e d  by t h e  cy toch rom e  P -450 enzyme s y s t e m  which
ipomeanol  i s  a h i g h l y  r e a c t i v e  e l e c t r o p h i l i c  a r e n e  o x i d e  c a p a b l e  of 
co m b in in g  w i t h  c e l l u l a r  n u c l e o p h i l e s  l o c a t e d  in c e l l  membranes of  lu n g  
t i s s u e .  Arene o x i d e s  can a l s o  form f r e e  r a d i c a l s .  F r e e  r a d i c a l s  in 
t u r n  c a u s e  l i p i d  p e r o x i d a t i o n  and membrane d e s t r u c t i o n .  As p r e v i o u s l y  
d i s c u s s e d ,  an a r e n e  o x i d e  i n t e r m e d i a t e  e x i s t s  in t h e  m e t a b o l i s m  o f  3-MI 
t o  o r t h o - a m i n o a c e t o p h e n o n e .  T h i s  i n t e r m e d i a t e  m e t a b o l i t e  of  3-MI may 
c a u s e  l i p i d  p e r o x i d a t i o n  and d e s t r u c t i o n  o f  c e l l u l a r  membranes a s  do es  t h e  
r e a c t i v e  m e t a b o l i t e  o f  4 - i p o m e a n o l .
Arene Oxide  And F re e  R a d i c a l  F o rm a t io n  From S e r o t o n i n  And 5-Hydroxy
The f o r m a t i o n  o f  f r e e  r a d i c a l s  and a r e n e  o x i d e s  f rom s e r o t o n i n ,  a
F i g u r e  16.  The p r o d u c t i o n  o f  f r e e  r a d i c a l s  and s u p e r o x i d e  ion c o u l d  
r e s u l t  in a p n eu m o to x ic  r e a c t i o n  s i m i l a r  t o  t h a t  p r o d u c e d  by p a r a q u a t .  
The i m p o r t a n c e  o f  f r e e  r a d i c a l  f o r m a t i o n  d u r i n g  3-MI m e t a b o l i s m  by t h i s  
mechanism r e q u i r e s  f u r t h e r  i n v e s t i g a t i o n .  However ,  many o f  t h e  
m e t a b o l i t e s  o f  3-MI a r e  h y d r o x y - 3 - m e t h y l i n d o l e s  and s h a r e  many of  t h e  
same ch em ica l  p r o p e r t i e s  o f  5-Ht  and 5 - h y d r o x y i n d o l e .
F i g u r e  16.  P r o p o s e d  mechanism f o r  p r o d u c t i o n  o f  f r e e  r a d i c a l s  by 
5 - h y d r o x y l a t e d  i n d o l e s  and 5 - h y d r o x y t r y p t a m j n e  ( s e r o t o n i n ) .
i s  a l s o  known as  mixed f u n c t i o n  o x i d a s e . T h e  t o x i c  m e t a b o l i t e  of  4-
I n d o l e
5 - h y d r o x y i n d o l e  has  been r e p o r t e d . O n e  mechanism i s  d iagrammed in
r.AD(P) ♦
.SERPTOM!. HAD(P)H
C o r u l o p l f i 5 r . i l
C y tc c r .r t re  c
SUMMARY
The s t r u c t u r e  a c t i v i t y  r e l a t i o n s h i p s  o f  3-MI m e t a b o l i t e s  co u ld  
s u p p o r t  a c h o l i n e r g i c  o r  s e r o t o n e r g i c  r e c e p t o r  b i n d i n g  mechanism.  6 -  
h y d ro x y -3 -M I ,  o r t h o - a m i n o a c e t o p h e n o n e  and N-for m am idoace tophen one 
s a t i s f y  a t  l e a s t  2 o r  more r e q u i r e m e n t s  f o r  m u s c a r i n i c  and s e r o t o n e r g i c  
b i n d i n g .  The a b i l i t y  t o  b ind  c h o l i n e r g i c  and s e r o t o n e r g i c  r e c e p t o r s  may 
a l s o  a l l o w  b i n d i n g  t o  a c e t y l c h o l i n e s t e r a s e ,  and i n h i b i t i o n  of  AChE 
a c t i v i t y .  In a d d i t i o n ,  t h e  p o t e n t i a l  e x i s t s  f o r  f r e e  r a d i c a l  fo r m a t i o n  
in v i t r o  and in v i v o . F r e e  r a d i c a l  f o r m a t i o n  may r e s u l t  in d e s t r u c t i o n  
o f  lu n g  t i s s u e  membrane,  b r o n c h i o l i t i s  and develo pm en t  o f  a 
f i b r o p r o l i f e r a t i v e  o b s t r u c t i v e  pulmonary d i s e a s e .  These  t h e o r e t i c a l  
mechanisms may p ro ve  t o  be of  v a lu e  in d e t e r m i n i n g  t h e  mechanism of  3-MI 
in d u ced  p n e u m o t o x i c i t y .
I f  3-MI and i t s  m e t a b o l i t e s  a l t e r  t h e  normal  b a l a n c e  between t h e  
c h o l i n e r g i c  and a d r e n e r g i c  n e rvous  sy s t em s  by b i n d i n g  t o  m u s c a r i n i c  
r e c e p t o r s  l o c a t e d  in t h e  l u n g ,  t h e  b i n d i n g  t o  t h e s e  r e c e p t o r s  can be 
i d e n t i f i e d  and c h a r a c t e r i z e d .  The f o l l o w i n g  2 c h a p t e r s  compare 
m u s c a r i n i c  r e c e p t o r s  between r a t  b r a i n ,  r a t  lu n g  and e q u i n e  l un g u s i n g  
r a d i o l i g a n d  t e c h n i q u e s  and d e t e r m i n e  t h e  a b i l i t y  of  OAAP and 3-MI t o  b in d  
t o  t h e s e  r e c e p t o r s .
C h ap te r  V
CHARACTERIZATION AND IDENTIFICATION OF MURINE 
AND EQUINE PULMONARY MUSCARINIC RECEPTORS
The p h y s i o l o g i c a l  r e s p o n s e s  o f  a i r w a y  smooth m usc le  and lung
f u n c t i o n  a r e  r e g u l a t e d  by a b a l a n c e  between t h e  p a r a s y m p a t h e t i c  ( c h o l i n ­
e r g i c )  and s y m p a t h e t i c  ( a d r e n e r g i c )  n e r v o u s  s y s t e m s .2 5 ,3 4
'C h o l i n e r g i c  i n n e r v a t i o n  o f  t h e  lung a r i s e s  f rom vaga l  n u c l e i  in  t h e
b r a i n .  In most  s p e c i e s ,  p r e s y n a p t i c  c h o l i n e r g i c  pathways t e r m i n a t e  on 
g a n g l i a  l o c a t e d  a d j a c e n t  t o  t h e  a i r w a y s .  These  g a n g l i a  s p r o u t  
p o s t g a n g l i o n i c  n e r v e  f i b e r s  which s y n ap se  on a i r w a y  smooth m usc le  and in 
a s s o c i a t i o n  w i th  s e c r e t o r y  g l a n d s  l i n i n g  t h e  a i r w a y s . 34 The 
p o s t s y n a p t i c  c h o l i n e r g i c  r e c e p t o r  i s  m u s c a r i n i c .  S t i m u l a t i o n  o f  
p o s t - s y n a p t i c  m u s c a r i n i c  r e c e p t o r s  in  lung c a u s e s  c o n t r a c t i o n  o f  
b r o n c h i a l  smooth m us cl e  and s e c r e t i o n  o f  g l a n d s  l i n i n g  t h e s e  a i r w a y s .
In a d d i t i o n ,  when m u s c a r i n i c  r e c e p t o r s  l o c a t e d  on b a s o p h i l  and mast  c e l l  
membranes a r e  s t i m u l a t e d ,  b r o n c h o a c t i v e  m e d i a t o r s  which ca u s e  
c o n t r a c t i o n  o f  a i rw ay  smooth m us cl e  a r e  r e l e a s e d . 6 , 3 0 , 3 4 , 1 0 7
U n d e r s t a n d i n g  t h e  m o l e c u l a r  pha rm a co logy  o f  m u s c a r i n i c  r e c e p t o r s  in  
e q u i n e  lung  may a i d  in  i d e n t i f y i n g  t h e  p a t h o g e n e s i s  o f  c e r t a i n  a b n o r ­
m a l i t i e s  o f  l ung  f u n c t i o n .  O v e r s t i m u l a t i o n  o f  t h e  m u s c a r i n i c  r e c e p t o r s  
o f  a i r w a y  smooth m uscl e  c a u s e s  a b r o n c h o c o n s t r i c t i v e  lung d i s e a s e  which 
i s  a s t h m a - l i k e  i n  c h a r a c t e r .  When t h e  m u s c a r i n i c  r e c e p t o r s  on mast  c e l l  
membranes a r e  s t i m u l a t e d ,  b r o n c h o a c t i v e  m e d i a t o r s  l i k e  h i s t a m i n e  and 
SRS-A a r e  r e l e a s e d  c a u s i n g  bronchospasm as w e l l . 2 In a d d i t i o n ,  
m u s c a r i n i c  r e c e p t o r  s t i m u l a t i o n  can c a u s e  e x c e s s i v e  s e c r e t i o n  o f  mucus
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by g l a n d s  l o c a t e d  in  c o n t a c t  w i th  t h e  a i r w a y  e p i t h e l i a l  l i n i n g .  Th is  
r e s u l t s  i n  mucus p l u g s  which o b s t r u c t  t h e  a i rw a y s  and u l t i m a t e l y  a l t e r  
normal pulmona ry  f u n c t i o n .
R ecen t  s t u d i e s  have c h a r a c t e r i z e d  m u s c a r i n i c  r e c e p t o r s  in  many 
t i s s u e s ,  i n c l u d i n g  r a t  l u n g  u s i n g  d i r e c t  r a d i o l i g a n d  b i n d i n g  t e c h ­
n i q u e s  . 1 0 8 - 1 1 4  C h a r a c t e r i z a t i o n  o f  m u s c a r i n i c  r e c e p t o r s  in  e q u i n e  
l un g  has  n o t  been r e p o r t e d .  Th i s  s t u d y  was c o n d u c te d  t o  i d e n t i f y  and 
c h a r a c t e r i z e  m u s c a r i n i c  r e c e p t o r s  in e q u i n e  lung and compare them both  
q u a n t i t a t i v e l y  and q u a l i t a t i v e l y  w i t h  t h o s e  in  r a t  l u n g .
MATERIALS AND METHODS
Chem ical s
Al l  d r u g s  used in  t h e  s t u d y  were o b t a i n e d  from Sigma Chemical 
Company I n c o r p o r a t e d  ( S t .  L o u i s ,  Mo.) w i th  t h e  e x c e p t i o n  o f  t h o s e  n o t e d  
be low .  M u s c a r i n i c  a g o n i s t s  used were o x o t r e m o r i n e  and a r e c o l i n e .  
A n t a g o n i s t s  used in  t h i s  s t u d y  were s c o p o l a m i n e ,  a t r o p i n e  and q u i n u c -  
l i d i n y l  b e n z i l a t e  (QNB). QNB was p r o v i d e d  by Hoffman-LaRoche I n c .  The 
r a d i o l i g a n d  q u i n u c l i d i n y l  [ p h e n y l - 4 - 3 h]-QNB ( 2 9 . 4  Ci /mmole) was 
o b t a i n e d  f rom New England N uc le a r  ( B o s t o n ,  M a s s . ) .  All d ru g s  were 
p r e p a r e d  f r e s h  a t  a p p r o p r i a t e  d i l u t i o n s  in d e i o n i z e d - d i s t i l l e d  w a t e r .
R a d i o l i g a n d  and u n l a b e l e d  l i g a n d  p u r i t y  were d e t e r m i n e d  by t h i n  
l a y e r  ch r o m a to g rap h y  or  m e l t i n g  p o i n t  a n a l y s i s .
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T i s s u e  p r e p a r a t i o n
Male Sprague -Daw ley  r a t s  (250g)  we re  s a c r i f i c e d  by d e c a p i t a t i o n  and 
t h e i r  l u n g s  removed and t r immed o f  t r a c h e a  and m a jo r  b r o n c h i .  The lu n g s  
were  weighed and homogenized in a p p r o x i m a t e l y  20 ml o f  4°C NaK p h o s p h a t e  
b u f f e r  (0.050M;pH 7 .4 )  f o r  2 -20  sec ond  b u r s t s  a t  maximum spee d  u s i n g  a 
Tekmar t i s s u e  h o m o g e n i z e r .  Lung homogenate  was c e n t r i f u g e d  t w i c e  a t  
lOOOg f o r  15 m i n u t e s .  The two s u p e r n a t a n t s  were combined,  and 
c e n t r i f u g e d  a t  4 0 ,0 0 0 g  f o r  10 m in .  a t o t a l  o f  two t i m e s .  The f i n a l  
p e l l e t  f o r  each r a t  was su sp en d e d  in  NaK p h o s p h a t e  b u f f e r  t o  a f i n a l  
c o n c e n t r a t i o n  o f  10% ( w / v ) .  P r o t e i n  c o n c e n t r a t i o n s  o f  t h e s e  homogena tes  
were d e t e r m i n e d  by t h e  BioRad® dye m e t h o d . 126
Male p o n i e s  were s a c r i f i c e d  by e l e c t r o c u t i o n .  The r i g h t  lung was 
removed and t h r e e  c o r e  sam ples  (> 5g) we re  o b t a i n e d  from t h e  p a r i e t a l  
s u r f a c e  a t  t h e  h i l a r  r e g i o n .  Samples were  p l a c e d  in  i n d i v i d u a l  p l a s t i c  
bags  and q u ic k  f r o z e n  in  a d r y - i c e / e t h a n o l  b a t h .  All samples  were 
s t o r e d  f r o z e n  ( -50°C)  f o r  t h r e e  months  o r  l e s s .  Frozen lun g t i s s u e  was 
thawed  and homogenized as d e s c r i b e d  f o r  r a t  l u n g .  In c o n t r a s t  t o  r a t  
l u n g ,  pony lung homogenate  was c e n t r i f u g e d  a t  5000g f o r  15 m i n u t e s .  The 
s u p e r n a t a n t  was s t r a i n e d  th r o u g h  c h e e s e  c l o t h  and c e n t r i f u g e d  a t  40 ,000g  
f o r  10 m i n s .  The r e s u l t i n g  p e l l e t  was t h e n  r e s u s p e n d e d  in  4°C b u f f e r ,  
homogenized and c e n t r i f u g e d  a t  40 ,000g  t w i c e  more .  The f i n a l  p e l l e t  was 
r e s u s p e n d e d  t o  a 10% homogenate  and a n a l y z e d  f o r  p r o t e i n  as  d e s c r i b e d  
f o r  r a t  l u n g .
B in d in g  Method
All  e x p e r i m e n t s  were run  in  t r i p l i c a t e  and t h e  f i n a l  volume in  a l l  
t u b e s  was 2 ml + 1%. Each t u b e  was i n c u b a t e d  a t  37°C in  a s h a k e r  b a t h
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f o r  60 m i n u t e s .  I n c u b a t i o n  was t e r m i n a t e d  by vacuum f i l t r a t i o n  th r o u g h  
Whatman GF/B g l a s s  f i b e r  f i l t e r s  f o l l o w e d  by t h r e e  -  4 ml washes  w i th  
i c e - c o l d  b u f f e r .
T i s s u e  l i n e a r i t y  e x p e r i m e n t s . [3h]-QNB was added t o  i n c u b a t i o n  
t u b e s  c o n t a i n i n g  v a r y i n g  amounts  o f  b u f f e r  and 10% lung homogenate  t o  a 
t o t a l  volume o f  2 m l . In a d d i t i o n ,  o n e - h a l f  o f  t h e  t u b e s  c o n t a i n e d  
1 . 0  uM a t r o p i n e .  T a b le  1 d e p i c t s  t h e  d e s i g n  o f  t h e s e  e x p e r i m e n t s .  One 
t r i a l  was run  f o r  t h i s  e x p e r i m e n t  f o r  each t i s s u e  t y p e .
S a t u r a b i l i t y  e x p e r i m e n t s . S a t u r a b i l i t y  o f  s p e c i f i c  b i n d i n g  was 
m easu red  by ad d in g  i n c r e a s i n g  amounts of  a 1 : 1 0 , 0 0 0  d i l u t i o n  of  
[3h]-QNB t o  t i s s u e  membrane h o m ogena te s .  T a b le  2 shows t h e  d e s i g n  o f  
t h e s e  e x p e r i m e n t s .  The r e c i p r o c a l  o f  t h e  s l o p e  and x - i n t e r c e p t  o f  t h e  
S c a t c h a r d  p l o t  o f  t h e s e  d a t a  were  used t o  d e t e r m i n e  t h e  a p p a r e n t  h igh 
a f f i n i t y  d i s s o c i a t i o n  c o n s t a n t  ( Kpa p p ) and t h e  r e c e p t o r  d e n s i t y  
(Bmax) ,  r e s p e c t i v e l y J  ^  s i x  t r i a l s  were run  f o r  both  r a t  and 
pony lung  homogena te .
Drug i n h i b i t i o n  e x p e r i m e n t s . Drug i n h i b i t i o n  c u r v e s  were d e t e r ­
mined u s i n g  t h e  p r o t o c o l  shown in  T ab le  3 t o  p e r f o r m  t h e  e x p e r i m e n t s .  
From t h e s e  d a t a  t h e  c o n c e n t r a t i o n  r e q u i r e d  f o r  f i f t y  p e r c e n t  i n h i b i t i o n  
o f  s p e c i f i c  b i n d i n g  ( I C 5 0 ) and t h e  H i l l  c o e f f i c i e n t  were d e t e r m in e d  
f o r  each  o f  t h e  d r u g s  u s e d .  The H i l l  e q u a t i o n  was used t o  c a l c u l a t e  t h e  
IC50  f o r  each  drug and t h e  H i l l  c o e f f i c i e n t s . 1 1 6 ,1 1 7  j n 
a d d i t i o n ,  t h e  c o n s t a n t  f o r  i n h i b i t i o n  o f  50% o f  t h e  s p e c i f i c  b i n d i n g  
(K-j) f o r  each  dr ug  was c a l c u l a t e d  from t h e s e  d a t a  a c c o r d i n g  t o  t h e  
e q u a t i o n
Ki = _ T̂ 5 0 _____  . 116
1 1 + L l j / k d
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T a b le  1 - Design  o f  t i s s u e  l i n e a r i t y  e x p e r i m e n t s  f o r  r a t  and pony lung.
VOLUMES ADDED ( u l )
Tube
No.
B u f f e r
(ml)
A t r o p i n e  
(100  UM)
L8 HJ-QNB 
1 : 1 0 0 0 0  
D i l u t i o n
10% T i s s u e  
Homogenate
T o ta l  
Volume ( u l )
1-3 0 . 9 5 20 50 1000 2020
4 -6 0 . 9 5
----
50 1000 2000
7-9 1.45 20 50 500 2020
1 0 -1 2 1.45 ---- 50 500 2000
13-15 1 .75 20 50 200 2020
16-18 1 .75
---
. 50 200 2000
19-21 1 .85 20 50 100 2020
22-24 1 .85 50 100 2000
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T ab le  2 - Design of s a t u r a b i l i t y  e x p e r i m e n t s  f o r  r a t  and pony lung.




B u f f e r
A t r o p i n e  
( 1 0 0  PM)
[3 H j-QNB 
1 : 1 0 , 0 0 0  
Di l u t i o n
10% T i s s u e  
Homogenate
T o ta l  
Volume (u l )
1-3 1.48 20 25 500 2025
4 -6 1.48
--- 25 500 2005
7-9 1.45 20 50 500 2020
10 -1 2 1.45
---
50 500 2000




19-21 1.30 20 200 500 2020
22-24 1.30 200 500 2000
T ab le  3 -  Design o f  drug i n h i b i t i o n  c u r v e  e x p e r i m e n t s  f o r  r a t  and pony lung .  
*20 pi o f  100 M A t r o p i n e  was added t o  each o f  t h e s e  t u b e s .
**A11 numbers in p a r e n t h e s e s  i n d i c a t e  molar  c o n c e n t r a t i o n s .
Volumes Added ( M l )
Tube
No.
B u f f e r
(ml)
L3h j - q n b
1 : 1 0 , 0 0 0
D i l u t i o n
T r i a l  1 
QNB
T r i a l  2 
Scopolamine
T r i a l  3 
A t r o p i n e
T r i a l  4 
Ox o t re mor in e
I
T r i a l  5 
A r e c o l i n e
10% T i s s u e  
Homogenate
1-3* 1 .4 80 ul None None None None None 500
4-6 1 .4 80 20 _q** 
( 1 0  y)
20 _7 
d o  )
20 _ 7 
d o  )
20  _6 
(1 0  )
20 _6 
(1 0  )




20 - 6  
(1 0  °)
20 -5  
( 1 0  b)
20 -5  
(1 0  )
10 -1 2 1 .4 80 20
( 1 0 - 7)
20
(1 0 - 5 )
20
(1 0 -5 )
20
(1 0 -4 )
20
(10 -4 )
13-15 1 .4 80 20
( 10 - 6 )
20
(1 0 - 4 )
20
(10 - 4 )
20
(1 0 -3 )
20
(1 0 - 3 )
16-18 1 .4 80 20
(1 0 - 5 )
20
(1 0 - 3 )
20
(10 - 3 )
20
( 1 0 - 2 )
20
( 1 0 - 2 )
19-21 1 .4 80 20
(10-4 )
20
( 10 - 2 )
20
( 1 0 - 2 )
200
( 1 0 - 2 )
200
( 1 0 - 2 )
22-24 1 .4 80 None None None None None
120
Th ree  t r i a l s  were ru n  f o r  p o n i e s  and f o u r  t r i a l s  f o r  r a t s  in t h e s e  
e x p e r i m e n t s .
Sample C oun t ing
R a d i o a c t i v i t y  bound t o  f i l t e r s  was e x t r a c t e d  f o r  one hour  in  6 ml 
o f  Beckman Ready Solv  EP and co u n t e d  f o r  5 m i n u te s  i n  a Beckman LS-7500 
l i q u i d  s c i n t i l l a t i o n  s p e c t r o p h o t o m e t e r .  An e x t e r n a l  s t a n d a r d  wi th  
a u t o m a t i c  quench c o r r e c t i o n  was used t o  d e t e r m i n e  c o u n t i n g  e f f i c i e n c y  
and d i s i n t e g r a t i o n s  p e r  m i n u te  p e r  fmole  (dpm s/fmole )  o f  [3h]-QNB f o r  
e a ch  sam ple  t u b e .  D u p l i c a t e  d i r e c t  c o u n t s  were t a k e n  t o  d e t e r m i n e  t h e  
a c t i v i t y  in  c o u n t s  p e r  m i n u te  (cpm) o f  t h e  [3h]-QNB s t a n d a r d  s o l u t i o n .
Sample q u en c h in g  was c o r r e c t e d  u s i n g  [ ^ H ] - t o l u e n e  and p y r i d i n e  
as  d e v e lo p e d  by P e d i g o . C o u n t i n g  e f f i c i e n c y  was 35% p e r c e n t .
The pr ogrammable  Beckman LS-7500 d e t e r m i n e d  a n o r m a l i z a t i o n  f a c t o r  which 
c a l c u l a t e d  t h e  dpm/fm oles  o f  [^H]-QNB based  upon i n p u t  o f  t h e  
r a d i o l i g a n d ' s  known s p e c i f i c  a c t i v i t y .  In c o m b i n a t i o n  w i th  t h e  
d e t e r m i n a t i o n  o f  e f f i c i e n c y ,  an a v e r a g e  sample  dpm -n orm al ized  was 
p r i n t e d  as fm o les  [^Hj-QNB bound o r  in  s o l u t i o n  f o r  each t u b e .
Samples were  run  in  t r i p l i c a t e  and each s e t  o f  3 - i d e n t i c a l  t u b e s  was 
a v e r a g e d .  In a l l  c a s e s  s p e c i f i c  [3h]-QNB b i n d i n g  was c a l c u l a t e d  as 
t h e  d i f f e r e n c e  between t h e  amount o f  b i n d i n g  in  t h e  a b s e n c e  and p r e s e n c e  
o f  1 . 0  uM a t r o p i n e .
S t a t i s t i c a l  co m p a r i s o n s  were d e t e r m in e d  u s i n g  S t u d e n t ' s  t - t e s t  a t  
p < 0 . 0 5 . 79
RESULTS
T i s s u e  l i n e a r i t y  e x p e r i m e n t s
S p e c i f i c  [^Hj-QNB b i n d i n g  i n c r e a s e d  in  a l i n e a r  manner w i th  
i n c r e a s i n g  t i s s u e  p r o t e i n  c o n t e n t  between 1 and 150 ng as shown in  
F i g u r e  1. The c o r r e s p o n d i n g  r a d i o l i g a n d  amounts  ra nged  f rom 0 . 2  t o  3 .5  
f m o l e s .  The v a l u e s  p l o t t e d  a r e  t h e  means f o r  t h r e e  e x p e r i m e n t s .
S a t u r a b i l i t y  e x p e r i m e n t s
H y p e r b o l i c  s a t u r a t i o n  i s o t h e r m s  were p r e s e n t  f o r  both  r a t  and pony 
lung as  shown in  F i g u r e s  2 and 3 .  These  f i g u r e s  a r e  f rom r e p r e s e n t a t i v e  
e x p e r i m e n t s  o f  s p e c i f i c  b i n d i n g  o f  [ ^ h]-QNB in r a t  and pony lung homo- 
g e n a t e s ,  r e s p e c t i v e l y .  The i n s e t  i n  each  f i g u r e  i s  a S c a t c h a r d  p l o t  o f  
t h i s  s p e c i f i c  b i n d i n g  d a t a  f o r  [ 3 h]-QNB.  I t  can be seen from t h e s e  
f i g u r e s  t h a t  s a t u r a b i l i t y  o f  s p e c i f i c  b i n d i n g  was p o s s i b l e  i n  lung 
homogenate  f o r  bot h  r a t s  and p o n i e s .
S c a t c h a r d  a n a l y s i s  o f  t h e  s a t u r a b i l i t y  e x p e r i m e n t  d a t a  produ ced  t h e  
v a l u e s  f o r  KQap p and Bmax t h a t  a p p e a r  in  T ab le  4 .  Mean 
^ D a p p ' s f ° r  r a t  ar,d Pony lung  were 3 9 .8 5  and 2 8 .0 8  pM r e s p e c ­
t i v e l y .  Mean Bmax was 7 4 . 3  fm oles /m g p r o t e i n  f o r  r a t  lung homo­
g e n a t e  and 8 1 . 2  fmoles /mg p r o t e i n  f o r  pony lun g homogenate .  No s t a t i s ­
t i c a l l y  s i g n i f i c a n t  d i f f e r e n c e  in K[)a pp o r  Bmax was 
o b s e r v e d  be tween r a t  and pony lun g m u s c a r i n i c  r e c e p t o r s .
Drug i n h i b i t i o n  e x p e r i m e n t s
F i g u r e s  4 and 5 a r e  r e p r e s e n t a t i v e  drug i n h i b i t i o n  c u r v e s  f o r  r a t  
and pony lung  r e s p e c t i v e l y  u s i n g  v a r i o u s  m u s c a r i n i c  r e c e p t o r  a n t a g o n i s t s  






















3 . 5 T i s s u e  L in e a r i t y
3 . 0 -
r = 0 . 9 9 3
2 . 0 -
P on y  Lung
Rat  Lung
r  0 . 9 9 2
0 .5 -
1 0 0  1 2 0  1 4 08 06 04 02 0
ng  P r o t e i n






















Bmax = 8 5 . 7  
f m o l e s / m g  p ro te in
Kd = 2 1 . 3 9  pM
r z  - 0 . 9 7 2
V  s z  - 0 . 0 4 6 7
0 . 5
5 0  6 0  7 0  8 0  9 0  1 0 0  
B o un d  ( f m o l e s / m g  p r o t e i n )1 0 0 -
6 0 -
5 0 3 0 0 4 0 0 5 0 0100 200
pM [3H]-QNB
F i g u r e  2 - A r e p r e s e n t a t i v e  e x p e r i m e n t  o f  s p e c i f i c  b i n d i n g  o f  [ ^ h]-QNB 






















Bm ax = 4 3 . 3 4  
f m o l e s / m g  p r o t e i n
Kd = 2 9 . 0 3  pM
r r  0 . 9 8 7
s = - 0 . 0 3 4 4
1 .On
0.5-
2 0  3 0  4 0  5 0  6 0  7 0  
Bound ( f m o l e s / m g  p r o t e i n )
5 0
3 0 05 0 2 0 01 0 0 5 0 04 0 0
pM l 3H)-QNB
F i g u r e  3 -  A r e p r e s e n t a t i v e  e x p e r i m e n t  o f  s p e c i f i c  b i n d i n g  o f  [ ^H]-QNB 
in  pony lu n g  ho mogena te .
T ab le  4:  D i s s o c i a t i o n  c o n s t a n t s  (K[)app) and r e l a t i v e  
c o n c e n t r a t i o n  o f  m u s c a r i n i c  r e c e p t o r s  (Bmax) in  r a t  and pony lung 
as  compared t o  t h e i r  v a l u e s  in  o t h e r  t i s s u e  p r e p a r a t i o n s .
^D Bmax
(pM) ( fmoles /m g p r o t e i n )  R e f e r e n c e s
Rat  Lung (n=6 ) 3 9 .8 5 + 6 . 0 7 4 .3  + 8 . 9
Pony Lung (n=6 ) 2 8 . 0 8 + 5 .9 8 1 . 2  + 9 . 6
Rat  B ra in 2 0 . 0 910 109
Guinea  P ig  Lung 617 + 3 6 .2 128 .8  + 2 7 .2 110
Guinea  P ig  H ear t 1 7 8 + 1 3 109
Dog Lung 1 9 4 .0 + 45 3 4 . 8  + 2 0 .4 110
Cat Duodenum 8 1 . 5  + 13 .5 111
Cat Stomach Fundus 2 4 0 .2  + 32 .1 111
Bovine  R e t i n a 2 7 .0 140 109
R a b b i t  Hear t 27.1 5 7 . 2  + 4 . 3 109
Rat H e a r t 2 6 .8 144 + 13 109
LES Muscle 1100  H- 100 147 + 5 .5 111
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11 -10 - 9 -8 -7 -6 - 5 - 3- 4
Log (M) Drug Concentration
F i g u r e  4 - Drug i n h i b i t i o n  cu r v e  o f  [ ^H]-QNB b i n d i n g  in  r a t  lung 
membrane homogenates  by m u s c a r i n i c  a n t a g o n i s t s  and a g o n i s t s .  Each p o i n t  




























'  A r e c o l i n e
A t r o p in e10 -
- 2- 3- 1 0 - 7 - 6- 8
Log (M) Drug C o n c e n t r a t i o n
F i g u r e  5 -  Drug i n h i b i t i o n  c u r v e s  o f  [ 3 h]-QNB b i n d i n g  in  pony lung 
membrane hom ogena te s  by m u s c a r i n i c  a n t a g o n i s t s  and a g o n i s t s .  Each p o i n t  
r e p r e s e n t s  t h e  mean o f  two v a l u e s .
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T ab le  5 a l o n g  w i th  IC50  v a l u e s  r e p o r t e d  f o r  o t h e r  t i s s u e s .  I t  can 
be see n  t h a t  IC50  was n o t  g r e a t l y  a l t e r e d  by t h e  t i s s u e  t y p e s  f o r  
any o f  t h e  d r u g s  u s e d .
The p o t e n c y  o f  t h e s e  a g o n i s t s  and a n t a g o n i s t s  in  d i s p l a c i n g  
[3h]-QNB from m u s c a r i n i c  r e c e p t o r s  i s  shown in  T ab le  6 . The compounds 
a r e  l i s t e d  f rom t o p  t o  bo t tom  in  d e c r e a s i n g  o r d e r  o f  p o t e n c y  f o r  r a t  
l u n g .  QNB was t h e  most  p o t e n t  in t h i s  r e g a r d  and i t s  e f f i c a c y  was 
a p p r o x i m a t e l y  f o u r  o r d e r s  o f  m a g n i tu d e  g r e a t e r  t h a n  t h a t  o f  a r e c o l i n e  
which was t h e  l e a s t  p o t e n t  in bot h  r a t s  and p o n i e s .
The H i l l  c o e f f i c i e n t s  c a l c u l a t e d  f o r  t h e  d ru g s  used in  t h e s e  
e x p e r i m e n t s  a r e  l i s t e d  in T a b le  7 .  These  v a l u e s  a r e  a p p r o x i m a t e l y  u n i t y  
f o r  a l l  t h e  d r u g s  used in  t h e s e  s t u d i e s ,  i n d i c a t i n g  no c o o p e r a t i v i t y  o f  
t h e  l i g a n d  and r e c e p t o r  in  t h e  b i n d i n g  p r o c e s s .
DISCUSSION
D e m o n s t r a t i o n  o f  t i s s u e  l i n e a r i t y  i s  m an d a to r y  in b i n d i n g  s t u d i e s  
t o  a s s u r e  t h e  a b s e n c e  o f  a r t i f a c t s ,  such as  r e c e p t o r  o r  l i g a n d  d e g r a ­
d a t i o n  d u r i n g  i n c u b a t i o n  and u n r e c o g n i z e d  endogenous  l i g a n d s .  Such 
a r t i f a c t s  may l e a d  t o  c a l c u l a t i o n  o f  i n c o r r e c t  v a l u e s  f o r  b i n d i n g  p a r a ­
m e t e r s .  I *6 Because  t i s s u e  l i n e a r i t y  was d e m o n s t r a t e d  in t h e s e  
e x p e r i m e n t s ,  such a r t i f a c t s  s h o u l d  n o t  have been a f a c t o r  in  t h e s e  
s t u d i e s .
T hre e  i m p o r t a n t  c r i t e r i a  a r e  r e q u i r e d  t o  e s t a b l i s h  t h e  p r e s e n c e  o f  
s p e c i f i c  r e c e p t o r  b i n d i n g  in  a t i s s u e .  They a r e :  (1)  d e t e r m i n a t i o n  of
a s a t u r a b l e  p o p u l a t i o n  o f  r e c e p t o r  s i t e s ,  ( 2 ) d e t e r m i n a t i o n  o f  a h igh
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T ab le  5 :  Mean and s t a n d a r d  d e v i a t i o n s  o f  IC50  v a l u e s  f o r  d ru g s  t h a t
i n h i b i t e d  s p e c i f i c  [^Hj-QNB b i n d i n g  t o  homogena tes  o f  r a t  and pony 
l u n g .  Values  f o r  r a t  b r a i n  and g u i n e a  p ig  i l eum a r e  p r o v i d e d  f o r  
co m p a r i s o n .
IC50
Rat Lung Pony Lung Rat B r a i n ' Guinea Pig
(M) (M) (M) (M)
QNB 2 . 3 2 x 1 0 " 10 4 . 8 3 x l 0 " 10 4 - 5 x l 0 - 10 2 - 3 x l 0 - 10
+ 0 .2 8 + 0 .4 6
Scopo lamine 2 . 1 5x 10"10 9 . 2 3 x l 0 ' 9 7-9x1 O' 10 2 - 3 x 1 0-1 0
+ 0 .5 7 + 0 . 9 4
A t r o p i n e 3 . 6 7 x 1 O-9 2 . 8 5 x l 0 ' 9 1 - 2x 10"9 2 -4 x 1 0"9
+ 1.17 + 0 . 6 0
O x o t re m or in e 2.57x1 O' 7 1 . 1 3 x 1 0"7 5-8x1 O' 7 5-8x1 CT7
+ 1.65 + 0 .7 5
A r e c o l i n e 13.6x1 O’ 6 9 .2 4 x l0 T 6 1-3x10-6 3-4x10-6
+ 0 .2 5 + 0 . 5 8
T ab le  6 .  K-j v a l u e s  f o r  m u s c a r i n i c  a g o n i s t s  and a n t a g o n i s t s  as an 
i n d i c a t o r  of  p o t e n c y .
Ki v a l u e s  (nM)
Drug Rat  Lung (n=4) Pony Lung (n=2)
QNB 0 .0 3 8 4  0 .0 4 9 9
Scopo lam ine  3 .8 6  0 .9 6 2
A t r o p i n e  6 . 2 6  0 .294
O x o t r e m o r in e  99 .02  117.0
A r e c o l i n e  3 0 3 .0  955 .0
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T ab le  7: H i l l  c o e f f i c i e n t s  f o r  m u s c a r i n i c  a n t a g o n i s t s  and a g o n i s t s  in 




A t r o p i n e  
O x o t re m o r in e  
A r e c o l i n e
Rat  Lung (n=4)
- 0 . 8 6 + 0 . 0 3
- 0 . 7 7 + 0 .0 4
- 0 . 9 2 + 0 . 0 7
- 0 . 7 1 + 0 . 0 8
- 0 . 7 7 + 0 . 1 2
Pony Lung (n=2)
- 0 . 9 1 + 0 .1 2
- 0 .6 0 + 0 .1 7
- 0 .9 3 + 0 .1 1
- 0 . 7 2 + 0 .4 2
- 0 . 6 7 + 0 .2 3
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a f f i n i t y  d i s s o c i a t i o n  c o n s t a n t ,  K[)app ,  and (3)  p h a r m a c o l o g i c a l  
s p e c i f i c i t y .
S a t u r a t i o n  i s o t h e r m s  and mon ophasi c  d i s p l a c e m e n t  c u r v e s  e s t a b l i s h  
t h e  p r e s e n c e  o f  a s i n g l e  p o p u l a t i o n  o f  s a t u r a b l e  s i t e s  i n  b o th  r a t  and
pony l u n g .  The d i s s o c i a t i o n  c o n s t a n t s ,  K[)app ,  d e t e r m in e d  from
S c a t c h a r d  a n a l y s i s  were i n  a g r ee m en t  w i th  t h o s e  v a l u e s  f rom r a t  b r a i n ,  
c a t  c e r v i c a l  g a n g l i o n ,  b o v i n e  r e t i n a ,  r a b b i t  h e a r t ,  and r a t  h e a r t  as 
shown in  T a b le  4 . 1 0 9 , 1 1 2 , 1 1 9  i n a d d i t i o n  t h e  maximum b i n d i n g  
d e n s i t i e s  (Bmax) f o r  r a t  and pony lung were co m par ab le  t o  t h o s e  
r e p o r t e d  f o r  c a t  duodenum and r a b b i t  h e a r t  as  l i s t e d  in  
T a b le  4 . 1 0 8 ,1 1 1  These  s t u d i e s  i n d i c a t e  t h a t  [ 3 h]-QNB b i n d s  t o  r a t  
and pony lu ng  in  a manner  c o n s i s t e n t  w i t h  m u s c a r i n i c  -  c h o l i n e r g i c  
b i n d i n g  in  o t h e r  t i s s u e s  and t h a t  t h e  numbers  o f  r e c e p t o r s  a r e  s i m i l a r .
S a t u r a b l e  b i n d i n g  o f  [ 3 h]-QNB was i n h i b i t e d  by t h e  m u s c a r i n i c  
a n t a g o n i s t s  QNB, s c o p o la m in e  and a t r o p i n e ,  and a g o n i s t s  o x o t r e m o r i n e  and
a r e c o l i n e .  The IC5Q1s f o r  t h e s e  a n t a g o n i s t s  and a g o n i s t s  were
s i m i l a r  i n  m ag n i tu d e  and o r d e r  o f  p o t e n c y  t o  t h e  b i o l o g i c a l  v a l u e s  f o r  
h a l f  maximal r e c e p t o r  o c c u p a t i o n  known as t h e  e f f e c t i v e  dose  f i f t y  
(ED5 0 ) f o r  t h e s e  same compounds .  ED50  v a l u e s  f o r  t h e  a b i l i t y  of  
t h e s e  compounds t o  e f f e c t  ch a n g es  in  t h e  c o n t r a c t a b i 1 i t y  o f  g u i n e a  p ig  
i leum a r e  l i s t e d  in T ab le  8 . A ccu racy o f  t h e  o r d e r  o f  p o t e n c y  f o r  
m u s c a r i n i c  a n t a g o n i s t s  and a g o n i s t s  used in  t h i s  s t u d y  can be d e t e r m in e d  
by compar ing v a l u e s  f o r  r a t  and pony lung t o  t h o s e  r e p o r t e d  in  t h e  
l i t e r a t u r e .  F i g u r e s  6 and 7 r e p r e s e n t  c o m p a r i so n s  o f  p o t e n c y  between 
r a t  and pony lung  ( F i g u r e  6 ) u s i n g  K-j ' s ,  and r a t  lung IC5 0 ’s t o  
r e p o r t e d  IC5Q' s f o r  r a t  b r a i n  ( F i g u r e  7 ) .  The s l o p e s  f o r  t h e s e
T ab le  8 : ED50  v a l u e s  f o r  a n t a g o n i s t s  and a g o n i s t s  f o r  m u s c a r i n i c
r e c e p t o r s  i n  i n t a c t  smooth m us cl e  p r e p a r a t i o n s  f rom v a r i o u s  
s o u r c e s .  113
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- l o g  Kj rot lung
Figure  6  -  Comparisons of  the r e l a t i v e  binding p o te n c ie s  of  muscar inic  
a g o n i s t s  and a n t a g o n i s t s  between pony lung and rat  lung homogenates  
us ing  - l o g  Kj va lue s  for  each drug.
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S c o p o l a m i n e
Atropine
O x o t r e m o r i n oo  G 
w
A r e c o l in e
2 3 4 5 6 7 8 9  10
- l o g  IC^q brain
Figure  7 -  Comparisons of  the r e l a t i v e  p o t e n c ie s  of  muscarinic  
a n t a g o n i s t s  and a g o n i s t s  between rat  lung and rat  brain using a X to  Y 
p l o t  of  the - l o g  IC5 0  f o r  each drug.
136
p l o t s  were bo th  0 . 9 1 ;  i n d i c a t i n g  (1) t h e  s i m i l a r i t y  o f  b i n d i n g  to  
m u s c a r i n i c  r e c e p t o r  s i t e s  f o r  t h e s e  t i s s u e s  and ( 2 ) t h a t  m u s c a r i n i c  
r e c e p t o r  s i t e s  in  t h e s e  t i s s u e s  ap p e a r  t o  be i d e n t i c a l  in  t h e i r  
p h a r m a c o l o g i c a l  b i n d i n g  p o t e n c i e s .  D i s p l ace m en t  o f  [ ^h]-QNB b i n d i n g  
was g r e a t e s t  w i t h  m u s c a r i n i c  a n t a g o n i s t s ,  and t h e  a f f i n i t y  o f  m u s c a r i n i c  
a g o n i s t s  was c o m p a r a b le  t o  t h e i r  p h a r m a c o l o g i c a l  p o t e n c y  o r  ED50 
v a l u e .
The v a l u e s  f o r  r a t  and pony lung membranes were n o t  i d e n t i c a l ,  
b u t  t h e  r a n k  o f  p o t e n c y  f o r  a n t a g o n i s t s  and a g o n i s t s  a r e  c o m p ar ab le  w i t h  
t h e  e x c e p t i o n  o f  s co p o l a m i n e  in  pony lung  as d e p i c t e d  in F i g u r e  5 and 
l i s t e d  in  T a b l e s  5 and 6 . Sco po lam ine in  pony lung sh o u ld  be more 
p o t e n t  t h a n  a t r o p i n e  was s ee n  in  r a t  lung ( T a b le s  5 and 6 ) .  Thi s  
d i s c r e p a n c y  may be t h e  r e s u l t  o f  t h e  h ig h  l e v e l s  o f  n o n - s p e c i f i c  b i n d i n g  
in  pony l u n g .  In a d d i t i o n ,  s co p o lam in e  i s  both  l i g h t  and h e a t  s e n s i t i v e  
and may have been  a d u l t e r a t e d  d u r i n g  p r e p a r a t i o n ,  d e c r e a s i n g  i t ' s  
b i n d i n g  a f f i n i t y  f o r  t h e  m u s c a r i n i c  r e c e p t o r  s i t e .
The d a t a  f rom t h i s  s t u d y  i d e n t i f y  and c h a r a c t e r i z e  t h e  s i m i l a r i t y  
o f  r a t  and pony lu ng  m u s c a r i n i c  c h o l i n o r e c e p t o r s  t o  t h o s e  o f  o t h e r  
t i s s u e s . 1 0 8 - 1 1 4 , 1 1 9  M u s c a r i n i c  a n t a g o n i s t s  and a g o n i s t s  b ind  to  
t h e s e  r e c e p t o r s  in  r a t  and pony lun g j u s t  as  o c c u r s  i n  o t h e r  t i s s u e s  
c o n t a i n i n g  m u s c a r i n i c  r e c e p t o r s .  P h a r m a c o l o g ic a l  s t u d i e s  have 
i d e n t i f i e d  t h e  p h y s i o l o g i c a l  s i g n i f i c a n c e  o f  lung  m u s c a r i n i c  
c h o l i n o r e c e p t o r s  in  e l i c i t i n g  changes  in  t h e  pu lm on ary  dynamics  o f  lung 
f u n c t i o n . ^  E x c e s s i v e  s t i m u l a t i o n  o f  lung m u s c a r i n i c  r e c e p t o r s  c a u s e s  
a s t h m a - l i k e  b r o n c h o c o n t r i c t i o n  and h y p e r s e c r e t i o n  o f  mucus i n t o  t h e  
a i r w a y .  The r e s u l t i n g  a i r w a y  o b s t r u c t i o n  would i n c r e a s e  a i rw a y
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r e s i s t a n c e  which in t u r n  d e c r e a s e s  a l v e o l a r  v e n t i l a t i o n .  The r e s u l t  
would be  a m ism a tc h in g  o f  v e n t i l a t i o n  and p e r f u s i o n  w i t h  p r o d u c t i o n  o f  
h y p o x ia  and p o s s i b l e  h y p e r c a r b i a .  R e s p i r a t o r y  d i s t r e s s  may become so 
s e v e r e  t h a t  d e a t h  may r e s u l t .  I d e n t i f i c a t i o n  and c h a r a c t e r i z a t i o n  o f  
m u s c a r i n i c  r e c e p o r t s  in l un g w i l l  a l l o w  c o m p ar i so n s  o f  t h e  b i n d i n g  
p a r a m e t e r s  f o r  normal  and abnormal  lu ng  t i s s u e .  In a d d i t i o n ,  t h e  use  
o f  r a d i o l i g a n d  t e c h n i q u e s  in lung  w i l l  a l l o w  d e t e r m i n a t i o n  o f  p o s s i b l e  
r e c e p t o r  a l t e r a t i o n s  c a u s e d  by d i s e a s e  o r  t o x i c  i n s u l t s  which a r e  known 
t o  l e a d  t o  p a t h o p h y s i o l o g i c a l  changes  in pu lmonary  f u n c t i o n .  The 
f o l l o w i n g  c h a p t e r  i n v e s t i g a t e s  t h e  p o s s i b l e  m u s c a r i n i c  r e c e p t o r  b i n d i n g  
p r o p e r t i e s  o f  3 -m et hyl  i n d o l e  and i t s  m e t a b o l i t e ,  o r t h o - a m i n o a c e t o p h e n o n e  
as  t h e  mechanism f o r  3 -m e thy l  i n d o l e  i n duced  p n e u m o t o x i c o s i s .
C h ap te r  VI
MUSCARINIC RECEPTOR BINDING OF 3-METHYLINDOLE 
AND ORTHO-AMINOACETOPHENONE
Heaves as  i t  o c c u r s  i n  h o r s e s  i n  t h e  S o u t h e a s t e r n  Un i t ed  S t a t e s  i s  
a s s o c i a t e d  w i th  i n g e s t i o n  o f  l u s h  f o r a g e  f rom r a p i d l y  growing  p a s t u r e s .  
3 - M e t h y l i n d o l e  (3MI) has  been used t o  i n d u c e  a b r o n c h i o l i t i s  i n  h o r s e s  
and p o n i e s  which r e s e m b l e s  t h i s  c o n d i t i o n . 1 8 , 5 8 , 5 9 , 6 1  /\ p a t h o ­
l o g i c a l l y  d i s s i m i l a r  r e s p i r a t o r y  d i s e a s e  in  c a t t l e ,  a c u t e  b o v in e  pulmo­
n a r y  emphysema,  has  been a s s o c i a t e d  w i th  i n g e s t i o n  o f  l u s h  f o r a g e  
c o n t a i n i n g  h ig h  l e v e l s  o f  t r y p t o p h a n  which was m e t a b o l i z e d  i n t r a -  
r u m i n a l l y  t o  3MI. 4 3 , 4 5 , 4 6 , 5 5  j h u s  heaves  in h o r s e s  may be t h e  
r e s u l t  o f  t r y p t o p h a n  i n g e s t i o n  o r  i n g e s t i o n  o f  some o t h e r  i n d o l e  which 
i s  t h e n  m e t a b o l i z e d  by i n t e s t i n a l  m i c r o o r g a n i s m s  t o  3MI o r  an i n d o l e  
w i th  s i m i l a r  s t r u c t u r e  a c t i v i t y  r e l a t i o n s h i p s .  3MI in  t u r n  i s  
t r a n s f o r m e d  t o  some o t h e r  m e t a b o l i t e  such as o r t h o - a m i n o a c e t o p h e n o n e  
( 0 A A P ) 5 6 , 5 8  by t h e  mixed f u n c t i o n  o x i d a s e  s y s t e m .  At t h i s  t i m e  t h e  
mechanism o f  e f f e c t  f o r  3M I- indu ced r e s p i r a t o r y  d i s e a s e  i s  unknown.
There  a r e  a t  l e a s t  two mechanisms which can p ro duce  a r e s p i r a t o r y  
d i s e a s e  r e s e m b l i n g  h e a v e s .  One p o s s i b l e  mechanism would be t h e  t o x i c  
e f f e c t  o f  3MI o r  a m e t a b o l i t e  o f  3MI on e p i t h e l i a l  c e l l s  l i n i n g  t h e  
a i r w a y s .  A second  mechanism would be t h e  i n t e r a c t i o n  o f  3MI o r  i t s  
m e t a b o l i t e  w i t h  membrane a s s o c i a t e d  r e c e p t o r s  which when s t i m u l a t e d  a r e  
r e s p o n s i b l e  f o r  b r o n c h o c o n s t r i c t i o n .  The m u s c a r i n i c  c h o l i n e r g i c  
r e c e p t o r  l o c a t e d  on t h e  a i r w a y  smooth m usc le  membranes and on mas t  c e l l s
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in t h e  submucosal  l i n i n g  o f  t h e  a i rw a y s  a r e  examples  of such a 
r e c e p t o r .
E p i t h e l i a l  damage can o cc u r  when e l e c t r o p h i l i c  c h e m i c a l s  i n t e r a c t  
w i t h  c e l l  membranes and o r g a n e l l e s .  High dos es  o f  3MI a r e  t h o u g h t  a r e  
t h o u g h t  to  c a u s e  p r o d u c t i o n  o f  an e l e c t r o p h i l i c  m e t a b o l i t e  which is  
r e s p o n s i b l e  f o r  c y t o t o x i c  damage to  t h e  b r o n c i o l a r  e p i t h e l i a l  
E l e c t r o p h i l e s  which r e a c t  w i th  n u c l e o p h i l i c  c e l l u l a r  DNA a r e  o f t e n  
r e s p o n s i b l e  f o r  p r o d u c t i o n  of m u t a t i o n s  which many t im es  r e s u l t  in 
c a n c e r o u s - l i k e  c e l l  p r o l i f e r a t i o n .  The m u tag en ic  p r o p e r t i e s  of  a 
ch e m ic a l  can be a s s e s s e d  by u s i n g  t h e  Ames t e s t .  I n t e r e s t i n g l y ,  3MI was 
found to  be n o n - m u t a g e n ic  when a c t i v a t e d  wi th  t h e  microsomal  S-9 
f r a c t i o n  from r a t  l i v e r  as d e t e r m in e d  by t h e  Ames t e s t . 120 x h i s  
would s u g g e s t  t h a t  an e l e c t r o p h i 1 ic i n t e r m e d i a t e  may no t  be t h e  
c a u s a t i v e  ag en t  in p r o d u c t i o n  of b r o n c h i o l a r  e p i t h e l i a l  n e c r o s i s .
At d o sag e s  o f  100 mg/kg o r  g r e a t e r  o f  3MI in h o r s e s  and p o n i e s ,  
t h e  major  p a t h o l o g i c a l  l e s i o n  i s  an o b s t r u c t i v e  bro ncho-  
i o l i t i s . 5 8 , 5 9  p rom o n e - h a l f  to  3 h o u r s  a f t e r  d o s i n g ,  t h e  major  
l e s i o n  was to  t h e  n o n - c i l i a t e d  b r o n c h i o l a r  e p i t h e l i a .  These  c e l l s  were 
d e v o id  o f  a p i c a l  c a p s ,  had e x t r u d e d  t h e i r  c y t o p l a s m i c  g r a n u l e s  and t h e  
smooth en d o p la s m ic  r e t i c u l u m  was d i l a t e d . 59 / \ t  12 h o u r s ,  b r o n c h i o l a r  
C l a r a  c e l l s  were n e c r o t i c .  S e v e r e  e p i t h e l i a l  damage and in f l a m m a t i o n  
was a p p a r e n t  t h ro u g h  6 d a y s  p o s t - t r e a t m e n t .  The damage i n c u r r e d  by t h e  
lung e p i t h e l i a  a t  t h e s e  h i g h e r  doses  o f  3MI cou ld  in no way be 
c o n s i d e r e d  r e v e r s i b l e  in a p h a r m a c o l o g i c a l  s e n s e .  However,  when h o r s e s
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were a d m i n i s t e r e d  3MI a t  10 and 20 mg/kg d o s e s ,  t h e r e  were changes  in 
t h e  pulmonary  dynamics  which were r e v e r s i b l e  w i t h i n  48 h o u r s . ^6
G r a s s e s  and o t h e r  f o r a g e  c o n t a i n  i n d o l e s  which may be p r e c u r s o r s  in  
t h e  s y n t h e s i s  of  3MI. I t  i s  p o s s i b l e  t h a t  i n g e s t i o n  of  t h e s e  i n d o l e s  
d u r i n g  r a p i d  growth p h a s e s  i s  r e s p o n s i b l e  f o r  p r o d u c t i o n  of heaves  j u s t  
as  i t  i s  r e s p o n s i b l e  f o r  a c u t e  bo v ine  pulmonary emphysema. S t u d i e s  on 
t h e  t o x i c i t y  o f  3MI have shown t h a t  m e ta b o l i s m  i s  r e q u i r e d  f o r  t o x i c  
a c t i v a t  i o n .56 A n a l y s i s  of  t h e  s t r u c t u r e  a c t i v i t y  r e l a t i o n s h i p s  of 
3MI and i t ' s  m e t a b o l i t e  o r t h o - a n i m o a c e t o p h e n o n e  (OAAP), s u p p o r t s  t h e  
h y p o t h e s i s  t h a t  t h e s e  compounds may bind m u s c a r i n i c  r e c e p t o r s . ^ 1  
S t i m u l a t i o n  of m u s c a r i n i c  r e c e p t o r s  in e q u in e  lung would cause  changes  
i n  t h e  pulmona ry  dynamics  s i m i l a r  t o  t h e s e  o b s e r v ed  a f t e r  a d m i n i s t r a t i o n  
of low doses  o f  3MI.
The m u s c a r i n i c  r e c e p t o r s  of  e q u i n e  lung have been i d e n t i f i e d  and 
c h a r a c t e r i z e d  u s i n g  t h e  r a d i o l i g a n d  [^h]-QNB and were found to  be 
i d e n t i c a l  t o  t h e  r e c e p t o r s  of r a t  lung and b r a i n .  T h e r e f o r e  i n t e r a c t i o n  
o f  b i n d i n g  of  3MI or  OAAP t o  lung m u s c a r i n i c  r e c e p t o r s  of h o r s e s  may be 
r e s p o n s i b l e  f o r  t h e  o b s e r v e d  changes  in  pulmonary  f u n c t i o n  which were in  
p a r t  r e v e r s e d  by t h e  a n t i c h o l i n e r g i c  drug a t r o p i n e .  The p u rp o se  of t h i s  
s t u d y  was t o  i n v e s t i g a t e  p o t e n t i a l  b i n d i n g  p r o p e r t i e s  or  o t h e r  e f f e c t s  
o f  3MI and OAAP on m u s c a r i n i c  r e c e p t o r  f u n c t i o n  u s in g  t h e  r a d i o l i g a n d  
C3 H]-QNB wi th  hope of  u n i f y i n g  a t o x i c  mechanism f o r  p r o d u c t i o n  of 
3M I- indu ced  lung d i s e a s e .
In t h i s  s t u d y  r a t  lung and b r a i n  t i s s u e  homogenates  were used 
i n s t e a d  of  pony lung to  i n v e s t i g a t e  t h e  m u s c a r i n i c  r e c e p t o r  b i n d i n g  
p r o p e r t i e s  of  3MI and OAAP. Rat  b r a i n  and lung were used b ec au s e  of
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t h e i r  low l e v e l  of  n o n - s p e c i f i c  b i n d i n g ,  as compared to  pony lu n g .  High 
l e v e l s  of  n o n - s p e c i f i c  b i n d i n g  of  r a d i o l i g a n d  r e s u l t  in e x c e s s  n o i s e  
which p r e v e n t s  a c c u r a t e  d e t e r m i n a t i o n  of t h e  l e v e l s  f o r  s p e c i f i c  b i n d in g  
of  t h e  r a d i o l i g a n d .
MATERIALS AND METHODS
Chem ica l s
The d ru g s  a r e c o l i n e ,  a t r o p i n e ,  3 - m e t h y l i n d o l e ,  o x o t r e m o r i n e  and 
s c o p o la m in e  were o b t a i n e d  f r om  Sigma Chemical  I n c .  ( S t .  L o u i s ,  Mo). 
O r t h o - a m in o a c e t o p h e n o n e  was p u rc h a s e d  from A l d r i c h  Chemical  (Milwaukee,
Ws). The m u s c a r i n i c  a n t a g o n i s t  dl-QNB was o b t a i n e d  from 
Hoffman-LaRoche,  I n c .  ( N u t l e y ,  N . J . ) .  The r a d i o l i g a n d  q u i n u c l i d i n y l  
[ p h e n y l - 4 - ^ h ]  b e n z i l a t e  ( [ ^H]-QNB) was used to  i d e n t i f y  s p e c i f i c  
m u s c a r i n i c  r e c e p t o r s  in t h i s  s t u d y .  [^H]-QNB ( 2 9 . 4  Ci /mmole)  was 
o b t a i n e d  f rom New En g lan d  N u c le a r  ( B o s to n ,  Mass ) .  Al l d ru gs  were 
d i l u t e d  in d e i o n i z e d - d i s t i 1 l ed  w a t e r ,  e x c e p t  f o r  3MI and OAAP. 3MI was 
d i s s o l v e d  i n i t i a l l y  in  1 0 0% e t h y l  a l c o h o l ,  and th en  was d i l u t e d  in 
d e i o n i z e d - d i s t i 1 l e d  w a t e r  t o  a 40% h y d r o a l c o h o l i c  s o l u t i o n .  OAAP was 
d i l u t e d  to  a 20% h y d r o a l c o h o l i c  s o l u t i o n .  All  d ru g s  were p r e p a r e d  f r e s h  
each day of t h e  e x p e r i m e n t .
R a d i o l i g a n d  and u n l a b e l e d  l i g a n d  p u r i t y  were d e t e r m in e d  by t h i n  
l a y e r  ch r o m a to g rap h y  or  m e l t i n g  p o i n t  a n a l y s i s .
T i s s u e  P r e p a r a t i o n
Ra t  lung and b r a i n  t i s s u e  homogenates  were used to  i n v e s t i g a t e  t h e  
m u s c a r i n i c  r e c e p t o r  b i n d i n g  p r o p e r t i e s  o f  3MI and OAAP. Rat  lung from
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250 gm male Spra gue -D aw le y  r a t s  and lung from p o n i e s  were o b t a i n e d  and
p r e p a r e d  as d e s c r i b e d  in  C h a p t e r  5.
Rat  b r a i n  t i s s u e  was o b t a i n e d  a t  t h e  same t ime t h e  lung s  were
removed.  The b r a i n s  were we ighed and homogenized in a p p r o x i m a t e l y  20 ml
o f  NaK p h o s p h a t e  4°C b u f f e r  ( 0 . 0 5  M; pH 7 . 4 )  f o r  2-20 second  b u r s t s
a t  maximum speed u s in g  a Tekmar t i s s u e  ho m ogen ize r .  B ra in  homogenate
was t h en  c e n t r i f u g e d  a t  4 0 ,0 0 0  g f o r  10 m i n u t e s .  The s u p e r n a t a n t  was
d i s c a r d e d  and t h e  p e l l e t  was a g a in  homogenized and c e n t r i f u g e d  as
p r e v i o u s l y  d e s c r i b e d .  T h i s  p r o c e s s  was r e p e a t e d  a t o t a l  of two t i m e s .
The f i n a l  p e l l e t  was suspended  in  NaK p h o s p h a te  b u f f e r  (4°C) t o  a f i n a l
c o n c e n t r a t i o n  of 10% ( w / v ) .  P r o t e i n  c o n c e n t r a t i o n s  of  t h e s e  homogenates
1
were d e t e r m in e d  by t h e  BioRad dye method.
B in d in g  Method
A l l  e x p e r i m e n t s  were run in  t r i p l i c a t e  and t h e  f i n a l  volume in  a l l  
t u b e s  was 2 ml +_ 1%. Each t u b e s  was i n c u b a t e d  a t  37°C in a s h a k e r  bath  
f o r  60 m i n u t e s .  I n c u b a t i o n  was t e r m i n a t e d  by vacuum f i l t r a t i o n  th ro u g h  
Whatman GF/B g l a s s  f i b e r  f i l t e r s  f o l l o w e d  by t h r e e - 4  ml washes w i th  
i c e - c o l d  b u f f e r .
S a t u r a b i l i t y  e x p e r i m e n t s
S a t u r a b i l i t y  of  s p e c i f i c  b i n d i n g  was measured by adding i n c r e a s i n g  
amounts  of [ 3 h]-QNB t o  t i s s u e  membrane ho m ogen at es .  T a b l e s  1 and 2 
shows t h e  d e s ig n  of t h e s e  e x p e r i m e n t s .  The r e c i p r o c a l  of t h e  s l o p e  and 
x - i n t e r c e p t  o f  t h e  S c a t c h a r d  p l o t  of  t h e  d a t a  f o r  r a t  and pony lung and 
r a t  b r a i n  were used to  d e t e r m i n e  t h e  a p p a r e n t  h igh  a f f i n i t y  d i s s o c i a t i o n  
c o n s t a n t  (Kgapp ) and t h e  r e c e p t o r  d e n s i t y  (Bmax)
T ab le  1 -  Design o f  s a t u r a b i l i t y  experim ents  f o r  r a t  and pony
1 ung.
Volumes Added ( u l )
Tube
No.
B u f f e r
(ml)
100  uM 
A t r o p i n e
[ 3 h ] - q n b
1 : 1 0 ,0 0 0
D i l u t i o n
10% T i s s u e  
Homogenate
T o t a l  
Volume
1-3 1 .4 8 20 25 500 2025
4 -6 1 .4 8 - - 25 500 2005
7-9 1 .45 20 50 500 2020
1 0 -1 2 1 .45 — 50 500 2000
13-15 1 .4 0 20 100 500 2020
16-18 1 .4 0 — 100 500 2000
19-21 1 .3 0 20 200 500 2020
22-24 1 .3 0 - - 200 500 2000
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T a b le  2 -  Design o f  s a t u r a b i l i t y  e x p e r i m e n t  f o r  r a t  b r a i n .
Volumes added ( u l )
Tube B u f f e r 100 uM [ 3 H]-QNB 10% T i s s u e T o ta l
No. (ml) A t r o p i n e 1 : 1 0 ,0 0 0
D i l u t i o n
Homogenate Volume
1 -2 1.85 20 25 100 1995
3-4 1.85 — 25 100 1975
5-6 1 .8 5 20 50 100 2020
7-8 1 .8 5 — 50 100 2000
9 -1 0 1 . 8 20 75 100 1995
1 1 -1 2 1 . 8 — 75 100 1975
13-14 1 .8 20 100 100 2020
15-16 1 .8 0 — 100 100 2000
17-18 1 .7 20 200 100 2020
19-20 1 .7 — 200 100 2000
2 1 -2 2 1 .5 20 400 100 2020
23 -24 1 .5 — 400 100 2000
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r e s p e c t i v e l y . $ - j x t r i a l s  were run f o r  both  r a t  and pony lung 
hom ogenate .
Drug I n h i b i t i o n  Curve E x p e r im e n t s
D i s p l a c e m e n t  o f  [ ^h]-QNB from m u s c a r i n i c  r e c e p t o r s  s i t e s  was 
d e t e r m in e d  u s i n g  t h e  p r o t o c o l  l i s t e d  in t a b l e s  3 a ,  3b,  and 3c,  t o  
g e n e r a t e  drug i n h i b i t i o n  cu r v e  (DIC) e x p e r i m e n t s .  From t h e s e  d a t a ,  t h e  
i n h i b i t o r y  c o n c e n t r a t i o n  f i f t y  or IC50 f o r  d i s p l a c e m e n t  of 50% o f  
t h e  s p e c i f i c a l l y  bound [3h]-QNB was d e t e r m in e d  f o r  i n d i v i d u a l  
m u s c a r i n i c  compounds and t h e  t o x i c a n t s  3MI and OAAP. DIC e x p e r i m e n t s  
were  a l s o  used to  d e t e r m i n e  t h e  Hi l l  c o e f f i c i e n t s  f o r  each drug or  
t o x i n .  Both t h e  IC5Q and Hi l l  c o e f f i c i e n t  v a lu e s  were c a l c u l a t e d  
f rom t h e  Hi l l  e q u a t i o n . H ?
109  (B ~B  '-El  = n 109 [L] “ 109 Kd'
'  max '
In  a d d i t i o n ,  t h e  c o n s t a n t  f o r  i n h i b i t i o n  of 50% o f  t h e  s p e c i f i c  b i n d in g  
( K - j )  f o r  each drug o r  t o x i c a n t  was c a l c u l a t e d  f o r  each d r u g /  t o x i n  
from t h e s e  d a t a  u s i n g  t h e  e q u a t i o n ,
1 + [L]/K[) •
DIC e x p e r i m e n t s  were run f o r  s i x  t r i a l s  in r a t  b r a i n ,  f o u r  t r i a l s  
in r a t  lung and two t r i a l s  in pony lu n g .  An e t h a n o l  DIC c o n t r o l  was run 
a c c o r d i n g  to  t h e  p r o t o c o l  in t a b l e  3b f o r  6 e x p e r i m e n t s .
Sample Coun t in g
R a d i o a c t i v i t y  bound t o  f i l t e r s  was e x t r a c t e d  f o r  one hour  in  6 ml 
o f  Beckman Ready Solv  EP and co u n ted  f o r  5 m in u te s  in a Beckman LS-7500 
l i q u i d  s c i n t i l l a t i o n  s p e c t r o p h o t o m e t e r .  An e x t e r n a l  s t a n d a r d  wi th
T ab le  3a -  Design of drug i n h i b i t i o n  curve experim ents  fo r  r a t  and pony lung.
*2 0  1 of 100 M A tro p in e  was added to each of these tubes.
**A11 numbers in p a r e n t h e s e s  i n d i c a t e  molar  c o n c e n t r a t i o n s .
Volumes Added " ( u l )
Tube
No.
B u f f e r
(ml)
Lj h j - qnb
1 : 1 0 ,0 0 0
D i l u t i o n
T r i a l  1 
QNB
T r i a l  2 
Scopolamine
T r i a l  3 
A t r o p in e
T r i a l  4 
O x o t re m or in e
T r i a l  5 
A r e c o l i n e
10% T i s s u e  
Homogenate
1-3* 1.4 80 ul None None None None None 500
4 -6 1.4 80 20 _ . , 20 , 20 , 20 20
o
1 >♦ ( io - 7) ( i o - 7) ( 1 0 - 6 ) ( 1 0 - 6 )
7 -9 1.4 80 20 O 20 c 20 c 20 20
( 1 0 “8 ) ( 10" 6 ) ( i o - 6) ( i o - 5) (1 0 - 5 )
1 0-12 1.4 80 20 _ 20 c 20 c 20 20
( l O ' 7 ) ( 10“ 5 ) ( i o - 5) ( I O " 4 ) (1 0 - 4 )
13-15 1.4 80 20 c 20 /, 20 „ 2 0  9 20
( I O " 6 ) ( 10- 4 ) ( io -4) ( I O " 3 ) ( I O ' 3 )
16-18 1.4 80 20 c 20 9 20 9 20 9 20 9
d o ' 5) ( io-3) ( 1 0“ 3 ) ( I O " 2 ) ( i o - 2)
19-21 1.4 80 20 /i 20 9 20 9 200  „ 200
d o -4) ( 10 ' 2 ) ( 10" 2 ) ( 10“ 2 ) ( io - 2)
22-24 1 .4 80 None None None None None
T a b le  3b -  Design o f  d ru g  i n h i b i t i o n  c u r v e  e x p e r i m e n t s  f o r  3MI and 
OAAP in  r a t  b r a i n .
*20 ul  o f  100 um A t r o p i n e  was added t o  ea ch  o f  t h e s e  t u b e s .
**A11 numbers i n  p a r e n t h e s e s  i n d i c a t e  m o l a r  (M) c o n c e n t r a t i o n s .






1 :1 0 ,0 0 0
D ilu tio n
T r ia l  1 
3MI
T r ia l  2 
OAAP




1-3* 1 .8 100 NONE NONE 100 NONE
4-b 1 .8 100 20
(10-5)**
20
( 1 C 5 )
100 20
(40X)
7-9 1 .8 100 20 a 




10-12 1 .8 100 20
(io-3) 20 ,  ( 1 C 3 )
100 20
(0.4X)






16-18 1 .8 100 20
( 1 C 1 )
20
( 1 C 1 )
100 20
(0.004X)
19-21 1 .8 100 200, 
( 1 C 1 )
200 
( 1 C 1 )
100 20
(0.0004X)
22-24 1 .8 100 NONE NONE 100 NONE
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T ab le  3c -  Design o f  d ru g i n h i b i t i o n  c u r v e  e x p e r i m e n t s  f o r  3MI and 
OAAP in  r a t  l u n g .
*20 ul o f  100 um A t r o p i n e  was added t o  each  o f  t h e s e  t u b e s .  
**Molar  c o n c e n t r a t i o n s  a r e  i d e n t i c a l  t o  t h o s e  i n  T a b l e  3b.
Volunes Added (u l)
Tube
No.
B u ffe r
(ml)
I3HJ-QNB 
1 :1 0 ,0 0 0  
Di 1u tio n
T r ia l  1 
3M1
T r ia l  2 
OAAP
10X t i s s u e  
Homoqenate
1-3* 1 .4 100 NONE NONE 500
4-6 1.4 100 20 20 500
7-9 1 .4 100 20 20 500
10-12 1.4 100 20 20 500
13-15 1 .4 100 20 20 500
16-18 1 .4 100 20 20 500
19-21 1 .4 100 20 20 500
22-24 1.4 100 NONE NONE 500
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a u t o m a t i c  quench c o r r e c t i o n  was used to  d e t e r m i n e  c o u n t i n g  e f f i c i e n c y  
and d i s i n t e g r a t i o n s  p e r  m in u te  p e r  fmole  (dpm s/fmole )  o f  [ 3 -QNB f o r  
each sample t u b e .  D u p l i c a t e  d i r e c t  c o u n t s  were t a k e n  to  d e t e r m in e  t h e  
a c t i v i t y  in c o u n t s  p e r  m i n u te  (cpm) o f  t h e  [^H]-QNB s t a n d a r d  
s o l u t i o n .
Sample q u e n c h in g  was c o r r e c t e d  u s i n g  [ ^ H ] t o l u e n e  and p y r i d i n e  as 
d e s i g n e d  by P e d i g o . ^ 8  C o u n t in g  e f f i c i e n c y  was 35 p e r c e n t .
The programmable  Beckman LS-7500 d e t e r m in e d  a n o r m a l i z a t i o n  f a c t o r  
which c a l c u l a t e d  t h e  dp m/fm oles  of  [^H]-QNB based upon i n p u t  of t h e  
r a d i o l i g a n d ' s  known s p e c i f i c  a c t i v i t y .  In c o m b in a t io n  wi th  t h e  
d e t e m i n a t i o n  of  e f f i c i e n c y ,  an a v e ra g e  sample dpm-norm al ized was p r i n t e d  
a s  fm oles  [3h]-QNB bound or  in s o l u t i o n  f o r  each t u b e .  Samples were 
run in t r i p l i c a t e  and each  s e t  o f  3 - i d e n t i c a l  t u b e s  was a v e r a g e d .  In 
a l l  c a s e s  s p e c i f i c  [^H]-QNB b i n d i n g  was c a l c u l a t e d  as t h e  d i f f e r e n c e  
between t h e  amount of b i n d i n g  in t h e  absence  and p r e s e n c e  o f  1 . 0  uM 
a t r o p i n e .
S t a t i s t i c a l  co m p a r i s o n s  were d e t e r m in e d  us in g  S t u d e n t ' s  t - t e s t  p<
0 . 0 5 . 79
RESULTS
S a t u r a b i l i t y  e x p e r i m e n t s
H y p e r b o l i c  s a t u r a t i o n  i s o t h e r m s  were p r e s e n t  f o r  both  r a t  and pony 
lung and r a t  b r a i n .  F i g u r e  1 r e p r e s e n t s  a t y p i c a l  s a t u r a t i o n  of 
s p e c i f i c  b i n d i n g  e x p e r i m e n t  f o r  pony and r a t  lung .  Values  f o r  each 
p o i n t  a r e  th e  means f o r  s i x  i n d i v i d u a l  e x p e r i m e n t s .  A s a t u r a t i o n  
i s o t h e r m  and l i n e a r  S c a t c h a r d  P l o t  ( r = 0 . 9 l )  were o b s e r v ed  f o r  r a t  b r a i n  
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F i g u r e  2 -  R e p r e s e n t a t i v e  e x p e r i m e n t  f o r  s p e c i f i c  b i n d i n g  o f  [ ^ h]-QNB 






















Rat and Pony Lung
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Figure 3 -  Scatchard P l o t  o f  [ 3 h]-QNB s a t u r a t i o n  b inding  in r a t  and 
pony lung.
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b i n d i n g  d a t a  f o r  r a t  and pony lung (n=6 ) .  These  f i g u r e s  show t h a t  
s p e c i f i c  b i n d i n g  in r a t  and pony lung and r a t  b r a i n  t i s s u e  homogenates 
was s a t u r a b l e .
The S c a t c h a r d  p l o t s  in F i g u r e s  2 and 3 were  used to  o b t a i n  
t h e  d i s s o c i a t i o n  c o n s t a n t  (K[>a p p ) and r e c e p t o r  d e n s i t y  
(Bmax) f ° r  r a t  and Pony lung as l i s t e d  in T a b le  4 .  Mean 
KD a p p ' s f o r  r a t  and Pony lung were 3 9 .8 5  and 28 .08  pM 
r e s p e c t i v e l y .  KQapp f o r  r a t  b r a i n  was 2 8 . 8  pM. Mean Bmax 
was 7 4 . 3  fmoles /mg p r o t e i n  f o r  r a t  lung homogenate and 7 7 . 9  fmoles /mg 
t i s s u e  f o r  r a t  b r a i n .  No s t a t i s t i c a l l y  s i g n i f i c a n t  d i f f e r e n c e  in 
l<Dapp o r  Bmax was o b s e r v e d  between r a t  and pony lung
m u s c a r i n i c  r e c e p t o r s .
Drug I n h i b i t i o n  E x p e r im e n t s
F i g u r e s  4 ,  5 ,  and 6 a r e  drug i n h i b i t i o n  cu r v e s  f o r  pony lung and 
r a t  l u n g ,  and r a t  b r a i n  r e s p e c t i v e l y  u s in g  v a r i o u s  m u s c a r i n i c  r e c e p t o r  
a n t a g o n i s t s  and a g o n i s t , w i t h  t h e  a d d i t i o n  of  and 3MI and OAAP t o  r a t  
lung and b r a i n .  The c u r v e s  in F i g u r e  4 (pony lung)  and 6 ( r a t  b r a i n )  
a r e  r e p r e s e n t a t i v e  of  t o t a l  bound [^H]-QNB f o r  compar i son  to  F i g u r e s  5 
( r a t  lung )  which d e p i c t s  s p e c i f i c  bound [^H]-QNB. N o n - s p e c i f i c  
b i n d i n g  in pony lung as shown in F i g u r e  4 was 50% or  more of t o t a l  
b i n d i n g .  In c o n t r a s t ,  n o n - s p e c i f i c  b i n d i n g  in r a t  b r a i n  ( F i g u r e  6 ) was 
l e s s  t h a n  10% of t o t a l  b i n d i n g .  F i g u r e  7 d e p i c t s  t h e  e f f e c t  of v a r i o u s  
c o n c e n t r a t i o n  of  e t h a n o l  in d i s p l a c i n g  s p e c i f i c  bound [^h]-QNB from 
m u s c a r i n i c  r e c e p t o r  s i t e s .
The IC50  v a l u e s  f o r  t h e  DIC p l o t s  in F i g u r e s  5 f o r  r a t  lung and 
6 f o r  r a t  b r a i n  a r e  l i s t e d  i n  T a b l e  5.  These v a l u e s  r e p r e s e n t  p o t e n c y
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T ab le  4 -  D i s s o c i a t i o n  c o n s t a n t s  (KQa p p ) and r e l a t i v e  
c o n c e n t r a t i o n  of  r e c e p t o r s  (Bmax) in  r a t  lung ,  pony lu n g ,  and r a t  
b r a i n . 17 Kgapp and Bmax v a l u e s  f o r  r a t  b r a i n  
d e t e r m in e d  by t h i s  e x p e r i m e n t .
(PM) Bmax Bmax
( fmo les /m g  t i s s u e  p r o t e i n )  ( fmoles /mq t i s s u e )
Rat  Lung 
Pony Lung 
Rat  B ra in
3 9 . 6 3 + 5 .8 9  6 6 . 3 + 8 .7 4  1 0 .58+ 0 .6 3
2 8 .0 8 + 5 .7 9  8 1 .2 + 0 .0 0 9 6  5 .7 7 + 0 .6 6 7
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F i g u r e  4 -  Drug i n h i b i t i o n  c u r v e  o f  t o t a l  [ 3 H]-QNB b i n d i n g  in  pony 
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F i g u r e  5 -  Drug i n h i b i t i o n  c u r v e  o f  t o t a l  [ 3 h]-QNB b i n d i n g  in  r a t  lung 
t i s s u e  homogena te s  w i t h  m u s c a r i n i c  a n t a g o n i s t s ,  a g o n i s t s ,  and t h e  


































-2-3-4-5-8-9 -7-1 1 - 1 0
Log (M) Drug Concentration
F i g u r e  6 -  Drug i n h i b i t i o n  c u r v e s  o f  t o t a l  [3h]-QNB b i n d i n g  in  r a t  
b r a i n  homogenate  w i t h  m u s c a r i n i c  a n t a g o n i s t ,  a g o n i s t ,  and t h e  s u s p e c t e d  
t o x i c a n t s  3MI and OAAP. The l e v e l  o f  n o n - s p e c i f i c  b i n d i n g  in r a t  b r a i n  
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Figure  7 -  Drug i n h i b i t i o n  curve for  100% eth anol  in c o n c e n tr a t io n s  from 
0 .0 0 0 4  t o  40% in  d e i o n iz e d  -  d i s t i l l e d  water on binding  o f  [ 3 h]-QNB in 
r a t  brain  homogenates c o n t a in i n g  muscarin ic  r e c e p t o r s .
T a b le  5 -  IC50  v a l u e s  f o r  d r u g s  t h a t  i n h i b i t e d  s p e c i f i c  [ 3H]-QNB 
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o f  m u s c a r i n i c  a n t a g o n i s t s ,  a g o n i s t s ,  3MI and OAAP in  d i s p l a c i n g  
[^H]-QNB from t h e  m u s c a r i n i c  r e c e p t o r  b i n d i n g  s i t e .  The a n t a g o n i s t s  
QNB and s c o p o la m in e  i n h i b i t e d  50% of t h e  s p e c i f i c  b i n d i n g  in t h e  
nanom olar  c o n c e n t r a t i o n  r a n g e .  The a g o n i s t s  o x o t r e m o r i n e  and a r e c o l i n e  
i n h i b i t e d  b i n d i n g  by 50% a t  m ic rom ola r  c o n c e n t r a t i o n s .  3MI and OAAP a r e  
a p p r o x i m a t e l y  1 0 , 0 0 0  t i m e s  l e s s  p o t e n t  th an  o x o t r e m o r i n e  wi th  i n h i b i t o r y  
c o n c e n t r a t i o n  f i f t i e s  in t h e  m i l l i m o l a r  r a n g e .
H i l l  c o e f f i c i e n t s  f o r  t h e  m u s c a r i n i c  a n t a g o n i s t s ,  a g o n i s t s ,  3MI and 
OAAP a r e  l i s t e d  in  T ab le  6 . Al l  v a l u e s  f o r  r a t  lung a r e  n e a r  u n i t y ;  
i n d i c a t i n g ,  no c o o p e r a t i v e  b i n d i n g  between t h e  r e c e p t o r  and l i g a n d .  
C o e f f i c i e n t s  f o r  3MI and OAAP in r a t  b r a i n  a r e  - 1 . 6 3  _+ 0 . 3 4 5  and - 1 . 8 7  
+ 0 . 2 9 ;  r e s p e c t i v e l y .
DISCUSSION
Three  i m p o r t a n t  c r i t e r i a  a r e  r e q u i r e d  to  e s t a b l i s h  t h e  p r e s e n c e  o f  
s p e c i f i c  r e c e p t o r  b i n d i n g  in a t i s s u e .  They a r e :  1) d e t e r m i n a t i o n  of a
s a t u r a b l e  p o p u l a t i o n  o r  r e c e p t o r  s i t e s ,  2 ) d e t e r m i n a t i o n  of h ig h  
a f f i n i t y  d i s s o c i a t i o n  c o n s t a n t ,  Kpapp ,  and 3) p h a r m a c o l o g i c a l  
s p e c i f i c i t y .116 j n a d d i t i o n ,  p h y s i o l o g i c a l  r e c e p t o r s  sh ou ld  e x h i b i t  
s t e r e o s e l e c t i v i t y  in b i n d i n g .
The high  a f f i n i t y  m u s c a r i n i c  a n t a g o n i s t  [ 3 h]-QNB b i n d s  cr u d e  
lung ( r a t  and pony) and b r a i n  membrane homogenates  w i th  s p e c i f i c i t y  and 
s a t u r a b i 1i t y .  B ind in g  of  r a d i o l a b e l e d  QNB was r e v e r s i b l e  and e x h i b i t e d  
h igh a f f i n i t y  a t  c o n c e n t r a t i o n s  f rom 0 t o  500 pM and g r e a t e r .  The 
s a t u r a t i o n  i s o t h e r m s  and monophasic  d i s p l a c e m e n t  c u r v e s  e s t a b l i s h e d  th e  
p r e s e n c e  of  a s i n g l e  p o p u l a t i o n  of  s a t u r a b l e  s i t e s  in both  r a t  and pony
T a b l e  6 -  H i l l  c o e f f i c i e n t s  f o r  m u s c a r i n i c  a n t a g o n i s t s ,  a g o n i s t s  and 
s u s p e c t e d  t o x i c a n t s  3MI and OAAP in  r a t  lung and b r a i n  ho m ogen at es .
Rat  Lung N Rat B ra in  N
QNB - 0 . 8 6 + 0 . 0 3 4 - 0 . 7 8 + 0 . 0 8  6
A t r o p i n e - 0 . 9 2 + 0 . 0 7 4 n o t  d e t e r m in e d
O x o t re m o r in e - 0 . 7 1 + 0 . 0 5 4 - 0 . 8 0 + 0 . 0 7  6
3MI - 0 . 7 3 + 0 . 1 1 3 - 1 . 6 3 + 0 . 3 4  6
OAAP - 0 . 9 5 + 0 . 0 4 4 - 1 . 8 7 + 0 . 2 9  6
lung and f o r  r a t  b r a i n .  The a p p a r e n t  d i s s o c i a t i o n  c o n s t a n t s  
(Kpapp) f o r  QNB in t h e s e  c r u d e  membranes r e c e p t o r  homogenates 
were  s i m i l a r  t o  t h o s e  found in o t h e r  t i s s u e s .  M u s c a r i n i c  a n t a g o n i s t s ,  
a g o n i s t s  and t h e  t o x i c a n t s  3MI and OAAP d i s p l a c e d  [^H]-QNB from 
m u s c a r i n i c  r e c e p t o r  s i t e s  in r a t  lung and b r a i n  t i s s u e  p r e p a r a t i o n s .  
M u s c a r i n i c  a g o n i s t s  and a n t a g o n i s t s  have a f f i n i t i e s  f o r  m u s c a r i n i c  s i t e s  
in r a t  lung and b r a i n ,  and pony lung as l i s t e d  in T ab le  5 and F i g u r e s  4 ,  
5 ,  and 6 . The o r d e r  of  p o t e n c i e s  f o r  d i s p l a c e m e n t  of r a d i o l i g a n d  was 
QNB > s c o p o l a m i n e  > a t r o p i n e  > o x o t r e m o r i n e  > a r e c o l i n e  > 3MI and OAAP. 
The m u s c a r i n i c  a g o n i s t s  o x o t r e m o r i n e  and a r e c o l i n e  a r e  l e s s  p o t e n t  t h a n  
t h e  a n t a g o n i s t s  QNB, s co p o l a m i n e  and a t r o p i n e  as l i s t e d  in  T a b l e  5.
When compared,  QNB i s  a p p r o x i m a t e l y  16 m i l l i o n  t im es  more p o t e n t  t h a n  
OAAP a t  d i s p l a c i n g  50% o f  t h e  s p e c i f i c a l l y  bound [ 3 h]-QNB.
F i g u r e s  8 and 9 d e p i c t  c o m p ar i so n s  of b i n d i n g  p o t e n c i e s  between 
QNB, o x o t r e m o r i n e  and o t h e r  m u s c a r i n i c  a n t a g o n i s t s  and a g o n i s t s  to  3MI 
and OAAP in r a t  lung and b r a i n  membrane hom ogenates .  The s l o p e  of t h e s e  
l i n e s  were 0 . 9 1  and 1 . 0 6 ;  i n d i c a t i n g ,  a s i m i l a r i t y  in b in d in g  f o r  t h e s e  
d rugs  between lung and b r a i n  r e c e p to r - m e m b r a n e  ho mogena te s .  T h i s  
s i m i l a r i t y  i s  c o n s i s t e n t  w i th  t h e  o b s e r v a t i o n  t h a t  m u s c a r i n i c  r e c e p t o r s  
in r a t  lung and b r a i n  a r e  i d e n t i c a l .  T h e r e f o r e ,  i t  i s  s u g g e s t e d  t h a t  
3MI and OAAP b in d  s i m i l a r  r e c e p t o r s  in r a t  lung and b r a i n  and t h a t  t h e s e  
r e c e p t o r s  a r e  presumed to  be of  t h e  m u s c a r i n i c  type  based upon t h e  d a t a  
f rom t h i s  e x p e r i m e n t .
The H i l l  e q u a t i o n  was used to  d e t e r m i n e  t h e  p r e s e n c e  of  s igmoid 
k i n e t i c s  (% bound vs l i g a n d  c o n c e n t r a t i o n ) .  Sigmoid k i n e t i c s  i n d i c a t e s  
t h e  p r e s e n c e  of  m u l t i p l e  i n t e r a c t i n g  b i n d i n g  s i t e s  f o r  a l i g a n d  on a
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Figure 8  -  Comparisons o f  the r e l a t i v e  binding  p o t e n c ie s  o f  muscar inic  
agents  QNB and oxotremor ine  with 3MI and OAAP fo r  whole r a t  f ore b r a in  
( o r d in a t e )  and r a t  lung ( a b s c i s s a )  homogenates by p l o t t i n g  -  log  
IC5 Q' s o f  each drug (r = 0 . 9 9 ) .  The s lo p e  was 1 .0 6 ,  i n d i c a t i n g  
s i m i l a r  p o t e n c i e s  o f  t h e s e  drugs fo r  muscarin ic  r e c e p t o r s  in r a t  brain  
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F i g u r e  9 -  C o m p ar i so n s  o f  t h e  r e l a t i v e  b i n d i n g  p o t e n c i e s  a s  l og  
IC50  f o r  m u s c a r i n i c  a n t a g o n i s t s ,  a g o n i s t s ,  3MI and OAAP i n  r a t  l u n g  
f r o m  t h i s  e x p e r i m e n t  t o  t h e i r  r e p o r t e d  v a l u e s  i n  r a t  b r a i n  f o r  a r e c o l i n e  
(AREC), o x o t r e m o r i n e  ( o x o ) ,  a t r o p i n e  (ATR),  s c o p o l a m i n e  (SCOP) and QNB. 
The s l o p e  was 0 . 9 2 ,  i n d i c a t i n g  s i m i l a r  p o t e n c i e s  o f  t h e s e  d r u g s  f o r  
m u s c a r i n i c  r e c e p t o r s  in  r a t  l u n g  and r a t  b r a i n .
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r e c e p t o r .  B ind in g  a t  one s i t e  may a f f e c t  s u b s e q u e n t  b i n d i n g s  a t  
a d j a c e n t  s i t e s . T h e  H i l l  c o e f f i c i e n t  (n)  r e p r e s e n t s  an e m p i r i c a l  
p a r a m e t e r  whose v a l u e  depends  upon t h e  number of i n t e r a c t i n g  b i n d i n g  
s i t e s  on a r e c e p t o r .
The H i l l  c o e f f i c i e n t s  of  3MI and OAAP in  r a t  b r a i n  a r e  - 1 . 6 3  and 
- 1 . 8 7 ;  r e s p e c t i v e l y  ( T a b l e  6 ) .  T h i s  s u g g e s t s  t h a t  b i n d i n g  o f  3MI and 
OAAP t o  m u s c a r i n i c  r e c e p t o r s  of  r a t  b r a i n  p o s s i b l y  d i s p l a y e d  n e g a t i v e  
c o o p e r a t i v i t y .  Here ,  t h e  i n i t i a l  b i n d i n g  o f  3MI o r  OAAP d e c r e a s e s  t h e  
a f f i n i t y  f o r  s u b s e q u e n t  b i n d i n g s  on t h e  same r e c e p t o r .  In c o n t r a s t ,  
b i n d i n g  c o e f f i c i e n t s  f o r  r a t  lung a r e  a p p r o x i m a t e l y  u n i t y ;  i n d i c a t i n g ,  
no c o o p e r a t i v i t y .
Kj i s  t h e  b i n d i n g  a f f i n i t y  c o n s t a n t  f o r  50% d i s p l a c e m e n t  by 
u n l a b e l e d  l i g a n d ,  and i s  r e p r e s e n t a t i v e  of t h e  p h a r m a c o l o g i c a l  p o t e n c i e s  
f o r  m u s c a r i n i c  a g o n i s t s  and a n t a g o n i s t s .  The K ■ s o f  3MI and OAAP 
were compared to  o t h e r  d ru g s  which bind c h o l i n e r g i c  ( m u s c a r i n i c )  
r e c e p t o r s  in c a r d i a c  t i s s u e  ( T a b le s  7 and 8 ) . 1 0 9  I m ip ram in e ,  an 
a n t i d e p r e s s a n t  w i th  a n t i c h o l i n g e r i c  p r o p e r t i e s  i s  a p p r o x i m a t e l y  4 ,000  
t i m e s  more p o t e n t  th an  OAAP a t  b i n d i n g  m u s c a r i n i c  r e c e p t o r s .
P ro c a in a m id e  is  an a n t i a r r h y t h m i c  ag en t  w i th  weak a n t i c h o l i n g e r i c  and 
g a n g l i o n i c  b l o c k i n g  p r o p e r t i e s  s i m i l a r  t o  q u i n i d i n e .  Thi s  drug was 
a p p r o x i m a t e l y  10 t i m e s  more p o t e n t  t h a n  3MI and OAAP.
C h o l in e  i s  a p r e c u r s o r  in t h e  s y n t h e s i s  of a c e t y l c h o l i n e ,  has t h e  
same p h a r m a c o l o g i c a l  f u n c t i o n s  as a c e t y l c h o l i n e ;  but  a p p r o x i m a t e l y  
1 / 6 0 , 0 0 0 th  t h e  p o t e n c y  in v i t r o .  When t h e  EDs q ' s ° f  c h o l i n e  and 
o x o t r e m o r i n e ,  which r e p r e s e n t s  t h e  p h a r m a c o l o g i c a l  v a l u e  f o r  e f f e c t i v e  
d o se  c o r r e s p o n d i n g  to  h a l f - m a x i m a l  r e c e p t o r  o c c u p a t i o n  and is
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T ab le  7 -  K-j v a l u e s  f o r  m u s c a r i n i c  a n t a g o n i s t s ,  a g o n i s t s  and t h e  
s u s p e c t e d  t o x i n s  3MI and OAAP in  r a t  lung ho m ogen at es .
QNB
Scopolamine
A t r o p i n e
Oxot remor i  ne
A r e c o l i n e
3MI
OAAP
K-j i n  r a t  lung




3 0 30 .0
0 .4 6 9  mM
0 .6 3 8  mM
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T ab le  8  -  K-j v a l u e s  f o r  d r u g s  w i th  m u s c a r i n i c  r e c e p t o r  b i n d i n g  
p r o p e r t i e s  in  r a b b i t  h e a r t  h o m o g e n a t e s .22 3MI and OAAP a r e  l i s t e d  
f o r  co m p a r i so n  p u r p o s e s .
Ki
Im ip ramine 0 .1 7  uM
C h lo rp ro m az in e 0 .1 7
D ro p e r i d o l 1 .57
Qu i n i  d i n e 2 . 0
S p i r o p e r i d o l 3 .2
L i d o c a i n e 18
H a l o p e r i d o l 28
P ro c a in a m id e 48
3MI ( r a t  lung ) 469
OAAP ( r a t  lung) 638
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a p p r o x i m a t e l y  e q u i v l e n t  t o  t h e  IC50  o f  a d r u g ,  were compared to  t h e  
IC5 0 ' s 3MI, and OAAP; 3MI and OAAP have a p p r o x i m a t e l y  12
t i m e s  more b i n d i n g  p o t e n c y  f o r  m u s c a r i n i c  r e c e p t o r  s i t e s  t h an  c h o l i n e  
and 1 / 5 , 0 0 0 th  t h a t  of  o x o t r e m o r i n e .  As a co m p a r i s o n ,  o x o t r e m o r i n e  has 
an ED50  f i v e  t im e s  more p o t e n t  t h an  a c e t y l c h o l i n e  making t h e  p o t e n c y  
o f  3MI and OAAP a p p r o x i m a t e l y  1 / 1 0 0 0 th  t h a t  of a c e t y l c h o l i n e .
Both 3MI and OAAP b in d  to  m u s c a r i n i c  r e c e p t o r s  in c rude  r a t  lung 
and b r a i n  membranes homogena te s  w i th  low a f f i n i t y  and p o t e n c y .  These  
c h e m i c a l s  d i s p l a c e  [^H]-QNB by 50% a t  t h e  m i l l i m o l a r  l e v e l .  F i f t y  
p e r c e n t  d i s p l a c e m e n t  f o r  3MI and OAAP o c c u r r e d  0 . 4 6 9  and 0 .6 3 8  mM; 
r e s p e c t i v e l y .  T h i s  c o r r e s p o n d s  t o  a b i o p h a s e  c o n c e n t r a t i o n  of  6 1 .4  
ug/ml f o r  3MI and 8 7 . 4  ug/ml f o r  OAAP. At t h i s  c o n c e n t r a t i o n ,  3MI i s  
o n l y  s p a r i n g l y  s o l u b l e  in  p h y s i o l o g i c a l  f l u i d .  T h e r e f o r e ,  i s  u n l i k e l y  
t h a t  t h e  mechanism of t o x i c i t y  f o r  3MI and OAAP was t h e  r e s u l t  of d i r e c t  
s t i m u l a t i o n  from a g o n i s t - t y p e  b i n d i n g  o f  m u s c a r i n i c  r e c e p t o r s  in  lung .  
However,  t h e  a b i l i t y  o f  3MI and OAAP to  d i s p l a c e  r a d i o l a b e l e d  
[3h]-QNB from c h o l i n g e r i c  b i n d i n g  s i t e s  may s u g g e s t  an a l t e r n a t e  
i n d i r e c t  mechanism which may r e s u l t  in s t i m u l a t i o n  of m u s c a r i n i c  
r e c e p t o r s  in t h e  l u n g .  I n h i b i t i o n  of  a c e t y l c h o l i n e s t e r a s e  ( A C h E )  by 3MI 
and OAAP i s  one p o s s i b l e  mechanism.  In s u p p o r t  of t h i s  mechanism,  a 
p h o t o l y s i s  p r o d u c t  of  t h e  i n d o l e  5 - h y d r o x y t r y p t a m i n e  was r e p o r t e d  t o  
i n h i b i t  A C h E . 122 i t  i s  c o n c e i v a b l e  t h a t  OAAP o r  a n o t h e r  m e t a b o l i t e  
o f  3MI may be an A C h E  i n h i b i t o r .  The r e l a t i o n s h i p  between t h e  
a c e t y l c h o l i n e  r e c e p t o r  t o  t h e  membrane e n v i r o n m e n t ,  and t h e  s t r u c t u r a l  
i n t e g r i t y  of t h i s  membrane u n i t  may i n f l u e n c e  r e c e p t o r  b i n d i n g  
a f f i n i t i e s  and p h y s i o l o g i c a l  a c t i v i t y .  I f  3MI o r  i t s  t o x i c  m e t a b o l i t e s
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a f f e c t  membrane s t r u c t u r a l  i n t e g r i t y  and f u n c t i o n  in a dose  dep enden t  
f a s h i o n ,  t h e  d i s p l a c e m e n t  of bound [ 3 h]-QNB from m u s c a r i n i c  s i t e s  may 
o c c u r .
R ece n t  s t u d i e s  have found an i n t e r a c t i o n  between membrane bound 
r a b i e s  v i r u s e s  w i th  a c e t y l c h o l i n e  r e c e p t o r s  in t h e  CNS.123 Many of 
t h e  i n i t i a l  s i g n s  of  r a b i e s  a r e  c o n s i s t e n t  w i th  s t i m u l a t i o n  of  
c h o l i n e r g i c  r e c e p t o r s .  Such s i g n s  as e x c e s s i v e  s a l i v a t i o n ,  
u n c o n t r o l l a b l e  e x c i t e m e n t ,  m uscl e  spasms and r e s p i r a t o r y  d i s t r e s s  can be 
ca u s e d  by s t i m u l a t i o n  of  m u s c a r i n i c - c h o l i n e r g i c  r e c e p t o r s .  I t  i s  
p o s s i b l e  t h a t  3MI c a u s e s  an a l t e r a t i o n  in membrane p r o p e r t i e s  of  t h e  
a s s o c i a t e d  m u s c a r i n i c  r e c e p t o r s  which r e s u l t s  in s t i m u l a t i o n  of t h e s e  
r e c e p t o r s  by a mechanism somewhat s i m i l a r  to  i n f e c t i o n  by r a b i e s  v i r u s .
I t  i s  a l s o  p o s s i b l e  t h a t  3MI o r  OAAP may a l t e r  t h e  s e n s i t i v i t y  of
m u s c a r i n i c  r e c e p t o r s  by a f f e c t i n g  t h e  s e n s i t i v i t y  of  an a s s o c i a t e d
r e c e p t o r  or membrane bound m ac rom ole cu le  which c o n t r o l s  r e s p o n s e  to
a c e t y l c h o l i n e .  R e c e n t l y  j u s t  such a mechanism has  been d e s c r i b e d  f o r
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v a s o a c t i v e  i n t e s t i n a l  p o l y p e p t i d e  (VIP) and m u s c a r i n i c  r e c e p t o r s .  In 
t h i s  e x p e r i m e n t ,  s u p e r s e n s i t i v i t y  o f  VIP r e c e p t o r s  in r a t  s a l i v a r y  g l a n d  
was induced  by l o n g - t e r m  p r e t r e a t m e n t  w i th  t h e  m u s c a r i n i c  a n t a g o n i s t  
a t r o p i n e .  The r o l e  o f  3MI and i t s  m e t a b o l i t e s  in a l t e r i n g  m u s c a r i n i c  
r e c e p t o r  s e n s i t i v i t i e s  t o  endogenous  a c e t y l c h o l i n e  r e l e a s e  r e q u i r e s  
f u r t h e r  e x a m i n a t i o n .
The o b s e r v a t i o n  t h a t  unchanged 3 - m e t h y l i n d o l e  does not  p a r t i t i o n  
and ac c u m u la t e  in lung membranes w h i l e  t h e  m e t a b o l i t e s  o f  3MI a c c u m u la t e  
i n  goa t  l u n g , 8 ? s u g g e s t s  t h a t  t h e  m e t a b o l i t e s  and no t  3MI a l o n e  a r e  
p o s s i b l y  r e s p o n s i b l e  f o r  a l t e r i n g  r e c e p t o r s  o r  membranes in c l o s e
a s s o c i a t i o n  w i th  a c e t y l c h o l i n e  r e c e p t o r s .  I f  m e t a b o l i t e s  l i k e  OAAP 
a l t e r  t h e  membrane or r e c e p t o r  en v i ro n m en t  a s s o c i a t e d  wi th  r e g u l a t i o n  of 
c h o l i n e r g i c  r e c e p t o r  f u n c t i o n ,  t h e  r e s u l t i n g  cha ng es  in r e c e p t o r  
s e n s i t i v i t y  co u ld  i n c r e a s e  ion c o n d u c ta n c e s  which ca us e  s t i m u l a t i o n  of 
m u s c a r i n i c  r e c e p t o r s  o f  t h e  l ung .  D e p o l a r i z a t i o n  o f  t h e  p o s t - s y n a p t i c  
membranes of  a i rw ay  smooth muscle  c e l l s  would cause  an i n i t i a l  change in  
pulmona ry  dynamic f u n c t i o n  s i m i l a r  t o  t h a t  seen d u r i n g  m u s c a r i n i c  
r e c e p t o r  s t i m u l a t i o n  and s i m i l a r  t o  t h o s e  changes  d e s c r i b e d  f o r  low dose 
3M I- indu ced  p n e u m o t o x i c o s i s .  In a d d i t i o n ,  m u s c a r i n i c  r e c e p t o r s  
a s s o c i a t e d  w i th  b a s o p h i l s  and mast  c e l l s  may be a l t e r e d  by 3MI o r  i t s  
m e t a b o l i t e  which in t u r n  c a u s e s  r e l e a s e  of  b r o n c h o a c t i v e  m e d i a t o r s  
c a p a b l e  of e l i c i t i n g  a r e v e r s i b l e  c o n t r a c t i o n  of a i rw ay  smooth m u s c le .
PHARMACOKINETIC GLOSSARY
i s  t h e  h y b r i d  r a t e  c o n s t a n t  r e p r e s e n t i n g  e l i m i n a t i o n  o f  
unchanged drug by e x c r e t i o n  a n d / o r  m e tab o l i s m  from t h e  
s y s t e m i c  c i r c u l a t i o n .
i s  t h e  h a l f  l i f e  o f  e l i m i n a t i o n  c a l c u l a t e d  by t h e  e q u a t i o n :  
t 1 /2p = 0 . 6 9 3 / B
i s  t h e  p o s t - a b s o r b t i o n  d i s t r i b u t i o n  h y b r i d  r a t e  c o n s t a n t .
i s  t h e  h a l f  l i f e  f o r  d i s t r i b u t i o n  o f  unchanged drug from t h e  
s y s t e m i c  c i r c u l a t i o n .
t l / 2a  = ° - 693/ a
i s  t h e  e l i m i n a t i o n  r a t e  c o n s t a n t  from t h e  c e n t r a l  
com par tm en t .
a b s o r p t i o n  r a t e  c o n s t a n t ,  
a b s o r p t i o n  h a l f - l i f e  e q u a l s  o 693/K
a
i s  t h e  d i s t r i b u t i o n  r a t e  c o n s t a n t  f o r  t r a n s f e r  o f  drug from 
t h e  c e n t r a l  compar tmen t  t o  p e r i p h e r a l  com par tmen t .
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K21 i s  t h e  d i s t r i b u t i o n  r a t e  c o n s t a n t  f o r  t r a n s f e r  o f  drug from
t h e  p e r i p h e r a l  compar tment  t o  c e n t r a l  co m par tm e n t .
Co i s  t h e  drug c o n c e n t r a t i o n  a t  t i m e  z e r o .
lag  t i m e  i s  t h e  t im e  f rom a d m i n i s t r a t i o n  f o r  f i r s t  a p p e a ra n c e  of  drug
in t h e  c e n t r a l  co m par tm e n t .
?
r  i s  t h e  c o r r e l a t i o n  c o e f f i c i e n t .
Do i s  t h e  a v e r a g e  do se  in  grams a d m i n i s t e r e d .
C i s  t h e  maximum c o n c e n t r a t i o n  a c h ie v e d  in  t h e  c e n t r a lpmax
c o m p a r t m e n t .
Viax is the time t0 reach CPmax‘
AUC^" ^ ( a r e a s  under  t h e  c u r v e )  i s  t h e  i n t e g r a l  o f  drug blood  l e v e l
ov e r  t im e  f rom 0 t o  48 ho ur s  a f t e r  d o s in g  and i s  a measure  o f  
q u a n t i t y  o f  drug a b s o r b ed  and p r e s e n t  in t h e  body.
FDo/Vd i s  a r a t e  i n d e p e n d e n t  measure  o f  t h e  a v a i l a b i l i t y  o f  a drug t o  
t h e  body.
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FDo/Vc i s  a r a t e  i n d e p e n d e n t  measure  o f  t h e  a v a i l a b i l i t y  o f  a drug 
t o  t h e  c e n t r a l  co m par tm en t .
Cl r e p r e s e n t s  t o t a l  c l e a r a n c e  and i s  d e t e r m in e d  from t h e
e q u a t i o n :
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